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SUMMARY 
 
Dementia is a highly debilitating disease that is growing in the world 
because of the progressive aging of the population. Dementia affects more 
than 25 million people in the world, with around 5 million new cases 
occurring every year (Brookmeyer et al., 2007). It has been estimated 
that 26% of women and 21% of men over 85 years of age suffer from several 
types of dementia, of which approximately 70% are of Alzheimer‟s type 
(Qui et al., 2009). The prevalence of dementia worldwide was estimated to 
be 3.9 in the elderly population over 65 years of age (Ferri et al., 
2005). The pooled data of population-based studies in Europe suggests 
that the prevalence of Alzheimer’s Disease (AD) in people  over 65 years 
of age is 6.4% (Lobo et al., 2000) for dementia and 4.4% while the pooled 
incidence rate for AD is 19.4 per 1000 person-years (Fratiglioni et al., 
2000).   
  
Dementia currently represents a social and health emergency because of 
clinical features of the disease (progressive disability, severe 
cognitive impairment, and behavioural disturbances), economic 
implications (impact on the Welfare State), and human costs of patients 
and caregivers. Thus, the boundary state between normal aging and early 
insanity is an area of research interest for both clinical-diagnostic and 
therapeutic-rehabilitative reasons.   
 
Literature presents many attempts to classify slight cognitive impairment 
in order to distinguish between physiological and pathological aging. The 
concept of slight cognitive impairment in aging appears confused with 
dementia until Kral (1962), who described senescent forgetfulness by 
distinguishing a physiological cognitive decline due to aging (“Benign 
Senescent Forgetfulness”) from a pathological cognitive decline 
(“Malignant Senescent Forgetfulness” or  “Amnestic Syndrome”) apt to 
convert into dementia. After Kral, several studies provided different 
classifications of slight cognitive impairment but they did not 
completely describe its clinical features. In 1995, Petersen et al. 
defined the primary diagnostic criteria for Mild Cognitive Impairment 
(MCI) that were subsequently reviewed (Petersen et al., 1999). In order 
to specify MCI subtypes, Petersen (2004) proposed a new classification 
model. 
 
Mild Cognitive Impairment refers to the clinical condition in which 
individuals show a slight cognitive impairment not severe enough to 
satisfy dementia diagnostic criteria but greater than expected for age 
and schooling, without notable interference in daily life activities. It 
represents the most valuable nosological entity currently adopted by 
clinicians to diagnose a specific form of slight cognitive impairment, 
believed to be a high-risk condition for developing dementia (especially 
Alzheimer‟s Disease) (AD). However, researchers have severely criticized 
MCI for its marked inaccuracy for both theoretical and clinical reasons 
(Chertkow et al., 2008). Clinical research did not completely describe 
the neuropsychological features of MCI and its subtypes, and it did not 
provide characteristic markers to predict dementia, except those related 
to memory decline (Perri et al., 2005; 2007).   
 
Starting from this assumption, the research project aims at: 
1. describing the historical and conceptual course of mild cognitive 
impairment and its associated clinical entities; 
2. critically analyzing psychodiagnostic procedures and psychometric 
rules commonly used for diagnosis; 
3. pointing out the potential role of cognitive Activation Therapy (AT) 
for MCI subjects in delaying dementia onset;     
4. estimating the proportion and defining the different 
neuropsychological profiles of each MCI subtype; 
5. investigating the possibility to find neuropsychological markers apt 
to predict dementia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. THE AGING PROCESS AMONG NORMALITY AND PATHOLOGY 
 
1.1 AGING AND SUCCESSFUL AGING 
 
From a biological perspective aging can be defined as a deterioration of 
a mature organism, a time-dependent and irreversible changing of each 
member of species that is unable to respond to environmental stress with 
more probabilities of dying (Hander, 1960). This deterioration is due to 
the action of several genes (from 7 to 10 thousand) that affects some 
aspects of the aging rhythm
1
 (Austad, 1997).  In the course of  the 
historical development of biology, scientists have suggested three causal 
theories of aging to allow a plausible explanation of “why we age”: 
- the theory of good for the species; 
- the theory of rhythm of life; 
- the evolutional theory of aging. 
The theory of good for species was based on the erroneous belief that 
ubiquitous phenomena such as the aging of the species, should have some 
evolutionary advantages. If aging did not exist, there would not be a 
generational change apt to favor a better adaptation to the environment.  
The  “theory of life rhythm” stated that  metabolism regulates aging and 
lifespan. The oxidative metabolism produces highly reactive radicals that 
damage proteins and DNA. The oxidants could be involved in many 
degenerative changes that characterize aging, such as atherosclerosis, 
rheumatoid arthritis, cataracts, cardiovascular disease, senile dementia 
and cancer (Knight, 2000). Within the evolutionary theories of aging 
(Kitwood and Austad, 2000) it has been suggested that the force of 
natural selection declines with age. Since all organisms eventually die 
of disease, accidents or predations, genes beneficial early in life are 
favored by natural selection over the genes beneficial later in life
2
. In 
                                                        
1 The genes involved in different physiological processes (proteinous metabolism, thophic activites, 
DNA reparation mechanisms, inflammatory processes of the brain, and stress) could be implicated in 
brain aging. 
2
 For example, imagine a species with an average longevity of 2 years. There is little evolutionary 
advantage in having beneficial genes at age 10 because only a small fraction of the population will 
reach that age. On the contrary, genes that are beneficial at age 1 will be selected by evolution. 
other words, the greatest contribution to create a new generation comes 
from young, not old organisms, and so the power of natural selection 
fades with age, making it possible for hazardous late-acting genes to 
exist.       
 
Aging is generally thought as a process of variable duration from 
individual to individual, resulting from the progressive and irreversible 
alteration of tissues and systems. However, it must be recognized that 
aging not only involves the loss of certain physiological functions but 
also the increase and improvement of others. In fact, if the individual 
can gradually become biologically vulnerable to death, at the same time, 
he can mature in wisdom
3
 (Meeks and Jeste, 2009) and expertise (Horton et 
al., 2008). Research on cognitive aging showed that cognitive domains 
maintain residual abilities and improve some abilities which become more 
active in time (Ratti & Amoretti, 1991).  
   
According to the “integrated theory of aging” (Birren & Schroots, 1996), 
aging should be defined as an ecological phenomenon that involves 
chromosomal inheritance and a physical and social environment. Several 
biological, genetic, educational, occupational, and lifestyle factors can 
explain how certain people age better than others (“successful aging”) 
and how many individuals are able to modify objectives and strategies to 
adapt themselves to environmental demand as best as possible. 
Psychological gerontology literature has indicated the importance of a 
multidimensional approach to define successful aging that should consider 
the following criteria: lifespan, biological and mental health, cognitive 
                                                                                                                                                                                        
Following the same reasoning, a gene that kills organisms at age 20 will have little impact on 
organisms bearing it since few will reach such advanced ages.  
3
 According to Meeks and Jeste (2009), the concept of wisdom includes prosocial attitudes/behaviors, 
social decision making/pragmatic knowledge of life, emotional homeostasis, reflection/self-
understanding, value relativism/tolerance, acknowledgment, and dealing effectively with uncertainty. 
efficacy, social competence, social productivity, and personal control 
(Baltes and Baltes, 1990). 
     
1.2 BRAIN AGING 
 
In healthy people over 65 years of age, a decrease of brain volume and 
weight and an increase of ventricular volume and of the other brain areas 
containing cephalorrhachidian liquor (Caltagirone and Spalletta, 2004) 
has been documented. The brain areas which are more affected by this 
phenomenon are frontal lobes and the hippocampus. In particular, in the 
range from 30-90 years of age, the loss of volume that is charged to the 
cortex is 40%, to the hippocampus is 35% and to white matter of the 
encephalon is 26%. All these modifications should be considered as 
physiological changes because they are commonly present in the general 
population (Anderton, 2002).   
 
The studies focused on the number of neurons of the central nervous 
system presented controversial results. However, the majority of the 
studies agree in retaining that there is a loss of neurons associated to 
aging in  the frontal cortex, amygdala, substantia nigra, and cerebellum. 
The results of the studies on the number of synapses associated to aging 
also reported contrasting data. An interesting research clarified that 
individuals over 65 years of age compared to young adults show a decrease 
of 20% of synapses in the frontal cortex. So, with advancing age the loss 
of 60% could be identified as the threshold characterizing AD (Masliah et 
al., 1993).                  
 
The intracellular modifications represent another important aspect of 
brain aging. A typology of cellular modification associated to aging is 
represented by neural accumulation of lipofuscin
4
 and neuromelanin
5
 that 
increase with age (Sulzer et al., 2008). Moreover, modifications of 
protein components of neuronal cytoskeleton increase in intensity with 
age (Geddes and Matus, 1997). They are defined as:   
1. senile plaques and neurofibrillary tangles: these components are 
present in normal elderly people in small numbers and only in some 
brain areas (hippocampus, amygdala, entorhinal cortex). The senile 
plaques are composed of deposits of β-amyloid protein while the 
neurofibrillary tangles are composed of abnormal filaments of tau 
protein; 
2. neuropil threads of gray matter, similar to neurofibrillary 
tangles. They are present in small numbers in healthy elderly 
people compared to AD patients; 
3. granulovacuolar degeneration: degeneration of hippocampal pyramidal 
neurons in elderly persons, characterized by apparently empty 
vacuoles except for dense central granules; this kind of 
degeneration is often associated to Hirano bodies and it is a 
specific feature of AD; 
4. Hirano bodies: they are structures that can be observed in the 
hippocampal pyramidal neurons similar to filaments of 
neurofibrillary tangles and granulovacuolar degeneration. They are 
mainly composed of some proteins associated to microfilaments that 
tend to increase in number with age and are present in significant 
quantity in AD patients; 
                                                        
4
 Lipofuscin is a pigment composed of residues of oxidation of lipids and proteins. It mostly 
affects certain areas of the nervous system such as the inferior olives, the lateral geniculate 
nuclei, the thalamus and the motor neurons of anterior horn.       
5
 Neuromelanin is a substance chemically similar to lipofuscin. It is believed to be implicated in 
Parkinson‟s disease (PD).   
5. cerebral amyloid angiopathy caused by extracellular deposition of 
β-amyloid in blood vessels of the encephalon. It increases in 
frequency with age; 
6. Lewy bodies: they are abnormal aggregates of proteins that develop 
inside the nerve cells in PD and in AD. They are characterized by 
intracellular formations of spherical shape with a single body or 
with clusters. They can be found in small numbers in the cytoplasm 
of substantia nigra and locus coreuleus neurons of normal elderly 
people.  
 
In addition to neuronal alterations, age-related modifications of 
astrocytes of glial cells have been documented  (De Vellis, 2002). 
Finally, it is very common in elderly people to find neurologically free 
small vascular ischemic lesions of the prefrontal subcortical circuit 
(Pugh and Lipsitz, 2002). If these lesions occur repeatedly, they can 
provoke neuropsychological and geriatric disorders, such as cognitive 
deficits, depressive syndromes, motor and urinary disorders.       
 
A consequence of an aging brain seems to be the global decrease of the 
blood flow and cerebral metabolism. The causes of these changes should be 
sought in some natural phenomena, such as the elasticity of blood 
vessels, the modification of vascular innervations and of endothelial 
mechanism, with the final result of a tendency to vasoconstriction 
(Silverman and Phelps, 2001).   
 
From the point of view of neurotransmission, modifications of 
serotonergic, noradrenergic, dopaminergic, GABAergic, and cholinergic 
systems have been documented with advantaging age. They can be due to 
both reduction of synaptic levels of the neurotransmitter and the 
alteration of mechanisms of signal transduction. Preliminary studies 
(Nobler et al., 1999) showed that both blood flow and neural metabolism 
can be mediated by the serotonergic system. In particular, a correlation 
has been suggested between advantaging age and reduction of serotonin 
receptors density (in the thalamus and mesencephalon for 5-HT; in the 
frontal cortex, the hippocampus and raphe nuclei for 5-HT1-A; in the basal 
ganglia, and the whole cortex for 5-HT2-a) (Meneses, 1999). The study of 
serotonergic systems in healthy elderly people and in patients with 
dementia is very important because a wide amount of scientific data 
indicate a strong implication of this system in memory and learning. A 
modest reduction of the number of noradrenergic neurons of locus 
coreuleus has been demonstrated with the advantaging of age while a 
considerable reduction is present in AD; furthermore, the concentration 
of noradrenalin in the cerebrospinal fluid increases both in elderly 
people and AD patients (Raskind et al., 1999). The dopamine plays an 
important role for some cognitive functions such as attention, memory, 
language and executive functions. The advantaged age seems to be 
associated to (i) a decline of dopamine levels in the extrapyramidal 
nuclei, limbic system, frontal and temporal cortex; (ii) a reduction of 
cellular bodies of dopaminergic neurons in the substantia nigra 
(Nieoullon, 2002). Other studies documented how the reduction of 
dopaminergic receptors density (especially D2) in the caudate nucleus was 
associated to cognitive impairment charged to prefrontal cortex (planning 
and mental flexibility abilities), in addition to motor impairment 
(Cooper et al., 1996). With regard to physiological aging,  a reduction 
and a no change of the number of GABAergic receptors, but a modification 
of GABA subunits (GABAA, GABAB and GABAc) (Cooper et al., 1996), have been 
described. In AD patients there has been noted: (i) a reduction of 60-95% 
of choline acetyltransferase (ChAT) activity which is a reliable index 
for the functionality of cholinergic neurons (Becker et al., 1991); (ii) 
a decrease in the transport of choline; (iii) a decrease in the synthesis 
of acetylcholine and its release; (iv) a reduction of the number of  the 
nicotinic and presinaptic M2 muscarinic receptors (Pomponi et al., 1990). 
In particular, a compromission of cholinergic innervations in the 
hippocampus and in the neocortex with reduction of density of cholinergic 
neurons of the medial septum and the basalis magnocellular nucleus 
(Cooper et al., 1996) has been described. The activity of ChAT seems to 
be reduced in elderly not-demented people, especially in the hippocampus; 
by contrast, other studies conducted by Positron Emission Tomography 
(PET) did not demonstrate a correlation between aging and cholinergic 
systems (Namba et al., 1999).   
 
In literature, functional modifications of the hypothalamus-hypophisis-
suprarenal gland (HPA) axis related to aging have been described (Ferrari 
et al., 2001). A reduction of glucocorticoids receptors in the 
hypothalamus, hippocampus and limbic systems provokes an alteration of 
the physiological response to stress. In elderly people, an alteration of 
the suprachiasmatic nucleus with consequent compromission of the 
circadian rhythm has been described, too (Racchi et al., 2003). With 
aging there is a modification of the suprarenal gland secretion with an 
increase of cortisol and a decrease of dehydroepiandrosterone (DHEA). 
This ratio is particularly high in demented people. A dissociation of the 
pattern of adreno-cortical secretion with aging thus exists.                       
 
1.3 COGNITIVE DECLINE OF HEALTY ELDERLY PEOPLE 
 
Overall, memory and learning tend to decline while some executive 
function abilities such as conceptualization and logic reasoning (Cesa 
Bianchi et al., 1997) are maintained. Crystallized intelligence 
components can be preserved while fluid intelligence ones usually 
decrease (Horn & Cattel, 1966).  
 
With regard to attention, the main differences between people of 
different ages are quantitative rather than qualitative. With advancing 
age, speed of information processing decreases: the attentional buffer 
becomes more rigid and selective; it appears less effective to allocate 
attentional resources on multiple stimuli. Finally, there is a decrease 
of attentional resources addressed to problem solving that require 
controlled processes to elaborate information. By contrast, attentional 
resources of automatic processes remain stable with advancing age. 
However, if administered cognitive tasks are designed by considering 
reduced abilities, differences in performances with elderly healthy 
individuals  are minimal (Comall et al., 1962; Birren, Schaie, 1977; 
McDown, 1986).  
 
With regard to language, there are no evident changes in the ability of 
repetition, reading aloud and writing from dictation but there are 
deficits of speech production with reduction of information content and 
increased use of pronouns in ambiguous reference and difficulty in 
retrieving lexical items (Obler, 1980; Hochnandel & Kaplan, 1984; 
Ulatosha, 1985). Individuals over seventy commit more errors in 
spontaneous speech than old adults in using different forms of the past, 
in adopting appropriate articles and possessive pronouns and in sentence 
syntax. This is more evident if elderly people use sentences with complex 
grammatical structures that require the use of short-term memory, leading 
to the assumption that these deficits can be attributed to senile memory 
decay rather than real syntactic abilities (Keynett & Kemper, 1986).  
 It is generally accepted that there are different forms of memory and 
multiple memory systems. Forms of memory can be distinguished on the 
basis of temporal characteristics (e.g. sensory memory, short/long- 
term), requirements for processing-encoding-retrieval (e.g. recognition/ 
familiarity) and stimulated domains (e.g. visual-space/verbal). Different 
memory systems can be distinguished on the basis of investigations of 
brain function and behavioural evidence (Roedige et al., 2002). A 
taxonomy from which a considerable amount of data was united is shown in 
Figure 1 (Squire, 2004).    
 
 
 
 
 
 
Figure 1. Memory system of the brain: A taxonomy (Squire, 2004). 
 
In normal aging there is a global decline that mainly involves the speed 
of information processing, episodic memory and working memory while 
verbal learning appears to remain stable (Allen et al., 2002; Rönnlund et 
al., 2005). Several studies have shown that procedural memory processes 
are not particularly influenced by aging (Craik & Jennings, 1992; 
Jennings & Jacoby, 1993; Light & La Voie, 1993). With regard to 
declarative memory, age-related deficits are estimated to be more 
specific for particular facts and events rather than general ones (Prull, 
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2000; Gabrieli, 2000; Bunge, 2000; Raz, 2000; 2005). Research suggests 
that although semantic memory shows a clear failure in patients with 
various forms of dementia, it remains fairly stable in normal aging 
(Light, 1992). Data show a considerable maintenance of word meaning in 
the elderly: knowledge and vocabulary use remains stable until at least 
70 years of age (Salthouse, 1991; Light, 1992). Although the loss of word 
meaning is minimal, elderly people make more errors and are slower than 
young people in detecting words when they are provided with a 
description, thus displaying an increase of difficulty in accessing 
semantic information in a quick and effective manner (Maylor, 1990). 
Moreover, one of the most frequent difficulties is represented by 
remembering people‟s names or finding a word temporarily unavailable 
(Burke et al., 1991; Maylor, 1993). Elderly people have lower 
performances than the young in verbal fluency tasks (Schaie & Willis, 
1993). Further studies outlined the impact of age, gender and education 
on memory and learning for healthy elderly people. Findings showed a 
decline of working memory with advantage age, a strong impact of age on 
visual-verbal association tasks as well as visual-space memory tasks, an 
increase of forgetfulness and a significant influence of age on visual-
space memory tasks (Panza et al., 1996). A considerable amount of recent 
data support the evidence of memory deficit related to two memory 
faculties: the power to recall contextual information about past events 
in time and place (recollection) and the feeling of recognition of past 
events in absence of contextual information recovery (familiarity). The 
comparison between young and elderly performances revealed that 
recollection is impaired in normal aging (Prull et al., 2003). The 
negative trend for semantic memory after 60 years of age is parallel to 
episodic memory (Dixon et al., 2004; Lodven et al., 2004). Old adults 
showed deficits regarding the source of information rather than its 
content; age-related deficits are present in cognitive tasks as 
associating target words with related items or with specific contents 
(Naveh-Benjamin et al., 2004). It is also demonstrated that older adults 
are more vulnerable to interference effects created by a misleading prime 
due to mnestic impoverishment for details (Prull et al., 2005). 
Differences of performance between young and old adults have been shown 
in digit span tasks (reading span, listening span and operational span  
(Boop and Verhaeghen, 2005; Reuter-Lorenz and Sylvester, 2005). Some 
laboratory studies demonstrated a slight failure in prospective memory 
tasks (Henry et al., 2004).   
  
According to the “frontal lobe hypothesis of aging” (Dempster, 1992; 
Hartley, 1993; West, 1996) the prefrontal cortex is the brain area that 
suffers more than others from the effects of aging. This hypothesis 
explains the observed behaviours of healthy elderly people, characterized 
by the reduction of the main three executive subsets: set shifting, 
information updating and monitoring, and inhibition (Miyake et al., 
2000). Elderly people present lower performances than adults on tests 
that evaluate mental flexibility (set shifting) and creation of plans and 
strategies (set formation) (Keys and White, 2000). In addition, many 
studies have shown that during aging there is the reduction of the 
ability to inhibit a previously learned and dominant response in favour 
of a more adequate one (Andrés et al., 2008).      
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. MILD COGNITIVE IMPAIRMENT: A HISTORICAL-CONCEPTUAL PERSPECTIVE  
    
2.1 INTRODUCTION  
 
The concept of slight cognitive impairment in aging appears confused with 
dementia until Kral (1962), who described senescent forgetfulness by 
distinguishing a physiological cognitive decline due to aging (“Benign 
Senescent Forgetfulness”) from a pathological cognitive decline 
(“Malignant Senescent Forgetfulness” or  “Amnestic Syndrome”) apt to 
convert into dementia. After Kral, several studies provided different 
classifications of slight cognitive impairment but they did not 
completely describe its neuropsychological features. In 1995, Petersen 
and his co-workers of Mayo Clinic defined the diagnostic criteria for 
Mild Cognitive Impairment (MCI) that were subsequently reviewed by 
Ritchie et al. (2001). In order to specify MCI subtypes, Petersen (2004) 
created a new classification model.  
Literature presents many attempts to classify slight cognitive impairment 
in order to distinguish between physiological and pathological aging. 
Every diagnostic category of slight cognitive impairment follows a 
timeline (Table 1). We would stress that for each category highlighted in 
bold, scientific studies produced supplementary diagnostic framing and/or 
new clinical entities over time. They will be treated sequentially in the 
main category they belong to.    
                    Table 1. Categories of slight cognitive impairment and related clinical entities: A            
           timeline. 
 
 2.2 HISTORICAL ANTECEDENTS 
 
Descriptions of cognitive impairment can be traced back to the last 
centuries. The first author who explained the loss of recent memory was 
James C. Prichard, who wrote “Treatise on Insanity and other Disorders 
affecting the Mind” (1837). He distinguished intellectual insanities from 
moral ones. He called “incoherence” or “dementia” a form of intellectual 
insanity where the first step was “forgetfulness” or “loss of recent 
memory”, with a preserved power of reasoning, judgement and attention. At 
the same time, remote memory experiences remained nearly in their 
original freshness and were able to be recalled when the attention 
focused on them. The disease accompanied aging and progressed slowly and 
gradually. The brain deficit did not consist of a past memories 
forgetfulness but of an attention system inability to receive influences 
from external agencies.  
 
“Les maladies de la mémoire” (Ribot, 1888) proposed a preliminary 
classification of amnesia, pointing out those of progressive nature (“les 
amnésies progressives”), thought to be a particular cognitive decline apt 
to convert into dementia. Ribot explicated the “loi de regréssion” to 
clarify the gradual loss of memory, by establishing that recent memories 
are more likely to be lost than more remote ones. The idea that 
deterioration of psychological functions through mental disorders or 
neurological impairments retraces in reverse the order of evolutionary 
development, was drawn on John H. Jackson‟s theory: recently acquired 
information will be lost before deeply stored older information (Taylor, 
1931).   
  
PSEUDODEMENTIA 
The term “pseudodementia” was used to describe a syndrome in which some 
psychiatric disorders could cause cognitive impairment. The impairment is 
not progressive and it is potentially reversible, if the primary cause 
(e.g. depression) is treated (e.g. with antidepressants). However, no 
neuropathological process can be identified or considered sufficient to 
explain the cognitive deficits. In their study conducted on a sample of 
300 psychiatric patients, Madden et al. (1952) noted that some symptoms 
ordinarily considered to indicate dementia, could be reversed with 
appropriate therapies. After ten years, Kiloh (1961) described a clinical 
state in which initially dementia may be very closely mimicked and 
associated with malingering, reactive or endogenous depression. He 
considered remote psychiatric disturbances, an abrupt onset of symptoms 
and antidepressant treatment, as risk factors of pseudodementia. Post 
(1965) discussed pseudodementia in the elderly but he did not suggest its 
association with psychiatric syndromes. Lipowski (1967) documented a case 
of pseudodementia in a young highly educated women with hysterical and 
depressive symptoms and amnestic syndrome. Folstein et al. (1978) argued 
that depression can give rise to dementia which, although reversible, has 
a biological basis and should not be viewed as false dementia. They 
hypothesized that pseudodementia develops when the neurobiological 
disturbances of affective disorders are superimposed on a compromised 
aging brain. Thus, they suggested that the cognitive impairment 
associated with depressive illness might be accurately described as the 
“demential syndrome of depression”, rather than a “pseudodementia”. Wells 
(1979) described 11 patients with a variety of psychiatric disorders, 
including depression (with or without personality disturbances), 
conversion reactions, post-traumatic neurosis and shizoaffective 
symptoms. He defined pseudodementia as a mimicked or caricatured dementia 
produced by functional mental illness, personality disorders and post-
traumatic neuroses with a previous history of psychiatric illness, 
symptoms of short duration suffered before a request for help, rapid 
progression of symptoms, complaints of cognitive deficits, behavioural 
and cognitive performance inconsistent with the apparent degree of 
cognitive dysfunction and incapacity to reply to questions. He also 
proposed a valid checklist to differentiate pseudodementia from dementia. 
Caine (1981) used the following diagnostic criteria to describe pseudo-
demented patients: 
1. cognitive impairment with primary mental disorder; 
2. superimposed symptoms or similar symptoms to primary organic 
disorder;  
3. reversible disorder; 
4. absence of organic pathology. 
He adopted the Neuropsychological Screening Test (NST) (Caine, 1981) to 
evaluate their cognitive impairment. The most impaired performances 
depended on attention, processing information speed, spontaneous 
elaboration and analysis of details. This could be observed during the 
following tasks: verbal learning trial, immediate visual recall, copying, 
clock drawing procedure, written description, proverb interpretation and 
the Trail Making Test part B (Reitan, 1971). Reifler (1982) provided 
arguments to avoid clinical use of pseduodementia, pointing out two 
related issues:  
1. it implied that patients had either an organic or a functional 
illness, whereas many individuals could have elements of both, 
especially when depression was superimposed on “true” dementia; 
2. the mistaken clinical use of pseudodementia in clinical practice, 
whereas it was only descriptive.  
More recently, Bianchetti and Pezzini (2001) have suggested deleting the 
term “pseudodementia” and introducing a temporal sequentiality between 
affective symptoms and cognitive ones (Table 2). 
  
Table 2. Differential diagnosis between mood disorders and cognitive disorders of Type I and Type II 
(Form: Bianchetti and Pezzini, 2001) (Note: AD, Alzheimer‟s Disease; VD, Vascular Dementia).       
 
On the basis of case reports, McAllister (1983) noted two different 
categories of pseudodementia: without associated cerebral dysfunction 
versus with coexisting cerebral dysfunction. Cognitive impairment was 
usually a caricature of dementia with exaggerated memory complaints and 
it was mainly observed in patients with personality disorders. By 
contrast,  it was entirely indistinguishable from diffuse organic 
cerebral dysfunctions in other patients. The most common feature of 
pseudodementia was a relatively acute onset with a duration of symptoms 
from 6-12 months, characterized by moderate cognitive impairment, 
psychiatric history (e.g. depressive disorder), age over 50, frequent “do 
not know” as opposed to “near miss” answers, normal brain activity and 
structure, as revealed by electroencephalogram (EEG) and computed 
tomography scan (CT scan), and absence of nocturnal worsening 
(McAllister, 1985).  
 
SENILE PSYCHOSIS  
(PRIMARY DEGENERATIVE DEMENTIA; DEMENTIA AND MILD COGNITIVE IMPAIRMENT 
DIAGNOSTIC CRITERIA; AGE-RELATED COGNITIVE DECLINE; MILD NEURO-COGNITIVE 
DISORDER)  
 
Roth (1955) described the diagnostic criteria of senile psychosis by 
evaluating a total of 472 patients with different mental disorders that 
had necessitated the institutionalization in Graylingwell Hospital 
(Chichester, UK). He classified the mental disorders of later life into 
six different categories: affective psychosis, senile psychosis, late 
paraphrenia, arteriosclerotic psychosis, acute confusion and other mental 
disorders. Results suggested that affective psychosis, late paraphrenia 
and acute confusion were distinct from senile and arteriosclerotic 
psychosis, thought as the two main causes of progressive dementia in old 
age. Senile psychosis was defined as «a condition with a history of 
gradually and continually progressive failure in the common activities of 
everyday life and a clinical picture dominated by failure of memory and 
intellect and disorganization of personality, where these were not 
attributable to specific causes as infection, neoplasm, chronic 
intoxication or cerebrovascular disease, known to have produced cerebral 
infarction» (Roth, 1955, p. 283).  
 
In 1980, the American Psychiatric Association (APA) revised diagnostic 
criteria for senile psychosis, by introducing “Primary Degenerative 
Dementia” as a diagnostic entity apt to describe the degeneration of 
dementia in elderly people. The APA recommended limiting the diagnosis of 
Primary Degenerative Dementia only in cases of notable evidence of 
progressive and significant decline of cognitive functions and 
compromised social activities. In 1982, Reisberg et al. published the 
Global Deterioration Scale (GDS) for the assessment of Primary 
Degenerative Dementia, identifying three major clinical phases: 
 an early “forgetfulness” phase  with subjective memory complaints and 
objective memory deficit; 
 an intermediate “confusional” phase in which an external observer 
becomes aware of the deficit; 
 a late dementia phase in which the patient cannot survive without a 
caregiver‟s assistance.      
To improve accuracy of Primary Degenerative Dementia, Sulkava et al. 
(1983) provided more extensive criteria for diagnosis (Table 3) by using 
a modified Luria-Nebraska Neuropsychological Test (Christensen, 1975; 
Sulkava and Amberla, 1982) to evaluate the first three criteria.     
Table 3. Revised diagnostic criteria for Primary Degenerative Dementia (From: Sulkava et al., 1983).  
 
The psychiatric classification for the diagnosis of dementia formulated 
by the Diagnostic and Statistical Manual of Mental Disorders 3rd Revision 
(DSM-III-R) (APA, 1987) provided valuable diagnostic criteria for Mild 
Cognitive Impairment (see also Zaudig, 1992). Subjects who satisfied 
criterion A but not criterion B, were included in “Mild Cognitive 
Impairment Type 1” (MCI Type 1). If DSM-III-R Criteria A and B, but non C 
were satisfied, the diagnostic label of “Mild Cognitive Impairment Type 
2” (MCI Type 2) was applied (Table 4).  
Table 4. DSM-III-R criteria for Dementia and Mild Cognitive Impairment (APA, 1987) (Note: ADL, 
Activities of Daily Living). 
 
Within the DSM-IV section “Additional conditions that may be a focus of 
clinical attention”, the “Age-Related Cognitive Decline” and the “Mild 
Neuro-cognitive Disorder” were mentioned (APA, 1994). The first category 
should be used when the object of clinical attention is a clear decline 
of cognitive functions in aging, compared to normal limits. Subjects do 
not remember names or dates and they have difficulty in problem solving. 
The category of “Age-related Cognitive Decline” should be considered if a 
specific mental disorder and a neurological condition are excluded (APA, 
1994). The diagnosis of “Mild Neuro-cognitive Disorder” was reported by 
DSM-IV (Table 5). 
 
Table 5. Diagnostic criteria for Mild Neuro-cognitive Disorder (APA, 1994).   
 
2.3. FROM KRAL‟S REVOLUTION TO PETERSEN‟S DIAGNOSTIC CRITERIA OF MILD    
     COGNITIVE IMPAIRMENT 
 
 
SENESCENT FORGETFULNESS  
(BENIGN SENESCENT FORGETFULNESS VERSUS INCIPIENT AMNESTIC SYNDROME) 
 
Even though literature reports different terms referring to mild changes 
in elderly cognition like “normal senility” (Bleuler, 1924), “normal 
senescent decline” (Dörken and Kral, 1951), and “mild senescent memory 
decline” (Kral, 1958), the principal attempt to define the normal tail-
end of the continuum normal aging/dementia dates back to 1962, when Kral 
introduced the term “Benign Senescent Forgetfulness” (BSF) to describe a 
loss of remote memories in elderly healthy people. As neuropsychiatric 
consultant at the “Hebrew Old People‟s and Sheltering Home” in Montreal, 
he conducted two surveys (1956-1957; 1957-1961) to evaluate mental health 
among patients and to recommend measures to improve their conditions 
(Heinik, 2010). In the first survey, based on DSM-I (APA, 1952) and 
Roth‟s categorization (1955), Kral classified 162 residents according to 
the following observational criteria: 
1. degree of personality preservation, judgment ability and emotional 
responsiveness; 
2. presence (or absence) and type of memory impairment;  
3. presence (or absence) of psychotic/neurotic symptoms. 
Kral adopted a meticulous comprehensive neurological examination and a 
psychiatric interview focused on particular aspects of mental functioning 
(especially memory) with the administration of a modified version of the 
Wechsler Memory Scale (WMS) (Wechsler, 1945). Based on these criteria, he 
suggested a classification of the entire population of the Home into five 
groups: 
- Group A (37 persons, 22.8%): well-preserved personality, 
appropriate emotional reactions, preserved judgment, no memory 
impairment, no history or signs of functional psychosis; 
- Group B (30 persons, 18.5%): well-preserved personality, preserved 
judgment, appropriate emotional reactions, no psychotic signs, 
“mild memory impairment” characterized by the inability to recall 
relatively unimportant data from the past, whereas the global 
experience can be recalled. The same data not recalled at one time, 
may be retrieved the next time. Remote memory was otherwise not 
impaired nor was there any clinically ascertainable defect of 
recent memory and immediate recall. Orientation was largely 
maintained. Confabulations were absent. Subjects were aware of 
their shortcomings and tried to compensate them by circumlocutions. 
Sometimes they might apologize. This group was classified as BSF, 
and was found with equal frequency in both sexes. This condition 
progressed relatively slowly; 
- Group C (24 persons, 14.8%): patients without memory deficit but 
with a history and/or signs of functional psychosis (affective or 
paraphrenic type); this group included “neurosis of late maturity” 
(Kral, 1958); 
- Group D (49 persons, 30.2%): typical amnestic syndrome, namely 
impairment of recent memory and immediate recall, disorientation 
(particularly in time), and loss of remote memory. Only some events 
with a strong emotional charge could still be evoked, although in a 
distorted fashion. At the beginning, subjects could produce 
confabulations. The amnestic syndrome varied from moderate to 
severe, and it was associated with thought, judgment and nominal 
aphasia impairments; 
- Group E (22 persons, 13.6%): amnestic syndrome with additional 
psychosis signs, like paranoid delusions, hallucinations, 
depressive or manic mood swings.    
Group D and E constituted “Incipient Amnestic Syndrome” (IAS), which was 
more frequent in women than in men. This condition was associated with a 
high risk of institutionalization and mortality. In the second survey, 
Kral included results of psychological tests administered to 54 well-
preserved residents by his colleague B.T. Wigdor: the verbal scale of the 
Wechsler Belleview Intelligence Scale I (Wechsler, 1939), the Bender 
Gestalt Visual Motor Test (Bender, 1938), and a modified version of the 
Wechsler Memory Scale (Wechsler, 1945). In addition, the Rorschach Test 
(Rorschach, 1942) was used to test personality structure and level of 
functioning. According to memory functions, four patient subgroups were 
formed: 
- Group I (25 persons, 48%): without memory deficit or previous 
depression; 
- Group II (13 persons, 13,25%): with mild type of memory impairment 
(BSF); 
- Group III (9 persons, 17.3%): without memory deficit but with a 
history of depression; 
- Group IV (5 persons, 9.6%): with signs of Incipient Amnestic 
Syndrome (IAS), with intact personal and social functioning. 
From the psychometric point of view, the findings showed:  
- low average of Intelligence Quotients (IQs) of the whole group 
(mean 87.5, range 66-105);  
- presence of memory impairment in all subjects with the average of 
83.7 being under the cut-off of 90, with 98 being the highest 
score; Group I had higher mean scores (87.7) than Group II (81.7) 
and III (82.5); Group IV had the lowest mean score (72.2); 
- indicative scores of marked impairment in the Bender Gestalt 
drawings (total group mean 113, range 41-215).     
As Heinik (2010) has suggested, Kral and Wigdor (1961) presented a sample 
with neuropsychological characteristics very similar to the current 
construct of Mild Cognitive Impairment (c.f. Petersen et al., 1995; 
Petersen, 2004):  
a. all well-preserved aged people; 
b. normal level of intelligence;  
c. subnormal performance on specific memory test;  
d. subnormal performance on a specific perceptual/organization test;  
e. no significant signs of malignant amnestic syndrome.  
 
 
MILD COGNITIVE IMPAIRMENT NOT AMOUNTING TO DEMENTIA  
(DEMENTIA AND MILD COGNITIVE IMPAIRMENT DIAGNOSTIC CRITERIA; MILD COGNITIVE 
DISORDER; MILD MEMORY DISTURBANCE; MEMORY LOSS) 
 
In 1978, the category of “Mild cognitive impairment not amounting to 
dementia” was formulated by the World Health Organization (WHO) in the 
International Classification of Disease 9th Revision, as a condition of 
mild memory disturbance associated with aging. Senile dementia, 
classified in the “Psychotics Organic States” headlight, occurs after 65 
years of age with an alteration of memory, understanding and calculating, 
compromised abilities to judge and learn, emotional lability, mood 
disturbances, lowering of ethical values, emergence of new aspects of 
personality or exaggeration of existing ones, and difficulty in decision-
making.  
The ICD-10 (10th Revision of the International Classification of Mental 
and Behavioural Disorders) (WHO, 1990) established diagnostic criteria 
for “Mild Cognitive Impairment”, by selecting them from those of dementia 
(Table 6). 
Table 6. ICD-10 diagnostic criteria for Dementia and Mild Cognitive Impairment (WHO, 1990).  
  
The diagnosis of MCI excluded the clouding of consciousness (Criterion B) 
and a significant interference with the activities of daily living. It 
was divided into three subtypes:  
- MCI Type 1 that meets only A1 criterion; 
- MCI Type 2 that meets A1 and A2 criteria;  
- MCI Type 3 that meets A1, A2 and C criteria.  
 
The diagnosis of “Mild Cognitive Disorder” (WHO, 1993) encompassed 
several clinical conditions such as memory decline, deficits in abstract 
thinking, difficulty in information processing, compared to a previously 
supposed higher level of cognitive functioning (Table 7). ICD-10 
“Diagnostic Criteria for Research” recommended the differential diagnosis 
when the cognitive impairment cannot be referred to dementia, delirium 
and other cognitive disturbances. 
 
 
Table 7. Diagnostic criteria for Mild Cognitive Disorder (WHO, 1993). 
 
 
Christensen et al. (1995) assessed 897 community-dwelling elderly people 
to evaluate the epidemiological evidence of Mild Cognitive Disorder 
validity. They recommended using the Informant Questionnaire of Cognitive 
Decline in the Elderly (Jorm and Korten, 1988) to evaluate Criterion B, 
and a wide neuropsychological battery, including the Symbol Digit 
Modalities Test (Smith, 1982), a verbal fluency task, the Mini Mental 
State Examination (Folstein et al., 1975), three items of the 
Similarities subtest of the Wechsler Adult Intelligence Scale Revised 
(WAIS-R) (Wechsler, 1981), a sentence verification task, Information 
subtest similar to that used in the WAIS-R, three items of the Vocabulary 
form of the WAIS-R, a cube drawing procedure, Face Recognition from the 
Rivermead Behavioural Memory Test (Wilson et al., 1985), a word 
recognition memory task, recall of name and address, three individual 
words and Visual Reproduction (one item from the Wechsler Memory Scale) 
(Wechsler, 1945), to evaluate Criterion C. They also suggested an 
estimation of premorbid intelligence using the National Adult Reading 
Test (Nelson, 1982).  
Mild Cognitive Disorder was restated by the World Health Organization in 
the “International Statistical Classification of Diseases and Related 
Health Problems 10
th
  Revision Version for 2007”. It was defined as «a 
disorder characterized by impairment of memory, learning difficulties and 
reduced ability to concentrate on a task for more than brief periods. 
There is often a marked feeling of mental fatigue when mental tasks are 
attempted, and new learning is found to be subjectively difficult even 
when objectively successful. None of these symptoms is so severe for a 
dementia or delirium diagnosis. The diagnosis of Mild Cognitive Disorder 
should be made only in association with a specified physical disorder. 
The cognitive disorder may precede, accompany, or follow a wide variety 
of infections and physical disorders, both cerebral and systemic, but 
direct evidence of cerebral involvement is not necessarily present. It 
can be differentiated from post-encephalitic syndrome and post-
concussional syndrome by its different aetiology, its more restricted 
range of generally milder symptoms, and usually shorter duration» (WHO, 
2007; F06.7 code).  
The classification of “Mild Cognitive Impairment” was formulated as a 
clinical entity in the “International Classification of Diseases 9th 
Revision Clinical Modification” (ICD-9-CM) (WHO, 2002), including memory 
complaints (preferably corroborate), objective memory impairment, 
relatively preserved general cognition and essentially intact activities 
of daily living. It did not include head trauma, dehydration, stroke, 
malnutrition.   
“Mild Cognitive Impairment” was not the only diagnostic category of 
cognitive decline. In fact, diagnostic criteria for “Mild Memory 
Disturbance” and “Memory Loss” were quoted, too. Mild Memory Disturbance 
was classified as another specific non-psychotic mental disorder, 
following organic brain damage (WHO, 2002). Alternatively, Memory Loss 
was characterized by the organic or psychogenetic loss of the ability to 
recall information, retrograde and anterograde amnesia, and a temporary 
or permanent loss of  recent memory caused by organic or psychological 
factors (WHO, 2002). Bowen et al. (1997) had studied the progression to 
dementia in patients with isolated memory loss, because the history of 
severe memory loss in patients without other cognitive impairments was 
poorly understood. Dementia criteria of the DSM-III-R involved impairment 
in two or more cognitive domains like the NINCDS-ADRDA criteria (criteria 
proposed by the National Institute of Neurological and Communicative 
Disorders and Stroke and the Alzheimer's Disease and Related Disorders 
Association for diagnosis of dementia) for probable Alzheimer‟s Disease 
(AD). Bowen's longitudinal study circumscribed subjects who did not meet 
diagnostic criteria for dementia, without other cognitive impairments. 
The neuropsychological test battery included the Mini Mental State 
Examination (Folstein et al., 1975), the Mattis Dementia Rating Scale 
(Mattis, 1988), the Fuld Object Memory Evaluation (Fuld, 1981), an 
abbreviated form of the Boston Naming Test (Morris et al., 1989), the 
Wechsler Adult Intelligence Scale Revised (Wechsler, 1981) and the Trail 
Making Test (Reitan, 1985). All patients scored at least 2 standard 
deviation (SD) below the average of memory tests, while other areas of 
cognition were preserved. By detecting conversion rates, the researchers 
concluded that isolated memory loss was frequently the incipient symptom 
of AD. According to this evidence, Bowen and colleagues recommend 
following isolated memory loss patients over time to verify conversion 
into dementia. 
LIMITED DEMENTIA OR LIMITED COGNITIVE DISTURBANCE 
Gurland et al. (1982) formulated criteria for the diagnosis of dementia, 
by adopting the Geriatric Mental State Examination (Copeland et al., 
1976) and the Comprehensive Assessment and Referral Evaluation (Gurland 
et al., 1977), a basically semi-structured interview guide with specific 
criteria for diagnosis and severity of dementia. The first step was named 
“Limited Dementia” or “Limited Cognitive Disturbance” and was 
characterized by mild memory dysfunction not severe enough to satisfy 
dementia diagnostic criteria and to interfere with the capability of 
patients to live independently. The diagnostic criteria included: 
1. subjective report of memory decline; 
2. increased reliance on notes as reminders; 
3. occasionally (less than once a week) forgetfulness of name, 
appointments and misplacing of objects; 
4. occasionally (less than once a month) destructive or dangerous 
memory lapses such as burning cooking or leaving on gas tap; 
5. one or two errors on cognitive testing: subject forgets current or 
past president, exact date, phone number, zip code, dates of 
marriage or moving to present location.  
 
QUESTIONABLE DEMENTIA 
In 1982, two independent tests for cognitive aging and dementia were 
published. One of these staging measures was the Clinical Dementia Rating 
(CDR) (Hughes et al., 1982). It identified five stages including a CDR 
0.5 termed “Questionable Dementia”, including mild dementia and earlier 
antecedents, with the following clinical features:  
1. mild consistent forgetfulness and partial recollection of events; 
2. fully oriented patient; 
3. only doubtful or mild impairment on independent functions at usual 
level of job, shopping, business and financial affairs, volunteer 
and social groups; 
4. life at home, hobbies, intellectual interest well-maintained or 
only slightly impaired; 
5. fully capable of self-care.  
Devanand et al. (1997) found that low scores on delayed recall of a 
modified Mini Mental Examination (Stern et al., 1987), consistent long-
term retrieval of the Free and Cued Selective Reminding Test category 
naming for animals (Buschke, 1984), digit symbol, picture arrangement and 
block design subtest of the Wechsler Adult Intelligence Scale Revised 
(Wechsler, 1981), were predictive of the final diagnosis of dementia in a 
sample of 127 subjects with questionable dementia. Daly et al. (2000) 
administered the Clinical Dementia Rating (Hughes et al., 1982) and the 
Mini Mental State Examination (Folstein et al., 1975) to 165 individuals 
of 65 years of age at baseline and annually for 3 years. The questionable 
group met the CDR 0.5 criteria at baseline and still had the same 
evaluation after 3-year follow-up. The researchers found that only three 
tests (among seventeen used) were sensitive to differentiate 
questionable, normal and converter groups: the California Verbal Learning 
Test (Delis et al., 1987), the Self-Ordering Test (Petrides and Minler, 
1982) and the Trail Making Test (Reitan, 1958). The questionable group 
showed scores in the normal-converter range. Daly and colleagues 
suggested using a wider neuropsychological test battery to identify 
subgroups of individuals within the category of questionable dementia, 
because only 23 of the 123 subjects met criteria for AD at follow-up.   
 
MILD COGNITIVE DECLINE 
Reisberg et al. (1982) created the Global Deterioration Scale (GDS) for 
the diagnosis of Primary Degenerative Dementia (c.f. APA, 1980), 
identifying seven stages of cognitive impairment, where stage 0 
corresponds to non cognitive decline and stage 7 corresponds to severe 
cognitive decline. GDS stage 3 termed “Mild Cognitive Decline”, was 
adopted to describe patients with evidence of memory deficits obtained by 
a rigorous interview conducted by trained geriatric psychiatrists. GDS 
Stage 3 established that: concentration deficit may be evident on 
clinical testing; subjects show decreased facility in remembering names 
or places and low performance in employment and social demand; co-workers 
may be aware of patient‟s declining work performance; difficulties in 
finding words and names also become evident to relatives; patients may 
get seriously lost when travelling to different places; the impairment 
provoked by symptoms may be increased by denial; anxiety (from mild to 
moderate) also accompanies cognitive symptoms. Patients perform 1 SD or 
more below the average for their age and WAIS vocabulary score on at 
least 3 of 5 Guild memory subtests (Gilbert and Ferris, 1980). However, 
patients may still make no errors on the 10-item Mental Status 
Questionnaire (Pfeiffer, 1975). After the GDS publication, a series of 
measures were developed to describe the progression of cognitive decline 
in aging. Among these, the Brief Cognitive Rating Scale (Reisberg and 
Ferris, 1988) assessed progressive changes along five major axes: (I) 
concentration, (II) recent memory, (III) remote memory, (IV) orientation, 
and (V) self-care functioning. These axes were enumerated to be 
concordant with GDS stages (Reisberg et al., 2008).   
 
MILD DEMENTIA 
Henderson and Huppert (1984) considered “mild dementia” as a rubric for 
the early stages of several neuropathological disorders without precise 
diagnostic criteria for diagnosis. The single common feature was a 
significantly cognitive deficit in relation to a previously supposed 
higher level of cognitive functioning. The term was adopted as synonymous 
of Limited Cognitive Disturbance (c.f. Gurland et al., 1982) or of 
Questionable Dementia (cf. Hughes et al., 1982). Some epidemiological 
studies had already tried to detect individuals suffering from mild 
dementia. In the “Newcastle Study”, Kay et al. (1964) had identified mild 
demented patients and they found that some cerebrovascular and senile 
diseases were associated with cognitive impairment. The mental 
deterioration provoked by aging was due to isolation and inadequate diets 
and it usually determined institutionalization. The study had reported 
that some individuals developed definite dementia within a 3-year period 
(Bergman et al., 1971). Nielsen et al. (1977) had found the prevalence of 
mild dementia at 15.4% among a Danish population: after 15 years the 
mildly demented group had a higher than expected mortality rate. It was 
unknown whether any of this group progressed to definite dementia. 
Because mild dementia was not a distinct diagnostic category, there was 
not a specific headlight in the DSM-III-R and ICD-10, but only the 
specification of a severe dementia degree. 
AGE-ASSOCIATED MEMORY IMPAIRMENT 
(AGE ASSOCIATED MEMORY IMPAIRMENT REVISED CRITERIA; AGE-CONSISTEN MEMORY 
IMPAIRMENT; LATE-LIFE FORGETFULNESS) 
 
In 1986, the National Institute of Mental Health (NIMH) Work Group 
proposed specific diagnostic criteria to describe memory loss of elderly 
healthy people. It tried to analyse the physiological cognitive decline 
with three objectives: 
- reaching an agreement on memory decline research in aging; 
- understanding the behavioural phenomena of memory decline and their 
neurobiological basis; 
- developing effective pharmacological and non-pharmacological 
treatments to improve cognitive functioning.  
Crook and colleagues established inclusion and exclusion diagnostic 
criteria for “Age-associated Memory Impairment” (AAMI) (Table 8). The 
neuropsychological test battery focused only on memory performance 
(visual memory, associative learning, digit span, logical memory, 
semantic memory, delayed recall), orientation to time and place and 
attention. The  assessment was composed of three tests with cut-off 
scores for each one. 
Table 8. Diagnostic criteria for Age-associated Memory Impairment (From: Crook et al., 1982) (Note: 
WMS, Wechsler Memory Scale; AD, Alzheimer‟s Disease).   
 
Blackford and La Rue (1989) modified the NIHM diagnostic criteria for 
AAMI (Table 9) and quoted a new clinical entity named “Age-consistent 
Memory Impairment” (ACMI), according to specific psychometric 
concomitants (performance within ± 1 SD of the mean established for age 
on 75% or more of the tests administered).   
 
Table 9. Revised diagnostic criteria for Age-associated Memory Impairment (From: Blackford and La 
Rue, 1989) (Note: AAMI, Age-associated Memory Impairment; ACMI, Age-consistent Memory Impairment; 
LLF, Late-life Forgetfulness; IQ, Intelligence Quotient; WAIS, Wechsler Adult Intelligence Scale, 
WAIS-R, Wechsler Adult Intelligence Scale-Revised; NINCDS-ADRDA, criteria proposed by the 
National Institute of Neurological and Communicative Disorders and 
Stroke and the Alzheimer's Disease and Related Disorders Association 
for diagnosis of dementia).  
 
 
In order to describe AAMI patients, they adopted an age range of 50-79, 
because no upper age limit had been specified by the NIMH work group. A 
perceived decrease in areas of day-to-day memory functioning had to be 
verified by standardized self-report memory questionnaires. In addition, 
“subjective memory complaints” of NIMH criteria did not suggest any means 
of quantification and they were overinclusive.  
 
Blackford and La Rue distinguished “Late-Life forgetfulness” (LLF) from 
AAMI and ACMI on the basis of memory performance in four tests of 
secondary memory. LLF performance was calculated between 1 and 2 SD below 
the mean established for age on 50% or more of the tests administered.  
 
 
 
 
MINIMAL DEMENTIA 
    
The term “Minimal Dementia” was used in the Cambridge Mental Disorders in 
the Elderly Examination (CAMDEX) (Roth et al., 1986). It was a structured 
psychiatric interview intended for use in studies of prevalence and 
incidence of dementia, especially mild. Patients were graded for dementia 
severity (minimal, mild, moderate, severe). Minimal Dementia was defined 
as «a limited and variable impairment of recall, minor and variable 
errors in orientation, a blunted capacity to follow arguments and solve 
problems and occasional errors in everyday tasks». The “Hughes Hall Study 
of the Elderly” in Cambridge identified 44 people with minimal dementia 
assessed by CAMDEX. At 1-year follow-up, 29 subjects had an objective 
deterioration of cognitive functioning (O'Connor et al., 1990). At 2-year 
follow-up, 12 subjects met dementia criteria of such a structured 
interview (O'Connor et al., 1991; Cooper et al., 1996). 
 
MILD COGNITIVE IMPAIRMENT 
The term “Mild Cognitive Impairment” was introduced into literature by 
Fliker et al. (1991) to describe patients obtaining a score of 3 on the 
Global Deterioration Scale (GDS) (Reisberg et al., 1982), who were not 
demented and who exhibited at least two of the following symptoms :  
1) getting lost when travelling to an unfamiliar location; 
2) decline in work performance apparent to co-workers; 
3) word- and name- finding deficit apparent to intimates; 
4) relatively little retention of material read in a passage of a 
book; 
5) decreased facility in remembering the names of newly introduced 
people; 
6) losing or misplacing an object of value; 
7) concentration deficit apparent upon clinical testing. 
They conducted a full diagnostic evaluation of elderly subjects diagnosed 
as having MCI, adopting tests of immediate memory (digit span and delayed 
spatial recall), verbal recall (paragraphs, shopping list), visuospatial 
recall (delayed spatial recall and misplace objects), visual recognition 
memory (visual recognition span and facial recognition), remote memory 
(remote memory questionnaire), language (vocabulary, category retrieval, 
object naming, object functional recall, object name recognition, object 
functional recognition, object formation), concept formation (object 
sorting), visuospatial praxis (digit symbol), visuoperceptual function 
(road map), psychomotor speed (i.e. finger tapping, driving test, 
release, travel). Mildly impaired subjects performed significantly more 
poorly than controls on tests of recent and remote memory, language 
function, concept formation and visuo-spatial praxis. These results were 
also revealed by 2-year follow-up, suggesting that most subjects with 
mild cognitive deficits could manifest the progressive symptoms of 
dementia. GDS stage 3 was evaluated as a psychometric predictor able to 
distinguish between benign and more severe deficits of mildly impaired 
subjects.  
The diagnosis of Mild Cognitive Impairment was also formulated on the 
basis of performance resulting in  the neuropsychological battery of the 
Structured Interview for the Diagnosis of Dementia of the Alzheimer Type, 
multi-infarct dementia, and dementias of other aetiology according to 
DSM-III and ICD-10 (SIDAM) (Zaudig, 1992). It was a short diagnostic 
screening instrument to service each item of DSM-III and ICD-10 criteria 
for dementia. All items of the SIDAM could be summed up as resulting in 
the SIDAM score (SISCO), which ranged from 0 (the worst cognitive 
impairment) to 55 (no cognitive impairment). The diagnosis of Mild 
Cognitive Impairment was given with a SISCO score of 34-47 and a Mini 
Mental State Examination (Folstein et al., 1975) score of 23-27.  
In 1995, Petersen et al. created the primary diagnostic criteria for Mild 
Cognitive Impairment:   
a. complaint of defective memory;  
b. normal activities of daily living; 
c. normal general cognitive function; 
d. abnormal memory function for age; 
e. absence of dementia.  
They studied a sample of 75 subjects during a period of five years who 
reported memory decline from 1.5-2.0 SD below the mean of individuals 
with similar age and education level. These patients were less able than 
healthy controls to benefit maximally from the use of semantic cues 
during the recall task in the Free and Cued Selective Reminding Test 
(Buschke, 1984); they also showed impairment in delayed recall in the Rey 
Auditory Verbal Learning Test (Rey, 1964). By contrast, the mean scores 
in the Mini Mental State Examination (Folstein et al., 1975) were 
approximately 26 and the measures of general cognitive function in the 
Wechsler Adult Intelligence Scale Revised (Wechsler, 1981) and in the 
Dementia Rating Scale (Mattis, 1988) were relatively unaffected (Petersen 
et al., 1997). The first major study focusing on the clinical 
characterization and outcome of MCI was published in 1999 by Petersen and 
colleagues to identify individuals at high risk for severe cognitive 
decline and progression to dementia. They recruited a sample of 76 
subjects with MCI, 243 healthy normal controls and 106 patients with mild 
AD. All subjects were administered two sets of tests. The first set was 
used for diagnostic purposes and it included the Wechsler Adult 
Intelligence Scale Revised (Wechsler, 1981), the Rey Auditory Verbal 
Learning Test (Rey, 1964), and the Wide-Range Achievement Test (Jastak 
and Jastak, 1978). The second set was used for research purposes and 
included the Mini Mental State Examination (Folstein et al., 1975), the 
Dementia Rating Scale (Mattis, 1988), the Free and Cued Selective 
Reminding Test (Buschke, 1984), the Boston Naming Test (Kaplan et al., 
1983), the Controlled Oral Word Association Test (Benton and Hamsher, 
1978), and a modified Category Fluency Test (Monsch et al., 1984). At the 
conclusion of the study, the patients were staged on the Clinical 
Dementia Rating (Hughes et al., 1982) and the Global Deterioration Scale 
(Reisberg et al., 1982). MCI subjects showed a poorer performance of 
healthy controls in memory tests but similar if compared to very mild AD 
patients. However, these patients were more impaired in other cognitive 
domains than MCI subjects. In conclusion, Petersen et al. (1999) 
formulated the original criteria to diagnose MCI:  
a. memory complaint, preferably corroborated by an informant; 
b. memory impairment documented according to appropriate reference 
values; 
c. essentially normal performance in non-memory cognitive domains; 
d. generally preserved activity of daily living; 
e. not demented. 
Given the great interest in this clinical category, the American Academy 
of Neurology (AAN) included MCI as a clinic parameter on early detection 
of dementia (Petersen et al., 2001a). However, evolutions of MCI criteria 
occurred over time from 1992 to 1999 (Table 10). 
 
    
Table 10. Evolutions of Mild Cognitive Impairment diagnostic criteria (From: Tuokko and Hultsch, 
2006) (Note: MMSE, Mini Mental State Examination; ADLs, Activities of Daily Living). 
 
 
Ritchie et al. (2001) evaluated the predictive validity and temporal 
stability of MCI diagnostic criteria compared with Age-associated 
Cognitive Decline (AACD) ones. They processed data of the “Eugeria 
longitudinal study of cognitive aging” network. The computerized 
neuropsychometric examination named “ECO” (Examen Cognitif par 
Ordinateur) (Ritchie et al., 1993) assessed 833 subjects who formed the 
sample. ECO evaluated primary memory, verbal and visuospatial secondary 
memory, language skills (word and syntax comprehension, naming, verbal 
fluency), visuospatial performance (ideational, ideomotor and 
constructive apraxia; functional and semantic categorization of visual 
data; form perception), and focused and divided attention (visual and 
auditory modalities). At baseline (wave 1) and at yearly follow-ups 
(waves 2 and 3), the subjects meeting MCI and AACD diagnostic criteria, 
were identified. In the general population, the prevalence of MCI was 
estimated to be 3.2% and AACD 19.3%. Ritchie and colleagues noted that 
MCI was a poor predictor of dementia within a 3-year period with an 11% 
conversion rate. The application of MCI criteria to a general population 
showed that MCI was a heterogeneous condition, presenting neither 
temporal stability nor a clear boundary between normal aging and 
dementia. By contrast, subjects classified as AACD represented a more 
stable group, with a 28.6% conversion rate to dementia over a 3-year 
period. The main difference between MCI and AACD was that Petersen‟s 
first formulation included only memory impairment without the decline of 
other cognitive domains. Although there was some evidence that a purely 
amnestic syndrome might exist within a clinical context, this appeared to 
be a rare occurrence when the full range of cognitive functions were 
examined (Richards et al., 1999). The second difference between MCI and 
AACD criteria was related to daily living activities: the previous 
analyses had shown slight changes in activity performance as commonly 
observed in incipient AD up to two years before diagnosis (Touchon and 
Ritchie, 1999). Thus, Ritchie et al. (2001) suggested introducing mild 
difficulties in activities of daily living performance as an inclusion 
criterion for MCI diagnosis.   
Based on the belief that  memory symptoms were not unique in different 
MCI clinical presentations, an international conference convened in 
Stockholm (Winbald et al., 2004) to expand MCI diagnostic criteria and 
pointed out MCI subtypes (Petersen, 2004):    
- Amnestic MCI (aMCI);  
- Non-Amnestic MCI (naMCI); 
aMCI can be further divided into two subgroups: 
- aMCI Single Domain, characterized by isolated memory impairment; 
- aMCI Multiple Domain, characterized by impairment of multiple 
cognitive domains, included memory;  
naMCI can also be divided into two subgroups: 
- naMCI Single Domain, characterized by a specific cognitive domain 
impairment, other than memory; 
- naMCI Multiple Domain, characterized by impairment of multiple 
cognitive domains without associated memory deficits. 
 
Petersen and O'Brien (2006) argued that MCI should be considered a 
clinical entity distinct from normal aging and probable AD and it 
deserved consideration as a separate construct. MCI can satisfy criteria 
for inclusion in DSM-V draft more adequately than many other conditions 
currently codified. They outlined:  
1. clear criteria for identification and description; 
2. the demonstration that MCI is a boundary entity between normal 
aging and dementia; 
3. a distinct course of its subcategories;  
4. a specific treatment response (cholinesterase inhibitors); 
5. neurobiological abnormalities compared to normal subjects;   
6. a genetic pattern (apolipoprotein E).   
 
The current diagnosis of MCI follows an algorithm (see Appendix 1) to 
typify MCI subcategories. This nomenclature is currently being used by 
the United States National Institute on Aging-sponsored Alzheimer‟s 
Disease Centers Program through their Uniform Data Set and by the 
Alzheimer's Disease Neuroimaging Initiative (Petersen et al., 2009). 
After the delineation of the clinical subtypes of MCI, the next step 
involves the determination of the aetiology of the syndrome, as outlined 
in Table 11.  
 Table 11. Combinations of Mild Cognitive Impairment clinical profile and presumed aetiology 
(Modified from: Petersen and Morris, 2005) (Note: AD, Alzheimer‟s Disease; DBL, Lewy Body Dementia, 
FTD, Frontotemporal Dementia; VaD, Vascular Dementia; Depr., Depression).       
 
Research on MCI subtypes has focused on amnestic MCI, belived to be a 
high risk condition for developing AD, or a prodromal state of this 
condition (Dubois et al., 2004). Theoretically, patients with other 
dementing typologies might pass through similar pre-clinical stages. 
Subcortical Vascular Dementia (SVD) is due to a small vessel disease 
causing lacunar infarcts and other subcortical ischemic changes. SVD 
patients are a heterogeneous group but with distinctive clinical 
features.  
A group of patients with pre-dementia stage of SVD, known as “subcortical 
vascular MCI” (svMCI), has been recently described by Frisoni et al. 
(2002) (Table 12). 
 
Table 12. Diagnostic criteria for Mild Cognitive Impairment with subcortical vascular features 
(From: Frisoni et al., 2002) (Note: CT,  Computed Tomography; MRI, Magnetic Resonance Imaging).        
 
They compared a sample of 29 patients with a vascular type of MCI with 14 
MCI subjects and 21 SVD patients. The neuropsychological assessments 
consisted of a test battery: tapping frontal functions, short term 
memory, verbal and non-verbal learning, and instrumental abilities 
(category and letter word fluency) (Novelli et al., 1986), the Wisconsin 
Card Sorting Tets (Heaton, 1981), digit span forward (Orsini et al., 
1987), prose recall (Spinner and Tognoni, 1987), Corsi (Orsini et al., 
1987), the Token Test (De Renzi and Vignolo, 1962), and limb apraxia (De 
Renzi et al., 1968). Results indicated that svMCI had a 
neuropsychological profile prevalently characterized by poor performance 
on frontal tests. At 40-month follow-up, 68% of the svMCI patients showed 
a more severe cognitive deterioration. Similar findings were recently 
confirmed by Galluzzi et al. (2005).   
 
 
2.4 THE STUDIES ON SLIGHT COGNITIVE DECLINE AFTER PETERSEN 
 
MILD MEMORY IMPAIRMENT 
 
Dawe et al. (1992) analysed the concept of “Mild Memory Impairment”, a 
diagnostic label apt to encompass some definitions of cognitive decline 
like Benign Senescent Forgetfulness (Kral, 1962), Mild Dementia 
(Henderson and Huppert, 1984), “Very mild Cognitive Decline” and Mild 
Cognitive Decline (Reisberg et al., 1982), Questionable Dementia (Hughes 
et al., 1982), Limited Cognitive Disturbance (Gurland et al., 1982), 
Minimal Dementia (Roth et al., 1986), and Age-Associated Memory 
Impairment (Crook et al., 1986). Mild Memory Impairment represents a wide 
category that includes different classifications of slight cognitive 
impairment from normal aging to mild cognitive decline; it is associated 
with an increased risk of developing dementia which is difficult to 
quantify because of its marked heterogeneity. The authors pointed out 
three main problems in examining the relationship between mild memory 
impairment and dementia, summarized as follows: 
 the lack of widely accepted and utilized diagnostic criteria; 
 the wide range of psychometric tests, some of which still lack 
adequate validation in elderly subjects and compared different samples 
(normal/mild impaired/AD patients); 
 the relatively small number of subjects who have been properly 
assessed and followed up over a suitable period of conversion into 
dementia. 
AGE-ASSOCIATED COGNITIVE DECLINE 
A task force of the International Psychogeriatric Association (IPA) in 
collaboration with the World Health Organization proposed diagnostic 
criteria for "Aging-associated Cognitive Decline" (AACD) (Levy, 1994). 
The diagnosis of AACD is based on a more specific evaluation of cognition 
than that of Age-associated Memory Impairment (AAMI) (c.f. Crook et al., 
1986) (Table 13).  
Table 13. Diagnostic criteria for Age-associated Cognitive Decline (From: Levy, 1994).   
AACD was defined as a cognitive decline characterized by difficulties in 
any one of the following areas: memory, language, attention, 
concentration, thinking, and visuo-spatial functioning. These domains 
were selected as being of particular importance in daily life activities 
and they were congruent with the ICD-10 diagnosis of Mild Cognitive 
Disorder. A diagnosis of Mild Cognitive Disorder should be made if there 
was evidence of cerebral or systemic disease or other conditions known to 
cause cerebral dysfunction (cf. WHO, 1993). Where such evidence was 
lacking and dementia criteria were not met, cognitive decline met 
diagnostic criteria for AACD. Levy and colleagues did not include an age 
restriction in order to consider a cognitive decline occurring in the 
last decades of adulthood. An individual or reliable informant report 
confirms cognitive functioning decline. It must be described as gradual 
and be present for at least 6 months. Differing from the AAMI criteria, 
subjects with AACD are required to score 1 SD below age and education 
norms in neuropsychological tests. Thus, the AACD diagnosis identifies 
individuals with subjectively and objectively evidenced cognitive decline 
which is not impairing enough to satisfy dementia diagnosis. To 
distinguish between AAMI and AACD, Richard et al. (1999) assessed 11 
partecipants of the “Eugeria Study of Cognitive Aging” by the Examen 
Cognitif par Ordinateur (ECO) (Ritchie et al., 1993). Although there was 
a large overlap between AAMI and AACD, the findings suggested that AACD 
delineated a more severe cognitive deterioration than AAMI, because AACD 
refers to impairment in respect to normal contemporary subjects while 
AAMI refers to young normals.  
 
VASCULAR COGNITIVE IMPAIRMENT NO-DEMENTIA 
COGNITIVE IMPAIRMENT NO-DEMENTIA 
 
The “Canadian Study of Health and Aging” (CSHA) was an epidemiological 
study of dementia in Canada. It followed 10.000 elderly Canadians over a 
ten-year period from 1991 to 2001 and it collected a wide range of data 
about their changing health status over time. The country was divided 
into five regions, each with an equivalent number of subjects assessed. 
During CSHA-1 and -2 phases, individuals who scored less than 78 in the 
Modified Mini Mental State (3MS) (Teng and Chui, 1978), plus a sample of 
institutionalized people who scored 78 or above, were assessed. 
Neuropsychological assessment formed an integral part of the CSHA-1 and -
2 phases of the whole clinical study. In CSHA-3, the neuropsychological 
assessment formed a separate component that was administered to all who 
scored below 90 in the Modified Mini Mental State (3MS) (Teng and Chui, 
1978) (see Appendix 2). The CSHA identified a significant number of 
elderly subjects (over 65 years) whose problems of memory and/or relative 
to another cognitive domain were not sufficient to meet DSM-III-R 
criteria for dementia; however, these subjects were thought to be a 
different subset, when compared to cognitively normal people. They were 
categorized as being “Cognitively Impaired Not Demented” (CIND). The 
clinical entity was divided into nine subcategories of patients affected 
by Age-associated Memory Impairment (Crook et al., 1986), Age-related 
Cognitive Decline (APA, 1994), Age-consistent Memory Impairment 
(Blackford and La Rue, 1989), Late-Life Forgetfulness (Blackford and La 
Rue, 1989), cerebrovascular disease, depression, general vascular 
disease, psychiatric disorders and other not specific conditions; the 
prevalence of CIND was estimated at 16.8% (Elby et al., 1995). Graham et 
al. (1997) reported that the most common impairment was represented by a 
circumscribed memory deficit and a low score (24/30) in the Mini Mental 
State Examination (Folstein et al., 1975).  
 
Hachinski (1994) had suggested an alternative approach to classify 
vascular dementia, identifying patients across the whole spectrum of 
vascular cognitive impairment, from high risk with no deficit (“brain-at-
risk stage”) to full-blown dementia. The slight cognitive impairment 
described by the author was named “Vascular Cognitive Impairment No-
Dementia” (vascular CIND) but with the lack of accurate diagnostic 
criteria. Ingles et al. (2002) tried to detect a neuropsychological 
profile of 102 vascular CIND patients, identifying specific 
neuropsychological measures (low baseline scores on tests of memory and 
of category fluency) as risk factors for incident dementia. The 
longitudinal study showed that after five years, 44% of the sample (45 
patients) develop dementia. Short and long term memory were assessed by 
the Benton Visual Retention Test Revised (Benton, 1974), the Buschke Cued 
Recall Test (Buschke, 1984), the Rey Auditory Verbal learning Test (Rey, 
1964), and the Wechsler Memory Scale Revised (Information and Digit Span 
subtests) (Wechsler, 1987); language was assessed by the Token Test (De 
Renzi and Vignolo, 1962), the Controlled Oral Word Association Test 
(Benton and Hamsher, 1989), and the Animal Naming Test (Rosen et al., 
1980). More recently, Garrett et al. (2004) showed that 
neuropsychological profile of 18 vascular CIND patients is characterized 
by the impairment of cognitive flexibility, verbal retrieval, and verbal 
recognition memory, by using the Trail Making Test (Reitan, 1992), the 
Controlled Oral Word Association Test (Benton and Hamsher, 1989), the 
Boston Naming Test (Kaplan et al., 1983), and the California Verbal 
Learning Test (Delis et al., 1987).      
 
SUBCLINICAL COGNITIVE IMPAIRMENT 
More recently, research focus has concentrated on the stage that should 
precede Mild Cognitive Impairment, named “Subclinical Cognitive 
Impairment” (SCI) (Ritchie et al., 1996). The importance to identify SCI 
lies on the potential role that it can play in dementia prevention 
(especially AD). SCI refers to subjective memory complaints very common 
in aging and it can be associated with other conditions, especially 
dementia and depression (Reisberg and Gauthier, 2008). On the basis of 
the Eugeria Study, Ritchie et al. (1993) tested 397 individuals with SCI 
by the Détérioration Cognitive Observée (DECO) structured questionnaire 
(Ritchie and Fuhrer, 1994) and by the Examen Cognitif par Ordinateur 
(ECO) (Ritchie et. al., 1993). It was concluded that individuals with SCI 
constituted a large heterogeneous group with an elevated risk for senile 
dementia with an estimated 18% incidence rate of conversion over three 
years, although SCI was more commonly associated with depression symptoms 
and physical illness. Only 13% of the sample with minimum cognitive 
impairment appeared to have a totally benign and transient syndrome. In a 
subsequent study, Ritchie and his team (2000) investigated SCI using the 
same assessment to determine if such a nosographic label could represent 
normal aging, early senile dementia or a separate clinical entity. Over 
the 1-year period, 48% of the sample had some degree of observable 
cognitive deterioration on attention, language performance and working 
memory. Over the 3-year period, 18% of the sample developed a form of 
senile dementia. It appeared that SCI was a highly heterogeneous group 
for which previous classification such as Benign Senescent Forgetfulness 
(Kral, 1962) or Age-associated Memory Impairment (Crook et al., 1986), 
were largely inappropriate. Other criteria for diagnosis of SCI were 
referred to GDS Stage 2 (Reisberg et al., 1985): 
a. patients‟ complaint of forgetting where familiar objects have been 
placed; 
b. they do not remember well-known names and display appropriate 
concern about the symptom; 
c. their performance is below average for age and education on the 
WAIS vocabulary score on 3 of 5 Guild memory subtests.  
The hypothesis that SCI was a first step in the course from SCI -> MCI -> 
AD continuum was supported by an important longitudinal study of Prichep 
et al. (2006). The researchers followed 44 SCI subjects (all GDS Stage 2 
at baseline) and examined outcomes after a minimum of seven years. The 
decline was defined as a cognitive change that met diagnostic criteria 
for MCI or dementia over the follow-up interval. They observed that 27 
out of 44 individuals progressed to MCI over a period of 9 years. Current 
research indicates that SCI is a common condition in elderly persons and 
it represents a primary stage of MCI. A probable duration of 15 years of 
SCI stage has been supported by many longitudinal studies as a 
potentially identifiable clinical entity (Reisberg and Gauthier, 2008).               
 
 
2.5 CONCLUSION 
Once the nosological and conceptual aspects of slight cognitive 
impairment in the context of its historic evolution have been reviewed, 
we can conclude that despite the great number of articles describing this 
category, only a few scientific contributions provide specific 
inclusion/exclusion criteria for diagnosis, such as Primary Degenerative 
Dementia (Sulkava et al., 1983), Age-associated Memory Impairment (Crook 
et al., 1982; Blackford and La Rue, 1989), Age-consistent Memory 
Impairment and Late-Life Forgetfulness (Blackford and La Rue, 1989), Age-
associated Cognitive Decline (Levy, 1994), Mild Cognitive Impairment 
(APA, 1990; WHO, 1993), Mild Cognitive Disorder (WHO, 1993), Mild Neuro-
cognitive Disorder (APA, 1994), and Mild Cognitive Impairment with 
subcortical vascular features (Frisoni et al., 2002). In fact, only some 
clinical entities refer to graded cognitive impairment of normal aging 
for which precise psychometric norms are available while the others 
belong to psychiatric manual classifications (also useful for 
differential diagnosis), or try to differentiate between degenerative and 
vascular dementia. Slight cognitive impairment appears to be a 
heterogeneous condition that shows the complex nature of cognitive 
decline in aging. The clinical entities we have described in the paper, 
should be divided into five sub-categories, based on clinical features 
and probable prognosis (Table 14):  
 normal aging, as benign cognitive impairment occurring in late life; 
 clinical preface of mild cognitive impairment; 
 mild cognitive decline, as a transitional state between physiological 
aging and early dementia; 
 dementia progression; 
 other pathological conditions related to psychiatric disorders.  
 Table 14. Classification of slight cognitive impairment clinical entities (Note: GDS, Global 
Deterioration Scale; CDR, Clinical Dementia Rating; CAMDEX, Cambridge Mental Disorders of the 
Elderly Examination; SISCO, Structured Interview for the Diagnosis of Dementia of the Alzheimer 
Type, multi-infarct dementia, and dementias of other aetiology according to DSM-III and ICD-10 
(SIDAM) score; MMSE, Mini Mental State Examination).   
 
A vast and various set of psychiatric, psychological, and 
neuropsychological tools have been used to assess slight cognitive 
impairment. However, the assessment was not able to provide an exact 
psychometric evaluation of impaired cognitive domains. Many researchers 
adopted the convention of 1-1.5 SD below the mean as the limit for normal 
performance. Therefore, test scores under 1.5 SD meet the diagnosis of 
MCI. This convention is referred only to measures of delayed recall 
(Petersen et al., 1999). The psychometric rule appears theoretically 
valid but practically inadequate. In fact, in clinical practice, it is 
not sufficient to analytically assess impaired cognitive domains, 
especially in the case of the memory system, attention system and 
executive functioning. In our opinion, the assessment of slight cognitive 
impairment should pursue the following targets:  
1. to distinguish age-related cognitive impairment from early 
dementia; 
2. to evaluate objective memory deficits reported by elderly people 
with subjective memory complains; 
3. to clarify if subclinical cognitive impairment can be considered 
a stage prior to Mild Cognitive Impairment;   
4. to manage decision in patient‟s care, including cognitive 
stimulation interventions, such as “Activation Therapy” (AT) 
(Cammisuli et al., 2009a; 2009b);  
5. to differentiate mood and cognitive symptoms in pseudodementia; 
6. to distinguish between Cognitive Impairment no-Dementia and Mild 
Cognitive Impairment.  
 
With reference to the fifth point, we would underline that the 
psychodiagnostic tools used to assess pseudodementia in the elderly 
include check-lists, structured interviews and self-rating scales for 
mental disorder evaluation, and they can be divided into “specific” and 
“non-specific” tools (Table 15).  
                                                            
Table 15. Specific and non-specific assessment for diagnosis of depression in dementia (Modified 
form: Bianchetti and Pezzini, 2001). 
 
The specific tools evaluate depressive symptoms in patients with dementia 
or discriminate depressive pseudodementia from organic dementia. By 
contrast, non-specific tools evaluate psychiatric symptoms with 
particular attention to depressive ones. They are mostly observational 
scales or tools used for epidemiological investigations.  
With regard to the sixth point, we do stress that the diagnosis of 
Cognitive Impairment no-Dementia (CIND) in clinical practice appears, at 
the moment, the most adequate to diagnose different types of slight 
cognitive impairment, from normal aging to mild cognitive decline. In 
recent years, some investigators have defined a subset of persons with 
CIND who resembled MCI subjects more closely (Fisk et al., 2003): MCI 
seems to be a subtype of CIND that can include impairments of single or 
multiple domains (Table 16).  
       
Table 16. Diagnostic criteria for Mild Cognitive Impairment and Cognitive Impairment no-Dementia: A 
comparison. 
 
We wish that further studies will investigate more deeply the 
relationship between CIND and MCI to clarify whether or not MCI might 
represent a specific subtype of CIND. Mild Cognitive Impairment has 
received a great deal of interest concerning the topic of a transitional 
state between normal aging and dementia, or more specifically Alzheimer‟s 
Disease. However, the controversy over the MCI well-definition and 
assessment is nowadays present. Because of marked MCI heterogeneity, it 
is desirable for future research to specify neuropsychological profiles 
of every MCI subcategory and to use comprehensive neuropsychological 
testing for exploring all cognitive domains. In a recent study (Timpano 
Sportiello and Cammisuli, 2010a), one hundred subjects with MCI were 
tested by using a wide neuropsychological test battery including: 
A. global cognitive screening: Milan Overall Dementia Assessment 
(Brazzelli et al., 1994); 
B. autonomy evaluation: Activities of Daily Living (Katz, 1970) and 
Instrumental Activities of Daily Living (Lawton and Brody, 
1969); 
C. specific evaluation for every cognitive domain: 
- Orientation:  
Temporal Orientation (From MODA); 
Spatial Orientation (From MODA); 
Personal Orientation (From MODA); 
Family Orientation (From MODA); 
- Memory System:  
a. structural tests: 
Pairs Associates Learning (Spinnler and Tognoni, 1987); 
Digit Span (Spinner and Tognoni, 1987); 
Corsi Span (Spinnler and Tognoni, 1987); 
Story Recall (Spinnler and Tognoni, 1987); 
Corsi Suvra-span learning (Spinnler and Tognoni, 1987); 
b. ecological tests:  
Rivermead Behavioural Memory Test (Della Sala et al., 2000); 
- Orientation: 
Temporal Orientation (from MODA); 
Spatial Orientation (from MODA); 
Personal Orientation (from MODA); 
Family Orientation (from MODA); 
- Attention System:  
Stroop Color Word Interference Test (Golden, 1978);  
Visual Search Test (Spinnler and Tognoni, 1987); 
- Visual Agnosia:  
Street‟s Completion Test (Spinnler and Tognoni, 1987); 
- Constructive Apraxia:  
Constructive Apraxia Test (Spinnler and Tognoni, 1987); 
- Language: 
Boston Naming Test (Kaplan et al., 1983);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
- Executive Functioning:  
Frontal Assessment Battery (Dubois and Litvan, 2000);  
Brixton Test (Burgess and Shallice, 1997);  
Towers of London (Shallice, 1982);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
Visual Search Test (Spinnler and Tognoni, 1987);  
Stroop Color Word Interference Test (Golden, 1978). 
 
While Petersen (2004) reported that the main subtype of MCI consists of 
the so-called amnestic MCI single domain, we found that amnestic MCI 
multiple domain appears to be the main subtype (60% of  subjects) of the 
whole sample. Within the memory system, declarative memory is the most 
fragile subdomain and verbal memory performance declines later than 
visual-space performance. Abilities of visual gnosia deteriorate more 
frequently than other instrumental extra-memory functions; alternatively, 
constructive apraxia performances remain fairly stable. Anomia is the 
most important language impairment. Amnestic MCI multiple domain probably 
represents the highest risk subgroup for incipient dementia, as confirmed 
by MODA 7-month follow-up. According to previous studies (Timpano 
Sportiello, 2006b; Timpano Sportiello & Cammisuli, 2009), for a 
considerable number of MCI subjects, the onset of  symptoms consists of 
combined deficits in memory and in executive functioning. This study 
(Timpano Sportiello and Cammisuli, 2010) confirms the preceding 
investigations of Zhang et al. (2007) and Brand et al. (2009): within 
frontal domains planning, selective attention and sensibility to 
interference deteriorate more frequently than inhibitory control and 
mental flexibility. It supports that such a kind of deficits could 
represent the main risk factors for MCI conversion into frank dementia. 
In our opinion, future studies should clarify the role of these factors 
in MCI conversion into dementia and if the amnestic MCI multiple domain 
can really represent the highest risk subgroup.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. MILD COGNITIVE IMPAIRMENT: CLINICAL FEATURES 
 
3.1 EPIDEMIOLOGY 
Although MCI is associated with an increased risk of developing dementia, 
there has been little work on its incidence and prevalence. Prevalence 
and incidence rates of MCI vary as a result of different diagnostic 
criteria as well as different sampling and assessment procedures 
(Petersen et al., 2001).   
Several investigations worldwide used MCI revised criteria to estimate 
frequency of MCI and its subtypes (Larrieu et al., 2002; DeCarli, 2003; 
Ganguli et al., 2004; Busse et al., 2006;).  
The Mayo Clinic Study on Aging (Roberts et al., 2008) was designed as a 
population-based study in Minnesota, involving a sample of nearly 3000 
participants, aged 70-89, with a diagnosis of MCI. The prevalence of the 
whole MCI was estimated at approximately 15% of the non-demented 
population, with a 2:1 ratio of aMCI to naMCI. The most common putative 
cause is degenerative and it predominates to a greater extent both for 
aMCI and naMCI.  
The other studies are summarized in Table 17. Although these studies 
incorporate different assessment tools to evaluate MCI, yielding some 
variability, there is a coalescence of prevalence rates from around the 
world (Lopez et al., 2003; Busse et al., 2006). 
  
 
 
 
 
Source Study Location No. of 
Participants  
Participants’ Age, 
y 
Prevalence of MCI, 
% 
Unverzagt al., 
2001 
Hänninen et 
al., 2002 
Lopez et al., 
2003 
Ganguli et al., 
2004 
Busse et al., 
2006 
Das et al., 
2007 
Di Carlo et 
al., 2007 
Fisher et al., 
2007 
Manly et al., 
2008 
Palmer et al., 
2008 
Plassman et 
al., 2008 
Roberts et al., 
2008 
Indianapolis, IN 
 
Finland 
 
CHS Washington DC, 
US 
MoVIES, 
Pennsylvania, US  
 
Leipzig, Germany 
India 
 
Italy 
 
Vienna, Austria 
 
Manhattan NY, US 
 
Stockholm, Sweden 
 
ADAMS Michigan, US 
 
Rochester MN, US 
2212 
 
806 
 
1690 
 
1248 
 
 
980 
745 
 
2830 
 
581 
 
2364 
 
379 
 
856 
 
1696 
≥65 
 
60-76 
 
≥75 
 
≥65 
 
 
75-79 
≥50 
 
65-84 
 
75 
 
≥65 
 
75-95 
 
≥71 
 
70-89 
23.4 
 
5.3 
 
22 
 
3.2 
 
 
19.3 
14.9 
 
16.1 
 
24.3 
 
21.8 
 
11.1 
 
22.2 
 
14.8 
Table 17. Prevalence studies on Mild Cognitive Impairment (From: Petersen et al., 2011). Note: 
ADAMS: Aging, Demographics and Memory Study; CHS: Cardiovascular Health Study; MoVIES: Monongahela 
Valley Independent Elders Survey). 
 
An epidemiological study of Tognoni et al. (2005) was designed to 
estimate the prevalence of cognitive deficits among residents of a Tuscan 
district. The prevalence of MCI and age-related cognitive decline was 
estimated at 4.9% and 9.3%, respectively.  
 
Few incidence studies have been carried out on MCI. An average incidence 
rate from 12 (Ganguli et al., 2000) to 15 (Andersen et al., 1999) per 
1000 person-years has been reported for individuals with MCI of 65 years 
of age and above. For 75 years of age and above, the incidence rate of 54 
per 1000 person-years has been estimated (Bischkopf et al., 2002).  
 
Similar to dementia, incidence rates of MCI seem to increase with age and 
it is higher for people with low education. In contrast to the 
epidemiology of dementia, a tendency of higher incidence rates of mild 
cognitive impairment for men compared with women has been reported, too 
(Roberts et al., 2008).    
 
The results of the Leipzig Longitudinal Study of the Aged (LEILA 75+) 
showed that the annual incidence rates applying different case 
definitions varied from 8 to 77 per 1000 person-years (Busse et al., 
2003). In particular, the annual rate incidence calculated on the studies 
that used Petersen‟s original criteria (1999) was 8.5 (95% CI 4.8-14.1); 
alternatively, for the studies that used the modified criteria (Petersen, 
2004) it was 12.2% (95% CI 63.3-92.9) (Amnestic MCI Single Domain – 8.5, 
12.2 and 14 cases per 1000 person-years; Amnestic MCI Multiple Domain – 9 
per 1000 person-years; Non-Amnestic MCI Single Domain – 23 per 1000 
person-years; Non-Amnestic MCI Multiple Domain – 5 per 1000 person- 
years)
6
. 
 
A recent review (Luke et al., 2010) has studied the incidence of MCI 
subtypes. Results show that amnestic MCI subtypes ranged between 9.9 and 
40.6 per 1000 person-years, and the incidence of non-amnestic MCI 
subtypes was 28 and 36.3 per 1000 person-years. Regarding any MCI, 
incidence rates of 51 and 76.8 per 1000 person-years were found. A higher 
risk of incident MCI mainly resulted for higher age, low education and 
hypertension..   
 
 
 
3.2 DIAGNOSIS
7
 
 
Patients first have a complete medical exam, along with a detailed 
history of symptoms and medical history, including medications.  
 
                                                        
6
 Epidemiological data reported could be affected by the diagnostic procedure used.  
7
 Mild Cognitive Impairment. Diagnosis (n.d.). Retrieved April, 20, 2011, from http://www.mayoclinic                           
 .org/mild-cognitive-impairment/diagnosis.html. 
Patients and caregivers are interviewed about patients‟ emotional state 
and day-to-day routines. Family members and co-workers can also provide 
valuable information about changes in a patient‟s behaviour and 
personality.  
 
A neurologist‟s examination helps identify signs of different dementias, 
strokes, tumors, and other medical conditions that may impair cognitive 
functioning. The neurological exam may test reflex, eye movements, 
walking and balance, and sense of touch.      
 
Patients were submitted to a global status examination
8
. Longer forms of 
neuropsychological testing can provide additional details about the 
specific impairment of cognitive domains
9
; in addition, patients may 
undergo psychiatric assessment to discover if depression or other mental 
illnesses are present (cf. 3.2.1).  
The patient's blood sample is checked for infections or conditions such 
as vitamin deficiency, anemia, medication levels, disorders of the 
thyroid, kidneys or liver, and other factors that can cause memory loss.  
 
Brain imaging techniques (Computed Tomography Scan, Magnetic Resonance 
Imaging and functional Magnetic Resonance Imaging, Positron Emission 
Tomography, and Single Photon Emission Computed Tomography) help detect 
strokes, tumors or other conditions that may have affected the brain, 
pointing out structural and functional changes of the brain associated 
with memory decline.  
                                                        
8
 Short forms of mental status testing can be done in about 10 minutes. Commonly used tests include 
the following tasks and questions: (i) draw a clock face with the hands showing a time specified by 
the examiner; (ii) name today's date and your location;  (iii) copy a picture, such as two 
intersecting pentagons; (iv) follow a three-step command; (v) remember a list of three words spoken 
to you by the examiner; (vi) follow a written instruction; (vii) write down a complete sentence; 
(viii) count backward from 100 by sevens. 
9
 Mild Cognitive Impairment. Tests and diagnosis. Retrieved April, 20, 2011, from 
http://www.mayoclinic.com/health/mild-cognitive-impairment/DS00553/DSECTION=tests-and-diagnosis 
 Other tests that provide important diagnostic information include an 
electroencephalogram, electromyogram, urine test, and cerebrospinal fluid 
test. However, physicians discuss with the patients and caregivers which 
tests are the most appropriate to establish the correct diagnosis.  
 
3.2.1 NEUROPSYCHOLOGICAL ASSESSMENT 
 
Initially, the clinical entity of Mild Cognitive Impairment was 
exclusively referred to the amnestic subtype (Petersen, 1995). 
Subsequently, in addition to memory impairment, further studies have 
shown the presence of extra-memory and executive functioning deficits 
(Richards et al., 1999; Ritchie et al., 2001). The current diagnosis of 
MCI follows an algorithm (see Appendix 1) that divided the category into 
four subgroups: MCI Type I (amnestic MCI single domain), MCI Type II 
(amnestic MCI multiple domain), MCI Type III (non-amnestic MCI single 
domain), MCI Type IV (non-amnestic MCI multiple domain).  
 
A vast and various set of psychodiagnostic tools (psychiatric, 
psychological and neuropsychological tests) have been used to diagnose 
MCI over time. Nelson and O‟Connor (2008) reported those more frequently 
used for the evaluation of global cognitive functioning, intelligence, 
attention system, memory system, language, gnosis and praxis and 
executive functioning respectively: Mini Mental Status Examination 
(Folstein et al., 1975) and Dementia Rating Scale (Mattis, 1988); 
Wechsler Adult Intelligence Scale-III (Wechsler, 1997); Trail Making Test 
(Reitan, 1971); Rey Auditory Verbal Learning Test (Rey, 1964), California 
Verbal Learning Test (Delis et al., 1987); Boston Naming Test (Kaplan et 
al., 1983), Controlled Oral Word Association Test (Benton and Hamsher, 
1978), Token Test (De Renzi and Vignolo, 1962) and Boston Diagnostic 
Aphasia Examination (Goodglass and Kaplan, 1976), Benton Facial 
Recognition Test (Benton et al., 1983), Wechsler Adult Intelligence 
Scale-III Picture Completion and Block Design subtests (Wechsler, 1997), 
Hooper Visual Organization Test (Hooper, 1958), Rey Complex Figure and 
Osterreith Clock/Cube-Drawing Test (Rey, 1941); Trail Making Test 
(Reitan, 1971), Stroop Color Word Interference Test (Golden, 1978) and 
Wisconsin Card Sorting Test (Heaton, 1981). More specifically, all the 
studies reporting diagnostic criteria and assessment used for the 
diagnosis of MCI are outlined in Table 18.      
 
MCI CLASSIFICATIONS DIAGNOSTIC CRITERIA ASSESSMENT 
Mild Cognitive Impairment not 
amounting to dementia (World 
Health Organization, 1978). 
Slight cognitive impairment 
associated with aging.  
Not specified. 
Mild Cognitive Impairment 
(diagnostic criteria selected 
from Dementia criteria) 
(American Psychiatric 
Association, 1987). 
Memory Impairment (MCI Type I); 
impairment of memory, executive 
functioning, language, praxis, 
and gnosis (MCI Type II). 
Not specified. 
Mild Cognitive Impairment 
(diagnostic criteria selected 
from Dementia criteria) (World 
Health Organization, 1987). 
Memory Impairment (MCI Type I); 
memory impairment and 
intellectual abilities decline 
(MCI Type II); memory 
impairment, intellectual 
abilities decline and 
deteriorated activities of 
daily living (MCY Type III). 
Not specified.  
Mild Cognitive Impairment 
(Fliker et al., 1991).  
Short- and long- term memory, 
language, visuo-spatial praxis, 
and executive functioning 
impairment. GDS Stage 3. 
 
Global Deterioration Scale 
(Reisberg et al., 1982). 
Mild Cognitive Impairment 
(according to diagnostic 
criteria of DSM-III and ICD-
10).  
Diagnosis of Mild Cognitive 
Impairment (APA, 1987) plus a 
SISCO (SIDAM score) of 34-47 
and MMSE of 23-27. 
 
Structured Interview for the 
Diagnosis of Dementia of the 
Alzheimer Type, multi-infarct 
dementia, and dementias of 
other aetiology according to 
DSM-III and ICD-10 (Zaudig, 
1992), Mini Mental State 
Examination (Folstein et al., 
1975).  
Mild Cognitive Impairment 
(Petersen, 1995).  
1. Complaint of 
defective memory; 
2. Normal activities of 
daily living; 
3. Normal general 
cognitive function; 
4. Abnormal memory 
function for age; 
5. Absence of dementia.  
Free and Cued Selective 
Reminding Test (Buschke, 1984), 
Rey Auditory Verbal Learning 
Test (Rey, 1964), Mini Mental 
State Examination (Folstein et 
al., 1975), Wechsler Adult 
Intelligence Scale Revised 
(Wechsler, 1981), Mattis 
Dementia Rating Scale  (Mattis, 
1988).  
Mild Cognitive Impairment 
(Petersen et al., 1999).  
f. Memory complaint, 
preferably 
corroborated by an 
informant; 
g. Memory impairment 
documented according 
Wechsler Adult Intelligence 
Scale Revised (Wechsler, 1981), 
Rey Auditory Verbal Learning 
Test (Rey,1964), Wide-Range 
Achievement Test (Jastak and 
Jastak, 1978), Mini Mental 
to appropriate 
reference values; 
h. Essentially normal 
performance in non-
memory cognitive 
domains; 
i. Generally preserved 
activity of daily 
living; 
j. Not demented. 
State Examination (Folstein et 
al., 1975), Mattis Dementia 
Rating Scale  (Mattis, 1988), 
Free and Cued Selective 
Reminding Test  (Buschke, 
1984), Boston Naming Test 
(Kaplan et al., 1983), 
Controlled Oral Word 
Association Test (Benton and 
Hamsher, 1978), modified 
Category Fluency (Monsch et 
al., 1984).  
Mild Cognitive Impairment with 
subcortical vascular features 
(Frisoni et al., 2002).  
Mild memory deficit (impaired 
recall, relative intact 
recognition, less severe 
forgetfulness, benefit form 
cues) and disexecutive syndrome 
(impairment in goal 
formulation, planning, 
organizing, set-shifting and 
self-maintenance, and 
abstracting). 
Category Fluency (Novelli et 
al., 1986), Wisconsin Card 
Sorting Test (Heaton, 1981), 
Finger Tapping Test (Halstead, 
1947), Token Test (De Renzi e 
Vignolo, 1962), Limb Apraxia 
(De Renzi et al., 1968),  Digit 
span forward and Corsi span 
(Orsini et al., 1987),  Story 
Recall (Spinnler e Tognoni, 
1987).  
Table 18. Classifications of Mild Cognitive Impairment: diagnostic criteria and assessment used for 
diagnosis   
 
 
In order to observe the longitudinal course of MCI and the probability of 
its conversion into dementia, a recent literature review (Gallssi et al., 
2008) has suggested the use of the following psychodiagnostic tools which 
are more sensitive to cognitive decline: learning, delayed recall, visual 
recognition and attention (Barbeau et al., 2004), phonemic and semantic 
verbal fluency (Canning et al., 2004, Carlesimo et al., 2008), 
psychomotor skills (Darby et al., 2002), executive functioning, and an 
ecological test apt to explore ongoing memory, such as the Rivermead 
Behavioural Memory Test (Wilson et al., 1985).   
 
Performance on the memory test is commonly reported as a predictive 
element of conversion into dementia. According to Petersen and Negash 
(2008), MCI patients with memory plus other cognitive domain deficits, 
rather than those with pure memory deficits, constituted the high-risk 
subgroup apt to develop dementia (Timpano Sportiello and Cammisuli, 
2010a).  
 
Neuropsychological testing can be extremely useful in making the MCI 
diagnosis and tracking the evolution of cognitive symptoms over time 
(Cammisuli et al., 2010a). A comprehensive test battery should include 
measures of baseline intellectual ability, memory, attention, visuo-
spatial skills, language and executive functions. Informant-based 
measures of neuropsychiatric symptoms such as the Neuropsychiatric 
Inventory Questionnaire (Kaufer et al., 2000), behaviour and competency 
in personal and instrumental activity as in the Blessed Dementia Scale  
(Kaufer et al., 2000), or The Record of Independent Living (Weintraub et 
al., 1982; Weintraub, 1986), are also included. 
 
For those individuals who show depressive symptoms associated with 
apparent cognitive decline (pseudodemented patients), it is useful to 
adopt psychodiagnostic tools for the evaluation of mental disorders, in 
addition to the neuropsychological battery. The psychodiagnostic tools 
used to assess pseudodementia in the elderly include check-lists, 
structured interviews and self-rating scales for mental disorders 
evaluation, and they can be divided into “specific” and “non-specific” 
tools (Table 19). The specific tools evaluate depressive symptoms in 
patients with dementia or discriminate depressive pseudodementia from 
organic dementia. By contrast, non-specific tools evaluate psychiatric 
symptoms with particular attention to depressive ones. They are mostly 
observational scales or tools used for epidemiological investigations.  
  
                 
Cornell Scale for Depression in Dementia Alexopoulos et al., 1988 
Dementia Mood Assessment Scale Sunderland and Minichiello, 1988 
The Pseudodementia Scale Yousef et al., 1999 
GMS-AGECAT Package Copeland et al., 1986 
Cambridge Mental Disorders of Elderly 
Examination (CAMDEX) 
Roth et al., 1986 
Neuropsychiatric Inventory (UCLA-NPI) Cummings et al., 1994 
Specific 
tools 
Non- 
specific 
tools 
Clinical Assessment of Psychopathology 
among the elderly residents (CAPER) 
Reichenfeld et al., 1992 
Nurses‟ Observation Scale for Inpatient 
Evolution (NOSIE) 
Honigfield et al., 1966 
Brief Assessment Scale McDonald et al., 1982 
Table 19. Specific and non-specific tools for the diagnosis of pseudodementia 
 
 
3.2.2 BIOLOGICAL AND GENETIC MARKERS 
 
Currently, biomarkers can be used mainly as a research tool and 
optionally by specialists with the purpose of identifying persons with a 
high risk of progressing to AD in conjunction with other types of 
evaluation. Multiple studies over recent years have confirmed that these 
biomarkers can effectively discriminate control subjects from demented 
patients with a clinical diagnosis of AD (Hampel et al., 2004). All 
groups who have studied CSF tau and Aβ1-42 in MCI populations, have found 
mean concentrations to be intermediary between AD and control values, but 
closer to the AD levels in patients who decline to dementia (Mayurama et 
al., 2004). As a potential index of AD, tau and Aβ1-42 concentrations 
could be useful outcome measures in treatment studies even if  
preliminary evidence suggests that repeated measurements may not always 
correlate with disease progression (Andersen et al., 1999).   
 
There are no major genes involved in MCI. Each of the disorders related 
to MCI, such as AD, vascular pathology and depression, may partly have a 
genetic origin (Winblad et al., 2004). Thus, different genes could 
explain the aetiology of MCI. Moreover, genetic and environmental 
interaction creates a complex picture. Identification of mutations in 
amyloid precursor protein (APP), presenilin 1 (PSEN 1) and 2 (PSEN2), 
tau, PRNP and α-synuclein may be useful in determining the aetiology of 
cognitive impairment in patients with a history of neurodegenerative 
diseases (Petersen et al., 2009). Prospective phenotypic studies of 
apolipoprotein E (ApoE) ε4 carriers may be useful for understanding the 
early clinical features of AD. 
 
It is well recognized that persons carrying the ε4 isoform of ApoE are at 
increasing risk of developing AD later (Saunders et al., 1993). Poirier 
et al. (1993) found that the prevalence of non-demented persons with at 
least one copy of the ε4 isoform was 22% while in AD the frequency was 
64%. Other studies have found that ε4 status was a significant risk 
factor for MCI conversion to AD (Lopez et al., 2003; Tervo et al., 2004). 
 
Even if epidemiological and clinical data support ε4 as risk factors for 
cognitive decline and dementia, its utility as a predictive outcome of 
the MCI population needs to be compared to imaging, biomarker and 
neuropsychological variables. 
 
 
3.2.3 NEUROIMAGING TECNIQUES 
 
Until the Nineties, the diagnosis of mild cognitive impairment (MCI) and 
dementia was based on clinical psychiatric observation, neurological 
examination, laboratory tests, and psychological and neuropsychological 
assessment. More recently, cognitive neuroscience of aging has focused on 
the links between cognitive decline and brain aging. These studies employ 
a variety of methods, but the most interesting are functional 
neuroimaging techniques, such as functional Magnetic Resonance Imaging 
(fMRI). It provides an in vivo means to investigate alterations in brain 
function related to the earliest symptoms of AD, possibly before 
development of irreversible brain modifications. The pathological process 
of AD begins years prior to the time that a clinical diagnosis can be 
established. This minimally symptomatic phase provides a potential period 
for early therapeutic interventions to prevent or delay the clinical 
onset of severe cognitive deterioration.  
Thus, neuroimaging techniques can help to predict the probability of 
developing dementia, by evaluating brain modifications in the course of 
cognitive decline. 
 
Structural imaging 
 
Neuroimaging research on MCI has focused on the medial temporal lobe, 
with particular emphasis on structures, such as the hippocampus and the 
entorhinal cortex that reflects a volume loss (Devanand et al., 2007).  
 
More recently, MRI studies have found atrophy of the entorhinal cortex in 
MCI patients with greater volume reductions in cases that decline to 
dementia (Du et al., 2001; Killiany et al., 2004).  
 
Some structural MRI studies showed also that the rate of medial temporal 
lobe atrophy can predict conversion from normal cognition to MCI (Rusinek 
et al., 2003; Jack et al., 2005). 
 
Functional imaging 
 
Positron emission tomography 
The recent development of Positron Emission Tomography (PET) 
methodologies has made possible the study of in vivo biochemical 
correlates of cognitive and behavioural functions of human beings 
(Pietrini et al., 1999). PET can provide measures of cerebral glucose 
metabolism, blood flow and neurotransmitter metabolism in a variety of 
physiological conditions and it can be used to evaluate the effects of 
neurological and psychiatric disorders (Holcomb et al., 1989). Moreover, 
in neurodegenerative disorders, such as Alzheimer‟s Disease, it offers 
the opportunity to determine the effects of the pathological process on 
brain function throughout the course of cognitive decline (including 
subtle changes in preclinical phase), to assess the relationship between 
the regional distribution of pathology and symptomatological and 
cognitive manifestation in clinical subtypes, and to evaluate the 
response to treatment (Furey et al., 2000). In agreement with autopsy 
study that indicated a variable distribution of neurofibrillary tangles 
in AD, studies using PET with 
18
FDG
10
 in the resting-state showed reduced 
rCMR-glc in the association neocortical areas, with a relative sparing of 
primary neocortical and subcortical regions, at least until the later 
stages of the disease (Pietrini et al., 1996). While it is well-known 
that there is a loss of 30-40% of cells in AD, the metabolic reductions 
measured by PET are not merely the result of cortical atrophy. Ibáñez and 
colleagues (1998) used a high-resolution segmented structural magnetic 
resonance images to correct rCMRglc measures for the partial volume 
effects (PVE) that occur as a result of brain atrophy in a group of 
patients with AD (from mild to severe) and in a group of age-matched 
healthy controls. Results demonstrated that rCMRglc reductions per 100 
grams of brain tissue in parietal, frontal and temporal cortex remained 
                                                        
10
 In the human nervous system, regional cerebral metabolic rates for glucose (rCMRglc), as 
determined by using PET with F-fluoro-2-deoxy-glucose (FDG) represents a reliable index of 
functional synaptic activity (Pietrini and Rapaport, 2000). The oxidative metabolism of glucose to 
which rCBF is coupled, produces adenosine triphoshate (ATP), the main energy carrier in the cell. 
More than 60% of the consumption of energy in the form of ATP is for maintenance and restoration of 
ionic gradients and membrane potentials due to electrical activity associated with action potentials 
and transmission of impulses from neuron-to-neuron (Jeuptner and Weiller, 1995). Therefore, 
increases functional electrical activity increase the demand for ATP and, in turn, for glucose 
utilization and are associated with parallel changes in capillary blood flow in the same brain 
regions (Pietrini et al., 2000).  
significantly lower in AD patients than in controls, after PVE 
correction.  
 
The evaluation of cerebral metabolism also can aid to identify different 
pathophysiological features in relation to different symptomatological 
and cognitive patterns observed in clinical subtypes of AD, such as the 
subtype with visuospatial functioning deficit in the absence of memory 
complaints. Compared to AD patients, subjects with this relative rare AD 
subtype showed a distinct distribution of metabolic abnormalities, 
characterized by a significantly greater reduction of glucose metabolism 
in occipital cortical areas, including the calcarine cortex (a region 
usually spared in typical Alzheimer‟s disease) and a metabolic 
preservation in frontal, temporal and limbic structures (greatly affected 
in patients with typical Alzheimer‟s disease). Differently, glucose 
metabolism in the parietal lobes was affected to the same extent in both 
groups (Pietrini et al., 1996).  
 
In the last few years, scientists have tried to identify early changes in 
brain metabolic function that could led to a diagnosis of Alzhiemer‟s 
disease prior to the onset of clinical symptoms. To pursue this goal, 
Pietrini et al. (1993; 1997a) conducted two longitudinal clinical, 
neuropsychological and brain metabolism studies in population at risk to 
develop AD, such as individuals with a family history of autosomal 
dominant Alzheimer‟s disease and with Down‟s syndrome11. In the first 
study, rCMRglc data did not reveal any consistent abnormality of the 
subjects with isolated memory impairment and with a family history for 
autosomal dominant AD as compared to control group. However, 1 year 
                                                        
11
 All subjects with Down‟s syndrome over 40 years of age show some neuropathological and 
neurochemical abnormalities post-mortem similar to those observed in Alzheimer‟s disease, and 90% 
develop dementia after 60 years of age (Holland and Oliver, 1995; Haxby and Schapiro, 1992). 
later, the follow-up did reveal reduced parietal rCMRglc values 
coinciding with a worsening of cognitive impairment. In the second study, 
starting form the observation that older nondemented adults with Down‟s 
syndrome showed normal rates of regional cerebral glucose metabolism at 
rest before the onset of dementia, the authors verified that the 
application of an audiovisual stimulation paradigm (acting as a stress 
test) could reveal abnormalities in cerebral glucose metabolism before 
the onset of dementia in the neocortical parietal and temporal areas, 
that result to be most vulnerable to AD. A previous investigation 
(Pietrini et al., 1997b) had shown that functional brain responsivness, 
evaluated by a passive audiovisual stimulation paradigm with PET, was 
within normal limits in mildly demented Alzheimer patients but failed 
with worsening dementia severity.  
 
Studies  in  patients  with  MCI  demonstrated  similar topographic 
patterns of AD, such as metabolic reduction in temporoparietal regions as 
well as in the posterior cingulate gyrus (Minoshima et al., 1997).   
 
de Leon et al. (2001) found metabolic reductions of entorhinal cortex to 
be associated with longitudinal decline in MCI. Small et al. (2006) 
examined 25 AD patients, 28 MCI subjects, and 30 with no cognitive 
impairment by using FDDNP-PET
12
, and found that global values for FDDNP-
PET binding (average of the
 
values for the temporal, parietal, posterior 
cingulate, and
 
frontal regions) were lower in the control group than in 
the
 
group with MCI (p<0.001) and that the values
 
for binding in the group 
with MCI were
 
lower than in the group with AD (p<0.001). They concluded 
the technique is a potential noninvasive method to determine regional 
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 By using the radiotracer 18F-FDDNP, a molecule that binds to the tangles and plaques, and positron 
emission tomography (PET). 
cerebral
 
patterns of amyloid plaques and tau neurofibrillary tangles in 
patients with different levels of cognitive deterioration.       
 
Functional magnetic resonance imaging 
Structurally, MCI is characterized by atrophy of the medial temporal lobe 
(MTL) regions, such as the hippocampus and entorhinal cortex (Dickerson 
and Spelring, 2008). Additionally, atrophy of the posterior cingulum and 
precuneus, has also been reported (Pihlajamäki et al., 2009). fMRI was 
used to study memory-associated activation of MTL structures in MCI. 
Subjects usually perform a visual encoding task during fMRI scanning and 
are tested for recognition of stimuli afterward. Overall, compared to 
healthy aging and AD, results have demonstrated both increased and 
decreased MTL activity during encoding task performance (Dickerson and 
Spelring, 2008). When individuals  begin to manifest memory impairment, 
the hippocampal formation and parahippocampal gyrus exhibit functional 
abnormalities during memory task performance. It appears that, early in 
the course of MCI when memory deficits and hippocampal atrophy are less 
prominent, there may be hyperactivation of MTL circuits, possibly 
representing inefficient compensatory activity. In the later phase of 
MCI, when considerable memory deficits are observed, MTL regions show 
hypoactivation because they are no longer able to activate during 
attempted learning (Dickerson and Spelring, 2008). These results should 
be considered as neurobiological criteria for MCI diagnosis consistent 
with the neurodiagnostic assessment for the early phase of dementia.   
 
Magnetic resonance spectroscopy 
Using MRS, some studies have found that brain metabolite concentration 
for N-acetylaspartate (NAA) and myoinositol (MI) can distinguish AD 
patients from control, although conflicting results have been reported 
regarding choline (Machulda et al., 2003). The decrease of NNA 
concentration relative to creatine (NAA/Cr) is considered to be an MRS 
marker of diminished neuronal density and viability, while elevation in 
MI/Cr ratios is less specific but may be associated with glial activation 
and other neurochemical processes (Catani et al., 2001). However, it is 
unclear in what way it may be related to AD. Specific studies have found 
increased MI/Cr in the posterior cingulate gyrus and white matter in MCI 
subjects. A recent study observed that decreased medial temporal lobe 
NAA/H2O ratios distinguished MCI patients from normal controls, while 
increased parietotemporal MI/H2O distinguished MCI cases from AD (Chantal 
et al., 2004).     
In the final analysis, the best prediction model should involve a 
combination of neuroimaging and biomarker measures that may be quite 
informative according to the evolution of MCI, from normal cognition to 
dementia (Jack et al., 2008).  
  
3.2.4 NEUROPATHOLOGICAL ANALYSIS 
 
Relatively few neuropathological studies have been carried out on MCI 
subjects. The Religious Order Study followed a group of nuns and priests 
for many years with an excellent autopsy rate. Markesbery et al.  (2006) 
found that approximately 60% of partecipants with MCI had 
neuropathological evidence of AD, but they indicated that vascular 
disease also accounts for a significant degree of neuropathological 
features. Guillozet et al. (2003) pointed out neurofibrillary tangles 
density when accounting for the symptoms of MCI.  
  
Two studies conducted at the Mayo Clinic highlighted other aspects of the 
previous investigations. One study (Petersen et al., 2006) revealed that 
participants with aMCI do not meet the neuropathological criteria for AD, 
but their pathologic findings suggest a transitional state of evolving 
AD. All the patients with aMCI had pathologic findings involving medial 
temporal lobe structures, probably accounting for their memory 
impairment. In addition, there were many concomitant pathologic 
abnormalities, including argyrophilic grain disease, hippocampal 
sclerosis, and vascular lesions. 
 
A second study (Jicha et al., 2006) observed participants who had been 
previously diagnosed with MCI and had converted into dementia, 
characterizing these subjects as having the final pathological 
characteristics. This study indicated also that while participants with 
aMCI developed AD later, a considerable number developed another type of 
dementing disorder.   
 
3.3 TREATMENT 
 
3.3.1 PHARMACOLOGICAL TREATMENT 
 
Since the introduction of the first cholinesterase inhibitor (ChEI) in 
1997, most clinicians consider donepezil (Aricept), galantamine (Reminyl) 
and rivastigmine (Exelon), as the first line pharmacotherapy for mild to 
moderate Alzheimer‟s Disease.  
These drugs have slightly different pharmacological properties, but they 
all work by inhibiting the breakdown of acetylcholine, an important 
neurotransmitter associated with memory and learning, by blocking the 
enzyme acetylcholinesterase.  
Alzheimer's disease is characterized by the development of senile plaques 
and neurofibrillary tangles, which are associated with neuronal 
destruction, particularly in cholinergic neurons. Thus, drugs that 
inhibit the degradation of acetylcholine within synapses are the mainstay 
of therapy. 
Acetylcholinesterase inhibitors appear to be effective, but the magnitude 
of benefit may be greater in clinical trials than in practice 
(Falgherazzi et al., 2009).  
The most that these drugs could achieve is to modify the cognitive and 
behavioural symptoms of Alzheimer‟s Disease, with positive implications 
for patients‟ ability to live independently.   
Currently, there are no Food and Drug Administration approved treatments 
for MCI. However, a number of clinical trials in MCI patients have been 
conducted to estimate the efficacy of pharmacological treatment.  
 
Since a high proportion of amnestic MCI subjects (MCI Type I) presumably 
progress to AD within a range from 2 to 4 years (Petersen, 2004), an 
increasing number of clinical trials focused on MCI type I. The most 
promising trial was conducted by the Alzheimer‟s Disease Cooperative 
Study (U.S.A.-Canada) by Petersen and Morris (2005). A sample of 769 
subjects with Amnestic MCI were randomly assigned to daily receive 10 mg 
of donepezil (Aricept, Memac),  2000 IU of vitamin E, or three-year 
placebo and were followed over three years. The aMCI subjects progressed 
to AD at a rate of 16% per year. Results indicated that vitamin E had no 
benefit in patients with MCI. Although donepezil therapy was associated 
with a lower rate of progression to AD during the first twelve months of 
treatment, the rate of progression to AD after three years was not lower 
among patients treated with donepezil than among those given placebo.  
 
Gold et al. (2004) carried out two international randomized double-blind 
placebo-controlled trials to test the ability of galantamine to slow the 
progression of aMCI subjects (CDR O.5) to AD (CDR 1). A total of 2048 
subjects (aMCI and controls) with a mean age of 70 were recruited. A 
trend of reduction in rate progression was recorded in both trials (13% 
galantamine vs 18% placebo; 17% galantamine vs 21% placebo) but the 
trials did not reach statistical significance. 
 
Another large trial was conducted by Feldman et al. (2007) using 
rivastigmine in a sample of 1018 (aMCI and controls) to evaluate the rate 
of aMCI progression toward AD over four years. Over this period, 17.3% of 
the rivastigmine group versus 21.4% of the placebo group progressed to AD 
with no significant statistical difference.  
 
In conclusion, cholinesterase inhibitors have not been found to delay the 
onset of AD or dementia in individuals with MCI (Anderson et al., 
2010)
13
.  
 
Vitamin E is a dietary compound with antioxidant properties involved in 
scavenging free radicals. Laboratory and animal studies have pointed 
towards a possible role for Vitamin E in the prevention and management of 
cognitive impairment. To date only one randomized controlled trial has 
assessed the efficacy of Vitamin E in subjects with mild cognitive 
impairment, showing that Vitamin E 2000 IU daily produces no significant 
                                                        
13 Mild Cognitive Impairment: Treatment and Management. Retrieved May, 1, 2011, from http://www. 
http://emedicine.medscape.com/article/1136393-treatment.  
difference in the rate of progression to AD compared to the placebo group 
(Mgekn et al., 2008)
14
.  
 
 
3.2.2 PSYCHOLOGICAL INTERVENTIONS 
 
The pharmacological treatment of dementia (especially for Alzheimer‟s 
Disease) focused on cognitive decline reduction, by using cholinesterase 
inhibitor drugs, that have shown weak effects on neurodegenerative 
illness progression (Birks et al., 2000).   
 
Psychological rehabilitation strategies set up for demented patients and 
subjects with mild cognitive impairment produced different techniques 
over time (Table 20) that can be divided into six groups according to 
their theoretical background: holistic-type techniques, brief 
psychotherapies, behavioural approaches, psychological methods, 
neuropsychological therapies, and alternative strategies. 
 
Holistic-type tecniques Reality Orientation Therapy 
Validation Therapy 
Reminiscence Therapy/Life review 
Remotivation Therapy 
Gentle Care 
Person-centred dementia care  
Brief Psychotherapies Psychodynamic Therapy 
Interpersonal Therapy 
Cognitive-behavioural Therapy 
Behavioural Approaches Milieu Therapy 
Occupational Therapy 
Psychological Methods Memory Training 
- Procedural Memory Training 
- Space-retrieval 
- Errorless Learning Approach 
- Vanishing Cues 
- External Memory Aids 
- Dyadic Approach 
- Visual Imagery 
Neuropsychological therapy Cognitive Stimulation Therapy/Activation Therapy 
Alternative strategies Art therapy 
Movement Therapy 
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http://www2.cochrane.org/reviews/en/ab002854.html. 
Music Therapy/Musictherapy  
Activity Therapy 
Aromatherapy 
Bright-light Therapy 
Multisensory Approaches 
Table 20.  Non-pharmacological intervention for dementia and mild cognitive impairment.    
 
Classic procedures considered cognitive, emotional and social aspects of 
demented people. Cognitive deterioration cannot be treated alone but by 
considering the role of environment, life style and care-giving. These 
procedures include individual or group sessions, structured and non-
structured activities, with three different objectives: i. designing 
activator environments and planning social activities to improve autonomy 
of patients; ii. providing communication techniques to aid demented 
people in expressing needs and emotions; iii. offering support to prevent 
caregivers distress (Cammisuli and Timpano Sportiello, 2009). Although a 
few validated studies were produced to test psychotherapy efficacy, over 
the past ten years there has been an increasing effort to apply 
psychodynamic, interpersonal and cognitive-behavioural theoretical 
principles to the treatment of demented people. Psychological methods 
provide different rehabilitation procedures to optimize residual 
cognitive abilities of people with dementia and mild cognitive 
impairment.  
According to Clare and Woods (2005), they can be summarized into three 
groups: 
- Cognitive Stimulation (Spector et al., 2003; 2006) in an evidence-
based program refers to involvement in group activities with the 
goal of increasing cognitive and social functioning in a non-
specific manner, including discussions, supervised leisure 
activities, list memorization, reality orientation and reminiscence 
techniques; 
- Cognitive Rehabilitation involves individually tailored programs 
centred on specific activities of daily life;  
- Standardized Cognitive Training involves teaching strategies to 
optimize cognitive functioning (e.g. mnemotechnics), experienced in 
small groups with a specialist supervisor.         
 
Since the Eighties, classical rehabilitation procedures (based on 
psychological assumptions, e.g. multiple intelligence theory, and “g” 
factor), were exceeded by neuropsychological findings on dementia: they 
have shown that all specific activities supporting intelligence, 
deteriorate in a disharmonious and sectorial way (Wilson, 2003). 
Subsequently, there have been increasing efforts to develop stimulation 
intervention
 
to ameliorate cognitive problems of which subjects suffering 
from mild cognitive impairment and mild-moderate dementia complain. 
There is increasing evidence of the role of individual features (age and 
education level), environmental (engagement in familiar, professional and 
leisure activities), lifestyle factors (physical exercise, balanced 
diet), expertise and experience, as protective agents against dementia 
development (Belleville, 2008). Given the involvement of these elements 
in aging outcomes, it is reasonable to assume that cognitive training may 
play a critical role in cognitive vitality promotion for elderly people 
with cognitive impairment.  
 
Activation Therapy (AT) constitutes a neuropsychological intervention for 
subjects suffering from mild cognitive impairment and mild-moderate 
dementia. It aims at enhancing remaining cognitive abilities of patients 
and delaying severe cognitive decline (Mondini and Bergamaschi, 2005). 
Based on the concepts of neuroplasticity and brain reserve, it is able to 
stimulate every cognitive domain, with positive effects on the patient‟s 
autonomy and on the caregiver‟s burden reduction (Cammisuli et al., 
2009c; 2011a).  
 
A pilot-study (Cammisuli et al., 2011a) selected 10 subjects (male 40% vs 
female 60%, age 81.6 ± 3.64, education level 9.2 ± 5) with a diagnosis of 
mild cognitive impairment (40%) and mild dementia (60%) from the 
outpatients population of Clinical Neuropsychology Laboratory (Pisa, 
Italy). Subjects were assessed by a wide neuropsychological battery 
including: 
A. Global cognitive screening: Milan Overall Dementia Assessment 
(Brazzelli et al., 1994); 
B. Autonomy evaluation: Activities of Daily Living (Katz, 1970) 
and Instrumental Activities of Daily Living (Lawton and Brody, 
1969); 
C. Specific evaluation for each cognitive domain: 
- Orientation:  
Temporal Orientation (From MODA); 
Spatial Orientation (From MODA); 
Personal Orientation (From MODA); 
Family Orientation (From MODA); 
- Memory System:  
       Structural tests: 
Digit Span (Spinner and Tognoni, 1987); 
Corsi Span (Spinnler and Tognoni, 1987); 
Pairs Associates Learning (Spinnler and Tognoni, 1987); 
Story Recall (Spinnler and Tognoni, 1987); 
Corsi Suvra-span learning (Spinnler and Tognoni, 1987); 
       Ecological test:  
Rivermead Behavioural Memory Test (Della Sala et al., 2000); 
- Orientation: 
Temporal Orientation (from MODA); 
Spatial Orientation (from MODA); 
Personal Orientation (from MODA); 
Family Orientation (from MODA); 
- Attention System:  
Stroop Color Word Interference Test (Golden, 1978);  
Visual Search Test (Spinnler and Tognoni, 1987); 
- Visual Agnosia:  
Street‟s Completion Test (Spinnler and Tognoni, 1987); 
- Constructive Apraxia:  
Constructive Apraxia Test (Spinnler and Tognoni, 1987); 
- Language: 
Boston Naming Test (Kaplan et al., 1983);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
- Executive Functioning:  
Frontal Assessment Battery (Dubois and Litvan, 2000);  
Brixton Test (Burgess and Shallice, 1997);  
Towers of London (Shallice, 1982);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
Visual Search Test (Spinnler and Tognoni, 1987);  
Stroop Color Word Interference Test (Golden, 1978). 
 
In addition, the Questionnaire for caregivers of patients with 
Alzheimer‟s disease (Timpano Sportiello, 2006a) and the Cognitive Burden 
Inventory (CBI)(Novak and Guest, 1989) were administered to caregivers. 
Patients were submitted to 6-month Cognitive Activation Therapy and they 
were reassessed at the end of the intervention. Neuropsychologists 
prescribed to patients tailored cognitive tasks (Table 21). 
 
Page 6-10 
AT exercises 
Cognitive domains involved Neuropsychological evaluation 
 
Verbal material recall Memory Declarative memory 
Visual search Attention Selective attention 
Scene sequencing 
Clock drawing 
Orientation Temporal orientation 
Figure naming 
Crossword puzzle 
Language Anomia 
Figures copying Praxis Constructive praxis 
Figures identification 
Puzzles construction 
Gnosis Visual gnosis 
Visual search 
Proverbs meaning 
Written texts comprehension 
Money value 
Executive functioning 
 
Visual search 
Verbal intelligence 
Abstract thinking 
Logical reasoning 
Table 21. AT exercises.  
 
Patients performed their exercises daily at home for five days under the 
caregiver‟s supervision. A behavioural diary was given to patients in 
order to record all the activities performed during the day and those 
planned for the day before (Figure 2). The diary was intended to improve 
topographic orientation and episodic and prospective memory.   
  
Page 1 
(To be completed at the beginning of the day) 
Date : ________ 
Day: _______ 
Month: __________ 
Year: __________ 
(To be completed at the end of exercises) 
Exercise start time: ________ 
Exercise final time: __________ 
Type of exercises? _______________________________________ 
Page 2 
Report of the morning 
(To be completed before lunch time) 
Get up at: __________ 
Breakfast time: _______ 
Food: ___________________________________________ 
Activites of the morning: 
____________________________________________ 
Watch TV? Yes/No. If yes, list TV programs ________________________ 
Page 3 
Report of the afternoon 
(Complete before dinner time) 
Lunch time: ___________ 
Food: __________________________________________________ 
Activities of the afternoon: 
____________________________________________ 
Watch TV? Yes/No. If yes, list TV programs: 
________________________ 
Page 4 
Report of the evening   
(To be completed before going to bed) 
Dinner time: _________ 
Food: ____________________________________________________ 
Activities of the evening : 
________________________________________________ 
Watch TV? Yes/No. If yes, list TV programs: 
________________________ 
Going to bed time: ______________________________________________ 
Page 5 
Planning of Tomorrow’s activites  
(To be completed after the “Report of the evening”) 
 ___________________________________________________________
___ 
 ___________________________________________________________
___ 
             Figure 2. AT behavioural diary. 
 
At the end of the week, they visited the Neuropsychology Clinic to be 
monitored. Neuropsychologists corrected the cognitive tasks and the 
patients were assigned further cognitive tasks which corresponded to the 
cognitive domains to be recovered and their complexity.     
 
The data collected by the Questionnaire for caregivers of patients with 
Alzheimer‟s disease (Timpano Sportiello, 2006a) showed that the caregiver 
(usually the spouse) assists the patient for an averages of 16 hours per 
day and suffers relationship (75%) and health (25%) problems as main 
disturbances. 
  
The comparison of average scores before and after treatment showed that 
systematic and intensive activation leads to stabilization of the 
patient‟s cognitive status, with significant improvements in executive 
functioning and memory (Table 22).  
 
    Table 22. Neurocognitive evaluation of the sample after and before AT (Note: *total score;    
    **equivalent score; ***profile score) (Cammisuli et al., 2011a) 
 
 
Compared with MD patients, the MCI subgroup (Table 23) obtained better 
results in tests that assess inhibitory control (2.5 ± 0.57) and set-
shifting (36 ± 12.7).  
 
 
    Table 23. Neurocognitive evaluation of the MCI subgroup before and after AT (Note: *total score;  
    **equivalent score; ***profile score) (Cammisuli et al., 2011a). 
 
 
 
Neurocognitive evaluation battery Before treatment After treatment 
Orientations (from MODA) 27.5±5.33 26.05±4.98 
Autonomy (from MODA) 15 15 
Neuropsychological tests (from MODA) 39.45±3.61 38.78±3.31 
Milan Overall Dementia Assessment*  83.23±8.62 80.08±8.78 
Digit Span** (Batteria di Memoria) 3.25±0.95 3.25±0.95 
Paired Associated Learning** (Batteria di Memoria) 0.5±1 1±0.81 
Corsi Span** (Batteria di Memoria) 3.25±1.5 3.25±1.5 
Story Recall** (Batteria di Memoria) 0.25±0.5 0.75±1.5 
Corsi Suvra-span Learning** (Batteria di Memoria) 1 1.25±0.5 
Rivermead Behavioural Memory Test***  25.75±10.23 28±12.38 
Visual Search Test** 1.75±1.5 2.5±1.29 
Stroop Color Word Interference Test (Effetto 
Interferenza/Tempo) 
53.12±13,59 29.87±9.89 
Boston Naming Test 28±10.23 27,25±8.84 
Verbal Fluency Test** 1±0.81 1.5±1.29 
Constructive Apraxia Test** 4 4 
Street‟s Completion Test** 2.25±1.25 2.75±1.25 
Frontal Assessment Battery 11±1.83 12.25±0.96 
Brixton Test 24.5±5.97 27.25±13.52 
Neurocognitive evaluation battery Before treatment After treatment 
Orientations (from MODA) 31.65±1.91 27.75±7.22 
Autonomy (from MODA) 15 15 
Neuropsychological tests (from MODA) 41±3.46 36.5±4.04 
Milan Overall Dementia Assessment*  90.5±2.25 82.04±11.95 
Digit Span** (Batteria di Memoria) 3±1.15 4 
Paired Associated Learning** (Batteria di Memoria) 1±1.15 1.5±0.57 
Corsi Span** (Batteria di Memoria) 2.5±1.73 2.5±1.73 
Story Recall** (Batteria di Memoria) 0.5±0.57 1.5±1.73 
Corsi Suvra-span Learning** (Batteria di Memoria) 1 1 
Rivermead Behavioural Memory Test***  33.5±9.81 33±13.85 
Visual Search Test** 2.5±1.73 3.5±0.57 
Stroop Color Word Interference Test (Effetto 
Interferenza/Tempo) 
60±8.66 27.25±6.63 
Boston Naming Test 34±8.08 31.5±8.66 
Verbal Fluency Test** 1.5±0.57 2.5±0.57 
Constructive Apraxia Test** 4 4 
Street‟s Completion Test** 3±1.15 3.5±0.57 
Frontal Assessment Battery 12 13 
Brixton Test 29±3.46 36±12.7 
Patients with MD (Table 24) improved verbal and space long-term memory 
(0.5 ± 0.54; 1.5 ± 0.54) while MCI subjects showed better results in 
verbal  long-term memory (1.5 ± 1.73).   
 
 
   Table 24. Neurocognitive evaluation of the MD subgroup before and after AT (Note: *total score;  
    **equivalent score; ***profile score) (Cammisuli et al., 2011a). 
     
 
Among the positive effects, the therapy is able to decrease the 
psychological distress experienced by caregivers thanks to the partial 
recovery of the patient's cognitive abilities, with improvements of 
autonomy in daily life activities. This result is confirmed by CBI 
subscales scores at the end of the treatment, especially for emotional 
burden, developmental burden and time-dependent burden (Figure 3). 
 
Neurocognitive evaluation battery Before treatment After treatment 
Orientations (from MODA) 22.45±2.6 23.40±0.99 
Autonomy (from MODA) 15 15 
Neuropsychological tests (from MODA) 37.9±2.63 39.05±1.04 
Milan Overall Dementia Assessment*  76±1.97 78.10±0.99 
Digit Span** (Batteria di Memoria) 2 2 
Paired Associated Learning** (Batteria di Memoria) 0 0.5±0.54 
Corsi Span** (Batteria di Memoria) 4 4 
Story Recall** (Batteria di Memoria) 0 0 
Corsi Suvra-span Learning** (Batteria di Memoria) 1 1.5±0.54 
Rivermead Behavioural Memory Test***  20 23±6.57 
Visual Search Test** 1 1.5±0.54 
Stroop Color Word Interference Test (Effetto 
Interferenza/Tempo) 
46.28±12.36 32.5±10.95 
Boston Naming Test 22±6.57 23±5.47 
Verbal Fluency Test** 0.5±0.54 0.5±0.54 
Constructive Apraxia Test** 4 4 
Street‟s Completion Test** 1.5±0.54 2±1.09 
Frontal Assessment Battery 9.5±0.55 11.5±0.55 
Brixton Test 21.6±3.66 18.5±0.54 
         
      Figure 3. AT therapy effects on caregiver‟s burden.  
 
 
A subsequent experimental study (Cammisuli et al., 2010b) compared the 
results obtained by the MCI subjects and MD patients with a control group 
(Table 25). Data analysis confirmed the results of previous studies 
(Talassi et al., 2007). In the experimental MCI subgroup, AT was more 
effective in enhancing verbal long-term memory (0.5±0.57 vs 1.5±1.73) and 
executive functioning (12 vs 13) than in the control subgroup (2.5±1.9 vs 
2±1.41; 11.25±1.70 vs 11.5±2.88). In particular, within frontal domains 
there is a significant improvement of selective attention, sensivity to 
interference (2.5±1.73 vs 3.5±0.57; 60±8.66 vs 27.25±6.63) and mental 
flexibility, both for capacity to produce words according to unusual 
procedure (1.5±0.57 vs 2.5±0.57) and set shifting (29±3.46 vs 36±12.7). 
The MD subgroup obtained the stabilization of cognitive status with 
slight improvement in verbal long-term memory (0 vs 0.5±0.54) and 
executive functioning (9.5±0.55 vs 11.5±0.55) compared to the control 
group (1.33±0.57 vs 0.5±0.54; 9.66±2.08 vs 10.5±2.12).      
 
  
 Table 25. Neurocognitive evaluation of MCI and MD subgroups before and after AT (Note: *total   
 score; **equivalent score; ***profile score) (Cammisuli et al., 2010). 
 
 
The findings reported by the studies on MCI starting symptomatology 
(Brandt et al., 2009; Timpano Sportiello and Cammisuli, 2010a) have 
suggested that combined deficits in declarative memory and executive 
functioning (especially for planning, selective attention and sensivity 
to interference) can probably represent the main risk factors for the 
conversion of MCI into frank dementia. Based on these assumptions, AT 
seems to be an effective and appropriate treatment to maintain or enhance 
impaired cognitive domains, although more substantial evidence is needed. 
A recent review (Stott and Spector, 2011) highlights the poor 
NEUROCOGNITIVE EVALUATION BATTERY BEFORE TREATMENT 
 
MCI Gs - MCI Gc 
MD Gs - MD Gc 
AFTER TREATMENT 
 
MCI Gs - MCI Gc 
MD Gs - MD Gc 
Orientations (from MODA) 31.65±1.91 - 34.55±0.47 
22.45±2.6 – 8.67±2.65 
27.75±7.22 - 33.12±2.58 
23.40±0.99 – 7.4±3 
Autonomy (from MODA) 15 - 15 
15 - 14±2 
15 - 15 
15 - 14±2 
Neuropsychological tests (from MODA) 41±3.46 - 41.1±5,2 
37.9±2.63 -  34.22±1.56 
36.5±4.04 - 41.3±2.94 
39.05±1.04 -  36.1±10.08 
Milan Overall Dementia Assessment*  90.5±2.25 - 93.22±5.63 
76±1.97 – 84.47±3.94 
82.04±11.96 - 91.7±5.47 
78.10±0.99 -  82.19±9.66 
Digit Span** (Batteria di Memoria) 3±1.15 - 3.5±1 
2 – 3.33±1.15 
4 - 3.5±1 
2 - 4 
Paired Associated Learning** (Batteria di Memoria) 1±1.15 - 2.75±1.5 
0 – 1.33±0.57 
1±1.15 - 2.75±1.5 
0 – 1.33±0.57 
Corsi Span** (Batteria di Memoria) 2.5±1.73 - 1.25±0.95 
4 – 2.33±2.08 
2.5±1.73 - 1.25±1.5 
4 – 1.5±2.12 
Story Recall** (Batteria di Memoria) 0.5±0.57 - 2.5±1.91 
0 – 1.33±2.3 
1.5±1.73 - 2±1.41 
0 – 2.5±2.12 
Corsi Suvra-span Learning** (Batteria di Memoria) 1 - 1.25±1.89 
1 – 0.66±0.57 
1 - 1.25±1.25 
1.5±0.54 - 2±2.82 
Rivermead Behavioural Memory Test***  33.5±9.81- 30.55±13.78 
20 – 56 
33±13.85 - 30.55±13.78 
20±6.57 - 45.5-7.77 
Visual Search Test** 2.5±1.73 - 3.25±0.95 
1 -  1.66±0.57 
3.5±0.57 - 3±1.41 
1.5±0.54 –  1.5±0.70 
Stroop Color Word Interference Test (Effetto 
Interferenza/Tempo) 
60±8.66 - 31.33±8.60 
46.28±12.36 – 38.5 
27.25±6.63 - 24.33±9.50 
32.5±10.95 – 38.5 
Boston Naming Test 34±8.08 – 39.75±6.89 
22±6.57 – 29±14.10 
31.5±8.66 – 45.75±4.5 
23±5.47 –  37.5±2.12 
Verbal Fluency Test** 1.5±0.57 – 3 
0.5±0.54 – 2 
2.5±0.57 – 2.33±1.15 
0.5±0.54 – 2.5±2.12 
Constructive Apraxia Test** 4 – 2.33±1.52 
4 – 2±1 
4 – 3±1.73 
4 - 2.5±2.12 
Street‟s Completion Test** 3±1.25 - 2.75±1.5 
1.5±0.54 – 1.66±0.57 
3.5±0.57 – 2.25±0.95 
2±1.09 – 1.5±0.70 
Frontal Assessment Battery 12 – 11.25±1.70 
9.5±0.55 – 9.66±2.08 
13 – 11.5±2.88 
11.5±0.55 -  10.5±2.12 
Brixton Test 29±3.46 – 30±4.24 
21.6±3.66 - 27 
36±12.7 – 24.33±0.57 
18.5±0.54 - 33 
methodological quality of studies on memory interventions on subjects 
with MCI. The authors suggest that memory interventions can enhance the 
ability to learn new information but they reported contradictory findings 
regarding improvements in everyday life.     
  
AT seems to be an effective and appropriate treatment to maintain or 
enhance impaired cognitive domains, although more substantial evidence is 
needed. A recent review (Stott and Spector, 2011) highlights the poor 
methodological quality of studies about memory interventions on subjects 
with MCI. The authors suggest that memory interventions can enhance the 
ability to learn new information but they reported contradictory findings 
regarding improvements in everyday life.     
 
In conclusion, we suggest that AT may be considered a protective therapy 
for subjects suffering from MCI and MD. It can also be used jointly with 
pharmacological treatments or included into holistic-type approaches, 
such as Reality Orientation Therapy or Validation Therapy.     
 
3.4 PROGNOSIS 
According to Petersen et al. (2001), the amnestic subtype is the most 
common subset of MCI subjects. While subjects with an amnestic subtype of 
MCI usually progress to AD at a high rate (Tierney et al., 1996; Rubin et 
al., 1998), other individuals who present clinically MCI symptoms may not 
share the same outcome. Because of MCI heterogeneity, Petersen et al. 
(2001) depicted other MCI hypothetical presentations in addition to aMCI 
(Figure 4), linking the specific clinical features of each subtype to the 
presumed outcome. 
 
Figure 4. Conversion of MCI subtypes into dementia (From: Petersen et al., 2001). 
 
Generally, it appears that participants from referral sources, such as 
memory clinics or AD centers, are likely to have a progression rate to 
dementia, particularly AD, of 10% to 15% per year (Farias et al., 2009). 
This is true also in some of the MCI clinical trials, such as the 
Alzheimer‟s Disease Cooperative Study and the ADNI (Petersen et al., 
2005). However, in a population from an epidemiologic perspective, in 
which participants are prospectively approached about participation, the 
progression rates are likely lower (6%-10% per year) (Solfrizzi et al., 
2004; Tschanz et al., 2006; Ravaglia et al., 2008). This outcome may be 
explained in relation to different factors. One factor concerns the prior 
probability of having an underlying disorder such as MCI when 
participants seek treatment at a referral clinic. In the referral clinic 
setting, this probability is reasonably high; hence, the annual 
progression rate to dementia is 10%-15% per year. In epidemiological 
studies, there is a broader spectrum of MCI severity, more heterogeneity 
as to the underlying condition, and likely lower annual rates of 
progression (6%-10% per year). It is noteworthy that in both the referral 
clinic and the epidemiologic settings, the rates are greatly elevated 
over the base incidence rates of dementia and AD of 1% to 2% per year 
(Petersen et al., 1999). 
 Several population and community-based studies have estimated the 
progression rate of MCI to dementia with some variability that reflects 
also the different diagnostic criteria used (Ritchie et al., 2001; 
Larrieu et al., 2002; Ganguli et al., 2004). Bruscoli and Lovestone 
(2004) identified 19 longitudinal studies with different diagnostic 
criteria for participants from 1991-2001 that reported conversion rates 
from MCI to dementia. Although large differences in conversion rates were 
observed among studies, the mean annual conversion rate was 10.24% (95% 
confidence interval [CI] 6.9%-11.9%). The typical rate at which aMCI 
patients progress to AD disease is 10% to 15% per year (Gauthier et al., 
2006). In a recent large prospectively designed trial from Germany, Busse 
et al. (2006) showed that MCI subjects progress to dementia at rates of 
7.2% to 10.2% per year. Some subjects improved from MCI to normal (~5% 
per year), but another subset initially improved and subsequently 
declined. The vast majority of dementia cases were believed to represent 
AD.   
 
 
 
 
 
 
 
 
4. RESEARCH 
4.1 AIM OF THE STUDY 
Mild Cognitive Impairment represents the most valuable nosological entity 
currently adopted by clinicians to diagnose a specific form of slight 
cognitive impairment, believed to be a high risk condition for developing 
dementia (especially Alzheimer‟s Disease). Researchers have severely 
criticized MCI for its marked inaccuracy, from both descriptive and 
theoretical points of view (Chertkow et al., 2008).  
  
Clinical research did not completely describe the neuropsychological 
features of MCI and its subtypes, and it did not provide characteristic 
markers to predict dementia, except those related to memory decline 
(Perri et al., 2005; 2007; Petersen and Negash, 2008). Moreover, a great 
and various set of psychodiagnostic tools have been used to assess MCI, 
without specifying the impairment of cognitive sub-domains and without 
providing specific norms for its psychometric evaluation.   
 
Many researchers adopted the convention of 1-1.5 SD below the mean as the 
limit for normal performance. This convention is referred only to 
measures of delayed recall (Petersen et al., 1999). Such a psychometric 
rule appears theoretically valid but practically inadequate. In fact, in 
clinical practice, it is not sufficient to analytically assess impaired 
cognitive domains, especially in the case of the memory system, attention 
system and executive functioning.   
 
On the basis of these assumptions, the objectives of the study are:  
1. To describe neuropsychological features of the whole MCI; 
2. To specify every neuropsychological profile of MCI subtypes; 
3. To study the course of cognitive decline; 
4. To indicate, if possible, neuropsychological markers apt to predict 
the MCI conversion into dementia.   
 4.2 METHODS 
4.2.1 SAMPLE 
162 subjects (76 male vs 87 female), age (73.27±7.10) and schooling 
(5.83±3.01) with diagnosis of Mild Cognitive Impairment form the sample. 
They were assessed in the Clinical Neuropsychology Laboratory of Pisa 
Psychology Hospital (Fifth Local Sanitary Authority) from January 2002 to 
December 2010. All the subjects underwent informed consent, under a 
protocol approved by the Fifth Local Sanitary Authority of Pisa in Italy.   
 
The subjects were classified according to Petersen‟s diagnostic criteria 
(2004) at baseline:   
- Amnestic MCI single domain (Type I)= n. 43;  
- Amnestic MCI multiple domain (Type II)= n. 101; 
- Non-amnestic MCI single domain (Type III)= n. 9; 
- Non-amnestic MCI multiple domain (Type IV)= n. 3; 
Some subjects did not present clinical conditions included in these four 
categories and were classified as “MCI with atypical profile” (n. 6).       
 
They were reassessed at different time intervals (t0, t1, t2, t3, and t4) 
with an average of 6-7 months between each evaluation.  
 
Even if the majority of the whole sample consists of MCI Type II, we do 
stress that this subtype may represent the evolution of MCI Type I. Many 
subjects, in fact, with diagnosis of MCI Type I at t0, presented a 
neuropsychological profile of MCI Type II at t1.           
 
4.2.2 COGNITIVE DOMAINS EVALUTATION 
The majority of the studies, starting from DSM-IV (APA, 1994), examined 
cognitive functioning only by evaluating the cognitive domains involved 
in the diagnosis of dementia
15
.  
 
Thus, the whole range of cognitive functions of individuals suffering 
from dementia and mild cognitive impairment has never been specifically 
evaluated. Moreover, the diagnosis of cognitive decline was a 
psychological assessment that evaluated cognitive deterioration by global 
measures, such as the “Index of Mental Decline”(Wechsler, 1955).  
 
More recently, the neuropsychological findings on dementia have exceeded 
traditional psychometric assessment, showing that all specific activities 
supporting intelligence deteriorate in a disharmonious and sectorial way 
(Trabucchi, 2002). Therefore, the use of a wide neuropsychological test 
battery can help clinicians to analytically describe the impairment of 
every cognitive domain involved in dementia and mild cognitive impairment 
(Cammisuli et al., 2009d).      
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 DSM-IV criteria for the diagnosis of Dementia of the Alzheimer's Type (APA, 1994):  
A. The development of multiple cognitive deficits manifested by both: 
1.Memory impairment (impaired ability to learn new information or to recall previously learned 
information); 
2.One or more of the following cognitive disturbances: 
(a) aphasia (language disturbance); 
(b) apraxia (impaired ability to carry out motor activities despite intact motor function); 
(c) agnosia (failure to recognize or identify objects despite intact sensory function); 
(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting). 
B. The cognitive deficits in criteria A1 and A2 each cause significant impairment in social or 
occupational functioning and represent a significant decline from a previous level of functioning. 
C. The course is characterized by gradual onset and continuing cognitive decline.  
D. The cognitive deficits in Criteria A1 and A2 are not due to any of the following:  
(1) other central nervous system conditions that cause progressive deficits in memory and cognition 
(e.g., cerebrovascular disease, Parkinson's disease, Huntington's disease, subdural hematoma, 
normal-pressure hydrocephalus, brain tumor);  
(2) systemic conditions that are known to cause dementia (e.g., hypothyroidism, vitamin B or folic 
acid deficiency, niacin deficiency, hypocalcaemia, neurosyphilis, HIV infection);  
(3) substance-induced conditions.  
E. The deficits do not occur exclusively during the course of a delirium. 
F. The disorder is not better accounted for by another mental disorder on Axis I (major depressive 
disorder, schizophrenia). 
 
Neuropsychological assessment examines several cognitive functions, 
checked by specific brain areas. Cognitive tasks generally require the 
implication of many cognitive processes, the so-called “task impurity” 
problem (Burgess, 1997). The problem is particularly evident in the case 
of cognitive tasks that investigate executive functioning. The 
conceptualization of executive functioning has been the subject of debate 
because of its difficult definition. According to Burgess (1997), the 
executive functions represent the abilities that allow the establishing 
of new patterns of behaviour and ways of thinking and of having an 
insight into them. This characterization highlights their control 
function on other cognitive processes, such as memory or learning. 
Despite the apparent clarity of this description, researchers and 
clinicians found it difficult to distinguish the various aspects of 
executive functioning. Rabbit (1997) outlined a series of consensus 
descriptions to depict frontal sub-domains: 
- executive planning involves delineation, organization and 
integration of behaviours needed to operationalize an intent or 
achieve a goal. The process of planning requires the ability to 
conceptualize change (anticipate or look-ahead), respond 
objectively, generate and select alternatives and substantial 
attention; 
- inhibitory control suppresses automatic behavioural responses not 
suitable to the context; 
- mental flexibility is required:  
a. to switch from one task to another and to initiate behavioural 
sequences interrupting the ongoing responses (set shifting); 
b. to produce words according to unusual procedures (verbal 
fluency);   
- selective attention allows the strategic allocation of attention 
on target stimuli; 
- sensivity to interference (c.f. “Stroop effect”) consists of the 
inhibition of well-learned and automatic behaviour to perform an 
unusual action.    
 
Executive functions are complex because they manifest themselves by 
operating on other cognitive processes; this implicates other cognitive 
processes not directly relevant to the target executive function 
(Philips, 1997). In an attempt to minimize the task impurity problem, 
Miyake et al. (2000) used a latent variable analysis to determine to what 
extent different executive processes can be considered to be unitary(in 
the sense that they are reflections of the same underlying mechanism or 
ability) or non-unitary. They focused on the following three basic 
executive functions: (1) shifting between tasks or mental sets, (2) 
inhibition of dominant or prepotent responses, and (3) updating and 
monitoring the contents of working memory. A confirmatory factor analysis 
indicated that these three executive processes, although moderately 
correlated with one another, are clearly separable. The model proposes 
relatively circumscribed lower (basic) level functions compared to many 
of the wider and higher level definitions and general measures of 
executive functioning, thus allowing precision as to which cognitive 
control functions are affected and which are not.  
 
The “Task impurity” problem leads to a reduced content and construct 
validity of neuropsychological tools. Therefore, caution should be 
exercised in interpreting the failure of performances.   
Studies on patients with deficits in executive functions have pointed out 
different clinical pictures, according to the articulate neuroanatomical 
organization of prefrontal cortex (Grossi and Trojano, 2005). Such an 
observation suggests that executive functions are divided into several 
sub-processes that can be selectively damaged. Patients with dorsolateral 
prefrontal cortex injury can show several cognitive deficits, such as 
easy distractibility and tendency to allocate attention toward irrelevant 
stimuli; reduced capacity to judge and critically evaluate a 
circumstance; poor mental flexibility and difficulty in copying difficult 
situations; disturbance of organization and planning of behaviour. A 
lesion of medial orbitofrontal cortex provokes marked alterations of 
emotional regulation and decision making processes. Cognitive deficits 
due to anterior cingulate cortex injury relate to inhibitory control of 
previously learned responses and the interference effect control.     
 
4.2.3 NEUROPSYCHOLOGICAL ASSESSMENT 
The subjects were tested by using a wide neuropsychological test battery, 
including: 
A. Global cognitive screening: Milan Overall Dementia Assessment 
(Brazzelli et al., 1994); 
B. Autonomy evaluation: Activities of Daily Living (Katz, 1970) and 
Instrumental Activities of Daily Living (Lawton and Brody, 
1969); 
C. Specific evaluation for each cognitive domain: 
- Orientation:  
Temporal Orientation (from MODA); 
Spatial Orientation (from MODA); 
Personal Orientation (from MODA); 
Family Orientation (from MODA); 
- Memory System:  
c. structural tests16: 
Digit Span
17
 (Spinner and Tognoni, 1987); 
Corsi Span
18
 (Spinnler and Tognoni, 1987); 
Pairs Associated Learning (Spinnler and Tognoni, 1987); 
Story Recall (Spinnler and Tognoni, 1987); 
Corsi Suvra-span learning (Spinnler and Tognoni, 1987); 
d. ecological test:  
Rivermead Behavioural Memory Test (Della Sala et al., 2000); 
- Attention System:  
Stroop Color Word Interference Test (Golden, 1978);  
Visual Search Test (Spinnler and Tognoni, 1987); 
- Visual Agnosia:  
Street‟s Completion Test (Spinnler and Tognoni, 1987); 
- Constructive Apraxia:  
Constructive Apraxia Test (Spinnler and Tognoni, 1987); 
- Language19: 
Boston Naming Test (Kaplan et al., 1983);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
- Executive Functioning:  
                                                        
16
 We adopted the system of memory structural aspects proposed by Baddeley (Baddeley and Hitch, 1974; 
Baddeley, 2000). There is no neuropsychological test able to assess slave systems together. We do 
not take into consideration the third component of Baddley‟s model, the episodic buffer.       
17
 Digit Span evaluates the phonological loop but it is unable to assess its sub-domains (a short-
term phonological store and a system of articulatory rehearsal).     
18
 Corsi Span evaluates the visuo-spatial sketchpad but it is unable to assess its visual, spatial 
and kinesthetic components. 
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 The neuropsychological exam of language focuses mainly on phonological-lexical aspects rather than 
syntactic-morphological ones that are evaluated by spontaneous language.   
Frontal Assessment Battery (Dubois and Litvan, 2000);  
Brixton Test (Burgess and Shallice, 1997);  
Towers of London (Shallice, 1982);  
Category Fluency Test (Spinnler and Tognoni, 1987);  
Visual Search Test (Spinnler and Tognoni, 1987);  
Stroop Color Word Interference Test (Golden, 1978). 
 
Milan Overall Dementia Assessment*(Brazzelli et al., 1994) 
The Milan Overall Dementia Assessment (MODA) was created in 1985 by 
Brazzelli and colleagues and subsequently calibrated on a wider sample in 
1993. It is used for the neuropsychological assessment of patients with 
suspected dementia and it is able to detect cognitive deficits of 
Alzheimer‟s type and to estimate the severity of cognitive impairment. 
The MODA consists of three sections that evaluate orientation, autonomy 
and cognitive functioning, respectively. For each subsection, the 
examiner assigns a specific score:    
a. Orientation: the evaluation is expressed both by a global index 
(Total score, range 0-35) and by four MODA parameters: (1) Temporal 
orientation (range 0-10); (2) Spatial orientation (range 0-3); (3) 
Personal orientation (range 0-10); (4) Family orientation (range 0-
12);   
b. Autonomy: the scale is divided into five subsections that evaluate 
deambulation, ability to dress, personal hygiene, sphincter 
control, ability to eat independently (range 0-15);  
c. Cognitive functioning (total score 50/50): a. reversal learning 
(range 0-5); b. visual search (range 0-10); c. verbal intelligence 
(range 0-6); d. Story Recall (range 0-8); e. verbal fluency (range 
0-5); f. token test (range 0-5); g. digital agnosia (range 0-5); h. 
constructive apraxia (range 0-3); i. Street‟s Completion Test 
(range 0-3).  
The total score ranges from 0 to 100. The administration time varies from 
half an hour for control subjects to three quarters of an hour for 
patients. The normative data are derived from a sample of 217 healthy 
controls, (114 female and 103 male) with a large range of age and 
schooling. The mean age of the normative sample is 60.8±18.5 years and 
the schooling mean is 9.1±4.9. The total score is given by the sum of the 
three sections score after the correction for age and schooling. The 
inside and outside limits of tolerance for less than 5% of the population 
with a cap of 95% were calculated on the distribution of correct score: 
- outside limit: under 85.5 (judgment of abnormality); 
- inside limit: over 89.0 (judgment of normality); 
- uncertain area: from 85.5 to 89.0 (borderline).  
The use of cut-off adjusted for age and schooling avoids attributing the 
poor performances of elderly and/or poorly educated subjects to cognitive 
deterioration. MODA is a useful tool for longitudinal studies also for 
patients with severe cognitive deterioration. The rate of progression in 
a group of patients with AD has been calculated on 1 point per month 
(Brazzelli et al., 1994). Della Sala et al. (1993) found a high 
correlation between MODA and Mini Mental State Examination (MMSE) 
(Folstein et al., 1975) (.61 in a group of healthy subjects; .84 in a 
group of AD patients) but a greater sensitivity of MODA (95.5%) to detect 
subjects with cognitive deficits than MMSE (67.4%). The main limitations 
are the excessive use of verbal material in many subtests. Thus, scores 
can be distorted by the presence of severe aphasia. The construction of 
the test is anchored to the theoretical concept of Spinnler‟s “cortical 
dementia” that makes the evaluation unsuitable for patients with 
psychosis symptoms in dementia or with subcortical dementia.  
 Activities of Daily Living (Katz et al., 1970) 
The Katz Index of Independence in Activities of Daily Living measures the 
patient‟s ability to perform activities of daily living independently. 
The Activities of Daily Living Index includes bathing, dressing, 
toileting, transferring, fecal and urine continence, feeding. The total 
score of ADL performances ranges from 0 (complete dependence) to 6 (full 
independence in all personal functions). A score of 6 indicates full 
function, 4  moderate impairment, and 2 or less, severe functional 
impairment. The Index is widely used in longitudinal studies of demented 
people to observe the course of personal autonomy loss.   
 
Instrumental Activities of Daily Living (Lawton and Brody, 1969) 
The Lawton Activities of Daily Living Scale is useful in evaluating 
patients with early-stage disease, in estimating the level of disability 
and in determining the patient‟s ability to care for him/her-self. While 
basic activities of daily living (ADLs) decrease in late-middle and later 
phases of illness, instrumental activities of daily living (IADLs) 
decrease earlier. IADL should be scored according to how an individual 
usually performs a task. The scale takes 10 to 15 minutes to be 
administered as a written questionnaire or interview. The patient or a 
knowledgeable family member or caregiver may provide answers. It contains 
8 items (using the telephone, shopping, food preparation, housekeeping, 
laundry, mode of transportation, responsibility for own medications, 
ability to handle finances), with a score that ranges from  0 (low 
function) to 8 (high function).   
 
 
 
Digit Span* (Spinnler and Tognoni, 1987) 
The test is used for the evaluation of verbal short-term memory, by 
calculating the quantity of information that the memory system can 
maintain (the so called “span”). It is a task that derives from the 
Wechsler Adult Intelligence Scale (Wechsler, 1955; 1981) and the Wechsler 
Memory Scale (1945; 1987). The Digit Span is also available in the 
version of Orsini et al. (1987) and it is included into the Brief 
Neuropsychological Exam of Mondini et al. (2003). The test consists of 
number sequences that are read by the examiner (one number per second). 
If the sequence is correctly repeated by the subject, the examiner reads 
the next one that is longer than the previous sequence and continues 
until the subject fails a pairs of sequences or he/she correctly repeats 
the last sequence (9 numbers). The Digit Forward range is 6±1 (Miller, 
1956; Spitz, 1972).  
 
Corsi Span* (Spinnler and Tognoni, 1987) 
The Corsi Blocks Tapping task was developed in the early 1970s as a 
visuospatial counterpart to the verbal-memory span task (Milner, 1971). 
Over the years, it has frequently been used to assess visuospatial short-
term memory performance in adults (De Renzi and Nichelli, 1975). The 
normative sample of Spinnler and Tognoni Manual (1987) consists of 321 
healthy subjects of more than 40 years of age with all levels of 
schooling. There are other two calibrated and standardized forms of the 
Corsi Test (Orsini et al., 1987; Capitani et al., 1991). The material is 
made from a wooden board on which nine cubes are glued. They are numbered 
on the side facing the examiner. The subject has to touch the cubes in 
the same order indicated by the examiner after his/her presentation. The 
examiner touches a cube every two seconds. The span is given by the 
number of cubes of the longest sequence that the subject is able to 
reproduce in the correct way. Five minutes after the last attempt (in 
which the patient is engaged in distracting activities) the subject is 
required to reproduce the sequence. The score is referred to the longest 
sequence of cubes repeated twice.   
 
Paired Associated Learning* (Spinnler and Tognoni, 1987) 
The test was originally created by De Renzi et al. (1977) to evaluate 
verbal long-term memory (episodic memory) and then improved by Novelli et 
al. (1986). It demonstrates the sensitivity of the subject to contextual 
facilitation represented by the word semantically associated. A similar 
test with other stimuli has been calibrated by Zappalà et al. (1995). The 
subject is read 10 word pairs at the rhythm of a pair every two second 
with an interval of one second between each pair. Subsequently, the 
subject is presented with the first member of the pair in a different 
order than the presentation, and he/she is asked to recall the second 
member. Five pairs have an easy association (e.g. high-low), to which 
half a point is assigned, while the others have a difficult association 
(e.g. bicycle-scissors), to which one point is assigned.   
      
Story Recall* (Babcock, 1930) 
This test is used for the evaluation of verbal long-term memory (episodic 
memory). Unlike the Pairs Associated Learning, the Story Recall test can 
point out the presence of confabulations. The original Babcock Story 
Recall Test (Babcock, 1930) was revised by Novelli et al. in 1896. This 
test with other scoring procedures is included into the Short 
Neuropsychological Exam of Mondini et al. (2003). The normative sample in 
the version of Spinnler and Tognoni (1987) that we used consists of  321 
healthy subjects with of more than 40 years of age with all levels of 
schooling. A text whose length exceeds the capacity of short-term memory 
is read; it is never mentioned in its entirety but only in its general 
parts. The examiner reads aloud a short story and the subject is asked to 
recall as many elements as possible. After the first recall of the 
subject, the examiner reads the short story for the second time without 
the subject‟s recall. The subject is subsequently administered other 
tests (interfering activity). The number of correct items recalled at the 
first and at the second time are summed up together and divided by 2. The 
raw score obtained is adjusted for age and schooling.   
 
Corsi Suvra-Span Learning* (Spinnler and Tognoni, 1987) 
This test is used for the evaluation of visual-space long-term memory. 
The normative sample consists of 321 healthy subjects of more than 40 
years of age with all levels of schooling. The test cannot be performed 
if the patient obtained a score equal or higher than 8 in the Corsi Span 
test. The patient has to reproduce a fixed sequence of eight cubes 
touched by the examiner, until the sequence is correctly reproduced three 
consecutive times for a maximum of 18 trials. The score refers to the 
fragments of the sequence correctly reproduced for each attempt. Suvra-
span Learning consists of administering a sequence equal to the span plus 
2 that the subject has to reproduce correctly three times consecutively. 
The test is still outstanding after 25 attempts.     
 
Rivermead Behavioural Memory Test (Wilson et al., 1985) 
In the presentation of the manual, Wilson et al. (1985) pointed out the 
limitation of traditional laboratory tests in identifying memory problems 
that patients encounter in everyday functioning and in quantifying the 
frequency and the severity of memory deficits. The Rivermead Behavioural 
Memory Test (RBMT) has been subsequently updated in three editions 
(Wilson et al., 1999; 2003; 2008). It is an ecological test for adults 
and elderly people that measures the memory abilities required to 
maintain the day-to-day living environment and to monitor their change 
over time. The test takes around 30 to 45 minutes to be completed. It 
includes 12 subtests covering a range of everyday memory abilities, 
including recall and recognition tasks. It also evaluates prospective 
memory. The profile scores are converted into a screening score (range 0-
12) that measures the suspicion of memory deficit
20
 and into a 
standardized profile score* (range 0-24). The test was adjusted and 
standardized for the Italian version by Brazzelli et al. (1993). The 
performances of 231 healthy subjects (122 women and 109 men, aged between 
18 and 87) were analyzed to determine the normative sample (Della Sala et 
al., 2000). The schooling ranged from 1 to 17 years. None of the subjects 
were suffering from a disease which could potentially affect cognitive 
performance, with the exclusion of illiterate people. Test-retest 
reliability is .73 (p˂.001), and inter-rater reliability is 100%. 
Correlation with tests assessing everyday memory (concurrent validity) is 
high.           
 
Temporal Orientation (from MODA): 
The subject is asked to respond to different questions regarding temporal 
orientation (day of the month, month of the year, year, day of the week, 
and time). This kind of cognitive task involves declarative memory.  
Spatial Orientation (from MODA): 
The subject is asked to respond to three questions about his/her city, 
location and nation. This kind of task implies the involvement of 
semantic memory and attention.  
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 Scores range from 0 to 12 and are divided into 4 sub-groups: 12-9= normal performance; 8-6: slight 
memory deficit; 5-3: moderate memory deficit; 2-0= severe memory deficit.       
Personal and Family Orientation (from MODA): 
The subject is asked to respond to questions regarding his/her life  
(name, age, birthday, hometown, personal address, the school he/she 
attended, the opportunity of meeting the examiner) and family (name, 
living/non-living persons, age of father, mother, spouse and children). 
This task mainly involves autobiographic memory.  
 
Stroop Color Word Interference Test* (Golden et al., 1978) 
This test is used to evaluate sensivity to interference. The Stroop test 
was created by Golden in 1978; it was subsequently calibrated and 
standardized for the first time in Italy by Venturini and colleagues in 
1983. Barbarotto et al. (1998) and Caffarra et al. (2002) produced two 
simplified versions of the test. In the classic version, three types of 
stimuli are sequentially presented:  
- Stroop reading task (the subject is asked to read color words 
printed in black ink); 
- Stroop color task (the subject is asked to name the color of 
dots); 
- Stroop color word task (the subject is asked to name the color of 
the ink of the colored word). 
Performance on section three is largely determined by the time needed to 
discard irrelevant but very salient information (verbal), in favor of a 
less obvious aspect (color naming), also known as “interference effect”. 
The number of errors and the time to perform the task are recorded for 
each trial.    
 
 
 
Visual Search Test* (Spinnler and Tognoni, 1987) 
The Visual Search Test, similar to the Barrage Test (Albert, 1973), 
evaluates visual selective attention. The subject is given three matrices 
of thirteen lines and ten numbers (from “0” to “9”) placed in random 
order. He/She is asked to cancel all the numbers equal to those published 
at the top of the matrix (5 for the first matrix 1; 2-6 for the second 
matrix 2; 1-4-9 for the third matrix). The maximum of time for each 
matrix is 45 seconds, starting from the “run-in”. The number of correct 
responses (range 0-60), false alarms (incorrect responses) (range 0-270), 
and omissions (omitted correct responses plus corrected responses given 
after maximum time) (range 0-60) are calculated.       
 
Street‟s Completion Test* (Street, 1931) 
The personality test is used nowadays to evaluate visual gnosia. It tries 
to verify whether the subject is able to integrate the fragments into a 
single realistic picture (“the closure phenomenon” of Gestalt theory). 
The pictures derive from the original series of Street (1931). The test, 
contained in the manual of Spinnler and Tognoni (1987),  consists of 17 
pictures (the initial three pictures are used to explain the task) which 
present a degraded form of several fragments separated between them. The 
subject is always asked to provide an answer and to continue until the 
end of the test. The maximum time allowed for stimulus recognition is 30 
seconds. All the exact recognitions or  responses with sufficient 
approximation (1 point) are considered correct, while omitted or extra-
time responses (0 point) are considered incorrect.  
 
Constructive Apraxia Test* (Spinnler and Tognoni, 1987) 
The test examines the ability to consistently copy the elements that 
constitute the geometric bi-dimensional models presented by the examiner. 
The figures are derived from those used in the test of Arrigoni and De 
Renzi (1964). After the run-in, the examiner presents 7 papers with the 
figures printed on the upper half of the paper; the subject is asked to 
copy them below as precisely as he/she can. A score of 2 is given if the 
reproduction is perfect, 1 if the copy is partially defective and 0 if 
the copy is unrecognizable or if there is “closing-in” (despite the 
instructions, the subject follows the contour of the figure printed 
above).  
 
Boston Naming Test (Kaplan et al., 1983) 
The Boston Naming Test (BNT) (Kaplan et al., 1983; 2001; Goodglass et. 
al., 2001) represents a measure of object naming from line drawings. It 
takes into account that patients with dysnomia often have greater 
difficulties in naming objects with low frequency. Items have been ranked 
in terms of their facility to be named, which is thought to be correlated 
with their frequency. Patients with perceptual problems are allowed 
categorical or semantic cues; patients with retrieval difficulties are 
allowed phonemic cues. This type of picture-naming vocabulary test is 
useful for children with learning disabilities and for brain-injured or 
demented patients. The BNT contains 60 items. Pictures are presented 
allowing up to 20 seconds for response. The total score is given by the 
number of correct items, with a cut-off of 40. We used the Anna Basso‟s  
version. The test is also recommended as a supplement to the Boston 
Diagnostic Aphasia Examination (BDAE) (Goodglass and Kaplan,1972; 1983; 
Goodglass et al., 2000). Information on reliability, validity and norms 
is not reported in the original manual. Normative data are available in 
Strass et al. (2006) and in Heaton et al. (2004). The Boston Naming Test 
suffers a cultural bias because there is currently no version of the test 
adapted to the Italian population available.  
 Category Fluency Test* (Spinnler and Tognoni, 1978) 
The Category Fluency Test measures the ability of rapid word search in 
internal lexicon (semantic lexicon access task). This test is often part 
of the aphasia evaluation, as in the Multilingual Aphasia Examination 
(Benton, 1976; Benton and Hamsher, 1983; Benton et al. 2000) or in the  
Boston Diagnostic Aphasia Examination (Goodglass and Kaplan,1972; 1983; 
Goodglass et al., 2000). The tool is used also as a frontal test to 
evaluate the ability to generate words by using an unusual procedure 
(mental flexibility). The subject is required to produce all the words 
belonging to the category presented by the examiner. A time production of 
2 minutes is allowed  for each of the four categories. The test has also 
been calibrated by Zappalà et al. (1995), Carlesimo et al. (1996) and 
Capitani et al. (1998).       
 
Frontal Assessment Battery* (Dubois and Litvan, 2000) 
The Frontal Assessment Battery (FAB) (Dubois and Litvan, 2000; Slachevsky 
and Dubois, 2004) is a brief tool that can be used in a clinical setting 
to assess frontal domains. The FAB consists of 6 subtests (similarities, 
lexical fluency, motor series, conflicting instructions, Go-No-Go, and 
prehension behaviour) to evaluate different executive functions 
(conceptualization, mental flexibility, programming, sensitivity to 
interference, inhibitory control, environmental autonomy). For each task, 
the score ranges from 3 to 0 points. The total score is 18 with a cut-off 
score of 12 (Age-related 5% Level). The Frontal Assessment Battery scores 
correlate with the Mattis Dementia Rating Scale scores (rho = 0.82, p < 
0.01) and with the number of criteria (rho = 0.77, p < 0.01) and 
perseverative errors (rho = 0.68, p < 0.01) of the Wisconsin Card Sorting 
Test. There is good inter-rater reliability (κ = 0.87, p < 0.001), 
internal consistency (Cronbach‟s coefficient alpha = 0.78), and 
discriminant validity (89.1% of cases correctly identified in a 
discriminant analysis of patients and controls). The Italian version was 
calibrated by Apollonio et al. (2005) (normative sample: 364 healthy 
subjects of more than 20 years of age and with all levels of schooling). 
A parallel calibration has been produced by Iavarone et al. (2004).     
 
 
Brixton Spatial Anticipation Test (Burgess and Shallice, 1997) 
The Brixton Spatial Anticipation Test, developed by Burgess and Shallice 
(1997) as part of the “Hayling and Brixton Test”, is a visuospatial 
sequencing task with rule changes. It measures the ability to detect 
rules in sequences of stimuli and is used to assess mental flexibility in 
patients with brain injuries, psychiatric disorders or dementia. It 
usually takes between 5 and 10 minutes to be administered. Participants 
are presented with a 56-page stimulus booklet in which each page contains 
an array of 10 circles (two rows of five circles) numbered from 1 to 10. 
On each page, one circle is filled with a blue color. The position of 
this filled-in circle changes from one page to the next, and the changes 
are governed by a series of simple rules that vary without warning. 
Participants are presented with one page at a time and they are required 
to point to where they think the filled-in circle will be on the next 
page, based on the pattern or rule inferred from the previous pages. The 
total number of errors across 55 trials represents the total score. Two 
groups of subjects (neurological lesion group versus control group) 
constitute the normative sample. The group of patients was formed by 77 
subjects with brain injuries of the frontal lobes. The control group 
consisted of 121 healthy volunteers who had no previous history of 
neurologic or psychiatric disorder, epilepsy or drug/alcohol abuse 
problems, with an age range from 18 to 80. The split-half reliability was 
found to be .62 (p˂0.001); the test-retest reliability was found to be 
.71 (p˂0.001). Dubois et al. (2000) investigated the concurrent validity 
of the FAB and they showed that its scores substantially correlate with 
tests known to be sensitive to executive dysfunction, such as the Mattis 
Dementia Rating Scale (Mattis, 1988) and the Wisconsin Card Sorting Test 
(Berg, 1948). For discriminant validity, both Appollonio et al. (2005) 
confirmed results previously found by Dubois et al. (2000): the FAB and 
MMSE scores did not present a correlation. We used the FAB to replace the 
Wisconsin Card Sorting Test (Heaton, 1981) for the evaluation of the 
ability of perseveration resistance.           
Towers of London (Shallice, 1982) 
The test was originally developed by Shallice in 1982 for the assessment 
of executive planning abilities in adult patients with frontal lobe 
damage and subsequently implemented by Culbertson and Zillmer in 2001 
(Tower of London Drexel University) (TOL
DX
). The administration requires 
approximately 10 to 15 minutes. Materials are composed of two tower 
boards (examiner‟s and examinee‟s), two sets of balls (red, green, and 
blue), child and adult recording forms, a stopwatch, and a reference 
card. In the classic version of Shallice, the test consists of a series 
of twelve trials of gradual difficulty depending on the number of moves 
that have to be performed to arrive at the solution. For this purpose it 
is necessary to adopt adequate strategies and, in particular, three 
cognitive abilities: (i) formulate a general plan; (ii) identify the 
subgoals and organize them into a motor sequence; (iii) retain the 
subgoals and the general plan in working memory. Shallice (1982) refers 
to the Supervisory Attentional System (SAS) as a system chaired by the 
prefrontal cortex whose purpose is to direct attention to the sub-goals 
and transfer attention from the sub-goals to the general plan. Three 
sticks of different length and three colored balls (red, blue, green) are 
shown to the subject. He/She is asked to place the balls as they were 
previously placed by the examiner, with three rules: (i) the subject must 
move only one ball at a time; (ii) he/she must move the balls from one 
stick to another one at a time, and he/she must not place the ball on the 
table or hold more than one ball at a time in his/her hands; (iii) he/she 
must place only one ball on the small stick, two balls on the middle 
stick and three balls on the big stick; (iv) the number of moves to solve 
the problem are previously communicated to the subject for all the 
trials. The raw scores of Move Score, Initiation Time, Execution Time, 
Total Motor Execution Time and Violation are converted into percentiles 
and standard scores (SS). Total Move score measures the level or quality 
of executive planning and it supports cognitive components of attentional 
allocation, response inhibition, working memory and mental flexibility. 
Total Initiation Time score measures inhibitory response processes. Total 
Motor Execution Time score measures the speed at which executive plans 
are operationalized. Total Time score appraises overall executive 
planning as related to overall problem-solving speed. Total Violation 
score measures the ability to plan and execute problem solving in a 
specified temporal period (executive planning efficiency). The normative 
sample of TOL
DX 
is formed by 972 normal individuals (50% male and 50% 
female) with an age range of 7-77 plus a clinical sample of children with 
attention-deficit hyperactivity disorder (ADHD). The studies apt to 
determine reliability and validity of TOL
DX
 were based only on the 
children sample data. 
4.2.4 STATISTICAL ANALYSIS 
For asterisked tests we adopted the Equivalent Score (ES) of Capitani and 
Laiacona (1997), ranging from 0-4: 4 = normal performance; 3 = 
performance between M and -1 SD; 2 = performance between -1 SD and 
borderline area; 1 = borderline area; 0 = abnormal performance. To 
transform raw scores into equivalent scores we used two tools:  
- the Spinnler and Tognoni  Manual (1987) for the following tests: 
Paired Associated Learning, Digit Span, Corsi Span, Story Recall, 
Corsi Suvra-span learning, Visual Search, Street’s Completion 
Test, Constructive Apraxia Test, and Verbal Fluency Test; 
- “Procape” software of Bianchi and Pagliuca (2011) for the 
following tests: Milan Overall Dementia Assessment, Rivermead 
Behavioural Memory Test, Stroop Color Word Interference Test 
(Interference/Time effect and Interference/Errors effect), and 
Frontal Assessment Battery.  
 
Statistical analysis was performed by using commercially available 
software (SPSS; Version 18.0; SPSS Inc, Chicago, IL).  
 
Descriptive analysis results derive from the first evaluation (t0) of 
total MCI (n = 162). Then, we selected those MCI subjects with 2 follow-
up after diagnosis (n = 28) to observe the course of cognitive decline.      
 
Descriptive analysis of RBMT subtests (Faces Recognition, Picture 
Recognition, Appointment, and Hidden personal belonging) was performed on 
an MCI subgroup (n = 43).  
 
For the descriptive analysis of the whole MCI we formed 3 clusters for 
the equivalent scores: 4; 3-1; 0. For convenience, we subsequently 
transformed equivalent scores into 3 groups to set data in SPSS (Table 
26).    
 
4 2 
3-1 1 
0 0 
Table 26. Transformation of equivalent scores for SPSS data setting. 
 
To analyze subject performance in the Temporal Orientation test, in the 
Total Orientation test, and in the Neuropsychological Tests, we 
confronted raw scores to the mean scores of the normative sample for age 
classes. We then divided scores into three clusters (cluster 2 = scores 
between M and + ∞; cluster 1 = scores between M and -2 SD; cluster 0 = 
scores under 2 SD). We then confronted Neuropsychological Tests (MODA 
subtest) score with the MODA total score, in order to verify if a global 
cognitive decline could correspond to a poor performance in 
neuropsychological tests.   
 
In order to compare BNT scores with the other test scores, we formed 3 
clusters, as follows: 
- 60-40= 2 (normal performance); 
- 39-30= 1 (borderline); 
- ≤29= abnormal performance.   
 
For the Brixton test scores we took into consideration the age-related 
cut-offs reported in the manual (Table 27). 
  
Age 5% level 
46-65 27 
66-80 29 
                          Table 27. Brixton errors-Age-related 5% levels.  
 In order to compare the Brixton scores with the other test scores, we 
divided scores into 3 clusters, as follows: 
a.  
- ˂27= 2 (normal performance); 
- 27= 1 (borderline); 
- >27= 0 (abnormal performance).  
b.  
- ˂29= 2 (normal performance); 
- 29=1 (borderline); 
- >29= 0 (abnormal performance). 
 
In order to compare Go-No-Go FAB subtest scores with the equivalent 
scores, we adopted the following transformation (Table 28): 
 
3 2 
2-1 1 
0 0 
Table 28. Transformation of Go-No-Go FAB subtest scores into SPSS clusters. 
 
To analyze subject performance in the ToL test we divided scores into 3 
clusters:  
- Cluster 2: scores between 75° and 51° percentile; 
- Cluster 1: scores between 50° percentile and 25° percentile; 
- Cluster 0: scores under 24° percentile.    
 
The distribution of our collected variables did not pass the Kolmogorov-
Smirnov Test (K-S test), so the hypothesis of normal distribution of the 
data had to be rejected. Thus, a non-parametrical (distribution-free) 
statistical test was used to compare our collected variables also because 
the majority of data were expressed in equivalent scores (ordinal 
measures). Specifically, we used the Friedman test because our data 
consisted of repeated observations on the same subjects and the Kruskal-
Wallis Test when we compared independent groups of subjects on the same 
psychometric measurements (as evaluated by neuropsychological tests). The 
Wilcoxon Signed-Rank Test was then applied to assess whether the 
population means of the two related samples differed significantly. 
Finally, we used the Bonferroni correction adjusting significance values 
in order to compensate for multiple comparisons and to prevent false 
positives. The significance level was set at p<0.05.  
 
We used a discriminant function analysis (DA) to determine whether MCI 
subgroups differ with regard to the mean of our collected variables and 
to use those variables to predict group membership of new cases. The goal 
is to detect predictors (variables) that allow us to discriminate between 
different groups.  
 
4.3 RESULTS 
The evaluation of the whole sample indicated a specific 
neuropsychological profile.  
Almost all the MCI subjects (88.4%) maintained the ability to live 
independently, as expected. Autonomy, both personal (0.95±0.14) and 
instrumental (0.89±0.16) is preserved. Only 4.1% of the total MCI showed 
a deterioration of autonomy.   
38.6% of the sample represented the abnormal area of Total Orientation 
score. Comparisons between MODA orientation subtests were all significant 
(spatial orientation vs temporal orientation p<0.0001; personal 
orientation vs temporal orientation p<0.002; family orientation vs 
temporal orientation p<0.0001; personal orientation vs spatial 
orientation p<0.0001; family orientation vs spatial orientation p<0.0001; 
family orientation vs personal orientation p<0.0001). 26.1% of the 
subjects obtained the poorest performance in the Temporal Orientation 
test. MCI subgroups performances in MODA subtest measuring Temporal 
Orientation were globally preserved, with major decreases for MCI Type I 
(9.36±1.18) and MCI Type II (9.46±1.2). However, multiple comparison 
between MCI Type I, II, III and IV on Temporal Orientation test did not 
reveal significant differences. MCI Type II showed significant lower 
scores than MCI Type I (2.97±0.16 vs 3.67±2.2) in the MODA Spatial 
orientation subtest (p<0.008). All the MCI subtypes presented normal 
performances in MODA subtests that evaluate personal (Type II: 9.82±0.47; 
Type IV: 9.67±0.57) and family orientation (Type II: 11.51±0.76; Type 
III: 11.8±0.4; Atypical: 10.9±1.15), with the exception of MCI Type I 
that showed the lowest scores (9.21±1.94; 11.05±2.26) of the whole 
sample. However, significant differences between all the MCI subgroups 
were not obtained. 
     
The majority of the subjects (62.3%) belonged to cluster 1 of the MODA 
total score. A low percentage of the sample (4.8%) represented the 
abnormal area (cluster O). We found also that a global cognitive decline 
not always corresponds to a poor performance in neuropsychological tests. 
This is true only for 42.85% of the subjects. The MODA Total Score of MCI 
Type II is the lowest (2.48±1.33) of the whole MCI. The other subtypes 
reported the following data in descending order: Type IV 3.33±0.57; Type 
III 3.12±1.35; Type I 2.93±1.19, Atypical: 2.8±1.64. None of the MCI 
subgroups comparison was significant at t0.  
The comparison of mean scores obtained by each MCI subtype on MODA total 
score at t0 vs t1, t1 vs t2, and t0 vs t2, was significant only for MCI 
Type II
21
 when t0 was compared with t2 (p<0.001).  
Within working memory, the phonological loop was less deteriorated than 
the visual-space sketchpad (0.6% vs 4.4%). The comparison between Digit 
Span and Corsi Span was significant for p<0.0001. The subgroup of 
subjects representing cluster O in the Corsi Span also presented an 
impairment of executive functions checked by dorsolateral prefrontal 
cortex. Such evidence suggested the compromission of Central Executive in 
visual-space memory tasks.         
In long-term memory, verbal performance declined later than visual-space 
performances [Pairs Associated Learning (9.4%); Story Recall (13.8%); 
Corsi Learning Suvra-span: (17.7%)]. Direct comparisons were all highly 
significant [Pairs Associates Learning/Story Recall (p<0.003); Story 
Recall/Corsi Learning Suvra-spa (p<0.0001); Pairs Associated 
Learning/Corsi Learning Suvra-span (p<0.009)]. 
MCI Type I showed the lowest scores of the whole MCI in tests that 
evaluate verbal learning (1.56±1.11; 2.02±1.48), while MCI Type II 
presented the same trend in short- and long- term memory (2.51±1.31; 
1.20±1) for visual-space modality. By considering results in descending 
order, MCI Type III and Type IV followed the main subtypes at third and 
at fourth position for each subtest of Memory Battery, respectively, with 
the exception of MCI Type III for Digit Span (3.13±0.99). The comparison 
between MCI Type I and MCI Type II on all the structural and ecological 
memory tests was not significant. MCI Type I performed significantly more 
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MCI Type I t0 (2.5±2.12) vs MCI Type I t2 (1.66±1.83) (within an interval of 29±10 months); MCI 
Type II t0 (2.22±1.55) vs MCI Type II t2 (1.15±1.46) (within an interval of 22±12 months).  
poorly than MCI Type II on memory for prose (2.02±1.4 vs 2.39±1.42,  
p>0.05). Results confirmed recall deficit, but data analysis of „Picture 
Recognition‟ and „Face Recognition‟ RBMT subtests showed also that 
recognition is only relatively spared, as expected. It appeared more 
damaged for picture (32.1%) than for face (8.9%) in the MCI subgroup 
examined. This observation was not reflected in the comparison between 
MCI subtypes mean scores: Picture Recognition subtest [MCI Type I 
(1.10±0.87), Type II (1.03±0.88), and Type III (1.50±1)] versus Face 
Recognition subtest [MCI Type I (1.60±0.84), Type II (1.55±0.60), and 
Type III (1.25±0.95)]. A significant difference was obtained by comparing 
Face Recognition with Picture Recognition (p<0.003).  
Data analysis pointed out that the difference between recall and 
recognition tests was always significant when long-term memory tests were 
compared to Face Recognition RBMT subtests (Pairs Associated Learning vs 
Picture Recognition, p<0.001; Story Recall vs Face Recognition, p<0.002; 
Corsi Suvra-span Learning vs Face Recognition, p<0.001).              
Within long-term memory, prospective memory, too, deteriorated. The 
„Appointment‟ and the „Hidden personal belonging‟ RBMT subtests revealed 
an impairment of this ability for 58.9% and for 42.9% of the MCI subgroup 
examined, respectively. Amnestic MCI single domain showed the greatest 
impairment of the whole MCI in prospective memory tasks (Appointment: 
0.5±0.7; Hidden personal belonging 0.5±0.7). The comparison between long-
term memory tests was always significant (Pairs Associated Learning vs 
Hidden personal belonging, p<0.002; Pairs Associated Learning vs 
Appointment, p<0.002; Story Recall vs Hidden personal belonging, p<0.001; 
Story Recall vs Appointment, p<0.001; Corsi Learning Suvra-span vs 
Appointment, p<0.02), except for one case (Corsi Learning Suvra-span vs 
Hidden personal belonging). 
 The examination of everyday memory abilities (ecological tasks) provided  
two main results:  
 41.2% of the subjects reported ongoing memory deficits, as 
confirmed by the RBMT standardized profile score; MCI Type II 
presented the lowest score (1.06±1.24) of the whole sample in the 
test that evaluates ongoing memory. No significant difference was 
found in the comparison of mean scores between MCI subtypes; 
 97.5% of the subjects were considered to have a suspected memory 
deficit, from mild to severe (8-6: 28%; 5-3: 35.4%; 2-0:34.1%), as 
confirmed by the RBMT standardized score; the suspicion of memory 
deficit was confirmed for 24.3% of the total MCI
22
.     
The majority of the sample (70.1%) belonged to cluster 1 in visual gnosia 
testing. Visual gnosia abilities were more damaged in MCI Types III and 
II (2.33±1.22; 2.51±1.18) than in MCI Type I and Type IV (2.85±0.94; 
3.33±0.57), even if all the comparisons between MCI subgroups did not 
show any significant difference.    
 
In the Boston Naming Test, 25.8% of the subjects represented the abnormal 
area. Anomia was the most important language impairment, as reported in 
the diagnosis for 13.38% of the subjects. MCY Type II was the subcategory 
with the lowest score in the Boston Naming Test (33.69±10.25), followed 
by MCI Type III (38.06±17.82). A significant difference was only found 
between MCI Type I versus MCI Type II (p<0.001).   
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 The suspicion of memory deficit is confirmed if a standardized profile score of less than 2 
Standard deviations from the Mean corresponds to a screening score under 9.   
Only 1.9% of the whole sample presented an impairment of constructive 
praxis. MCI Type II and Type IV reported the poorest performances in the 
constructive apraxia task (2.93±1.16; 3±1.73) compared to the other 
subcategories (MCI Type I: 3.48±0.78; MCI Type III: 3.56±0.72). Only one 
significant difference between subgroups was found (comparison of MCI 
Type I with MCI Type II: p<0.0001).  
 
60% of the whole sample presented a deterioration of frontal domains, as 
confirmed by the FAB total score. MCI Type III and  Type II (0.56±0.72; 
0.61±1.19) presented the most impaired overall executive functioning of 
the whole sample. No significant difference was found by comparing MCI 
subgroups mean scores. 
In the ToL test, the following percentages represented those scores that 
fell between the 50° and 25° percentile and from 24° to - ∞; 
Move Score (16.7%-27.8%) [sum: 44.5%]; 
Initiation Time (27.8%-50%), [sum: 77.8%]; 
Execution Time (16.7%-72.2%), [sum: 88.9%]; 
Total Time (17.6%-76.5%), [sum: 94.1%]; 
Violation (0%-100%), [sum: 100%]. 
Planning abilities were more deteriorated in MCI Type II (Move Score: 
37±34.63; Initiation Time 86.17±63.29; Execution Time: 341.55±212; Total 
Time: 427.73±238.21; Violation: 8.67±2.88) than MCI Type I (Move Score: 
18±22.21; Initiation Time 75.5±18.26; Execution Time: 258.25±190.81; 
Total Time: 333.75±200.40). However, the comparison between MCI subtypes 
did not reveal any significant difference. Conversely, the comparison 
between ToL Total Time (overall problem-solving speed) and Stroop 
interference/time was significant for p<0.02.      
 
Sensitivity to interference was more damaged in interference/error 
(43.2%) than in interference/time (30.7%). By comparing sensitivity to 
interference/time with sensitivity to interference/error, we found a high 
significant difference (p<0.009). Sensitivity to interference was more 
damaged in MCI Type II, both for time (1.80±1.77) and error (1.26±1.53), 
than in the other subcategories. The comparison between MCI Type II and 
MCI Type III on Stroop interference/time showed a significant difference 
(p<0.006), as well as in the comparison between MCI Type I and MCI Type 
II on Stroop interference/error (p<0.003).       
Most of the subjects (66.2%) belonged to cluster 1 in the visual search 
task. Selective attention was more impaired in MCI Type IV (1.67±2.08) 
and Type II (2.23±1.3) than in the other subgroups (MCI Type I: 
2.69±1.07; MCI Type III: 2.50±1.3). However, this observation was not 
supported by any significant difference between subgroups. Conversely, 
the comparison of the mean scores obtained by MCI subjects on the Stroop 
Test and on the Visual Search Test, revealed a significant difference in 
interference/error (p<0.001) but not in interference/time.  
In the mental flexibility subdomain, the set-shifting ability was less 
compromised than capacity to produce words by following an unusual 
procedure. We pointed out that none of the MCI subjects had an abnormal 
performance in verbal fluency. The set-shifting ability was more impaired 
for MCI Type II (27.58±6.09) than for MCI Type III (24.57±11.51); MCI 
Type II is also the subgroup with the lowest scores in verbal fluency 
testing (2.44±1.01), followed by MCI Type I (2.78±0.83). No significant 
difference was found by comparing MCI subtypes in the Brixton test as 
well as in the Verbal Fluency Test. Comparison of the mean scores 
obtained by MCI subjects on the Stroop test and on the Verbal Fluency 
Test was significant for interference/error (p<0.0001) but not 
significant for interference/time, while no significant difference was 
found between the Brixton Test and the Stroop Test, both for 
interference/error and interference/time. 
Finally, 14.8% of the sample showed an impairment of inhibitory control. 
The GO-No-GO FAB subtest revealed that MCY Type II is the subgroup with 
the greatest impairment in inhibitory control (1.86±1.16) of the total 
MCI. No significant difference was revealed by comparing mean scores of  
the MCI subtypes in the FAB GO-No-GO subtest. The comparison between GO-
No-GO FAB subtest and tests assessing mental flexibility lacked 
statistical significance. 
On the basis of discriminant function analysis, we concluded that the set 
of variables taken into consideration (Story Recall, Pairs Associates 
Learning, Corsi Suvra-span Learning, Stroop Interference/Time and 
Interference/Error, and Visual Search Test) show a significant difference 
between MCI Type I and MCI Type II subgroups (p<0.009). Such a kind of 
analysis correctly classified 78.6% of MCI Type I subjects and 85.4% of 
MCI Type II subjects, respectively.     
 
 
 
4.4 DISCUSSION 
 
By definition, Mild Cognitive Impairment does not present a loss of 
autonomy, both personal and instrumental (Petersen et al., 1999; 
Petersen, 2004; Nelson and O‟Connor, 2008). For a restricted minority of 
MCI subjects who show an impairment of the ability to live independently, 
the autonomy loss is due to physical illnesses (e.g. urinary 
incontinence, decreased visual acuity, bone fractures, etc.).      
Overall, total orientation seems to be globally preserved. Comparisons 
between MODA Orientation subtests present significant differences due to 
different cognitive abilities examined. According to literature (Morris 
et al., 2001; Fernandez-Turrado et al., 2011), temporal orientation tends 
to deteriorate more frequently than the other orientation parameters, 
because it cannot count on semantic memory support. This may explain the 
lowest performance of MCI Type I in temporal orientation testing. In 
addition, the dysexecutive syndrome usually shown by MCI Type II, 
implicates the impairment of the ability to place events in a correct 
chronological order. This subgroup showed also a significant difference 
if compared to MCI Type I in the Spatial orientation test, probably due 
to attention deficits usually reported in diagnosis. Spatial orientation 
disorders that are sometimes accompanied by topographical disorientation 
due to hippocampal damage (Iachini et al., 2009) are currently considered 
as early symptoms of dementia.       
The examination of structural aspects of the memory system highlights an 
inhomogeneous profile, generally characterized by poor efficiency which 
is less marked for working memory sub-domains and more pronunced for  
long-term consolidation-recall (episodic memory) (cf. Cammisuli et al., 
2011b). In keeping with previous investigations on MCI memory profile 
(Traykof et al., 2007; Muangpaisan et al., 2010), our results confirm a 
preservation of short-term memory abilities in MCI subjects, in 
particular for verbal memory. Despite the use of the same tests, our 
results are not consistent with the findings of Perri et al. (2005) and 
Traykov et al. (2007) which showed greater impairment of verbal short-
term memory rather than visual-space short-term memory. In keeping with 
our findings, other studies have suggested that visual-space short-term 
memory deficit can precede typical memory impairments in the prodromal 
phase of AD (Hort et al., 2007). Moreover, many studies found a 
deterioration of visual-space sketchpad (assessed by Corsi test) in early 
AD and in mildly demented patients (Baudic et al., 2006; Buccione et al., 
2007), suggesting that visual-space short-term memory deficits may even 
constitute an early predictor of frank dementia. Results indicate a 
significant difference between short-term memory tests (p<0.001) probably 
due to the examination of different working memory sub-domains. MCI 
subjects learning and recognition abilities are slightly impaired
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, as 
expected (cf. Perri et al., 2005; 2007). Some studies associated these 
deficits to the hippocampus and to related mesial temporal lobe structure 
degeneration (Pennanen et al., 2004). Our results confirm the greatest 
impairment of verbal memory abilities for pure amnestic MCI (cf. Lonie et 
al., 2008), and, conversely, of visual-space memory abilities for 
amnestic MCI multiple domain (cf. Alescio-Lautier et al., 2007). Within 
memory systems, episodic memory is the most fragile subdomain of 
declarative memory. MCI subjects have a poor performance on visual-space 
tasks rather than on verbal tasks, as reveled by significant differences 
obtained by comparison of long-term memory tests. Literature does not 
report any explanation about difference of performances of MCI Type I and 
Type II on memory of prose tasks. It indicates only that performance 
level of amnestic MCI subjects in Story Recall falls between those of 
healthy controls and AD patients (Perri et al., 2005; 2007). Episodic 
memory testing show the dissociation between deterioration of free recall 
and preservation of recognition. Such finding is considered to be a 
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 None of the MCI subjects have a pathological score on the three recall tests.   
specific neuropsychological feature of memory performance of patients 
with frontal syndrome (Grossi and Trojano, 2005). Moreover, recognition 
of picture is significantly more deteriorated than recognition of face. 
Nevertheless, we are not surprising by this finding because picture 
recognition and face recognition are two distinct cognitive functions. In 
addition, significant differences have been found by comparing long-term 
memory tests with Face Recognition RBMT subtest, probably because of 
distinct neuropsychological deficit detected by tests (recall deficit vs 
prosopagnosia). According to Bennett et al. (2006), recall and 
recognition deficits reported by MCI subjects suggest that a combination 
of tests evaluating these memory functions may be useful for defining 
episodic memory impairment associated with MCI and early AD. In addition 
to retrospective memory decline, individuals with MCI often complain of 
the difficulty in remembering to carry out intended actions, consistent 
with the findings of impaired prospective memory. Retrospective memory 
appears significantly less compromised than prospective memory, as 
demonstrated by comparisons between retrospective and prospective memory 
tests. Associative retrieval is automatic and associated with medial 
temporal lobe structures; strategic retrieval consists of several 
processes applied to memory and it is associated to prefrontal cortex 
(Lepore and Grossi, 2005). Our study confirms previous investigations 
(Kazui et al., 2005; Karantzoulis et al., 2008; Costa et al., 2011), 
showing that the amnestic subtype also presents a deterioration of 
prospective memory. Such an impairment is likely due to episodic memory 
deficits along with slight executive functioning deficits (decreased 
self-initiation, attention switching, and/or inhibition on memory tasks) 
(cf. Kramer et al., 2006) and it is associated to neuropathological 
changes in medial-temporal and frontal-system structures (Troyer and 
Murphy, 2007). As previously observed by Blanco-Campal et al. (2008) and 
Thompson et al. (2009), prospective memory failure is an early sign of 
cognitive decline in MCI and incipient AD, and it may be more pronounced 
than retrospective memory failure. Kazui et al. (2005) demonstrated also 
that MCI subjects show an impairment of everyday memory abilities, 
especially for (1) recalling the name of a person that they met for the 
first time, (2) faces of some unfamiliar person, (3) some visual 
information, (4) a new route, (5) a short story about 20 minutes after 
memorizing it. The orientation for time, place and person was also 
somewhat impaired in patients with MCI. These results suggest that 
subjects with MCI have disabilities in situations in which delayed recall 
is needed.                    
 
Preceding studies on dementia (Laatu et al., 2003; Kirby et al., 2010) 
demonstrated that abilities of visual gnosia decline more frequently than 
other instrumental extra-memory functioning (cf. Timpano Sportiello and 
Cammisuli, 2009; Timpano Sportiello and Cammisuli, 2010a). They are 
associated to visual association cortex injuries (Giannakopoulos et al., 
1999). Visual object perception suffers a progressive deterioration in AD 
from the early stages of the disease (Mendez et al., 1990). Although the 
deterioration of visuoperceptual abilities is well known in dementia, 
little information is available for subjects with MCI. Probably, because 
of the neuropsychological tests used, our study is not consistent with 
the findings of Nordlund et al. (2005) and Alegret et al. (2009), who 
found visuoperceptual deficits for 40%
24
 and for 68.8%
25
 of the examined 
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 The visuoperceptual deficits were measured by the Visual Object and Space Perception Battery 
Silhouette subtest (Warrington and James, 1999). The VOSP is based upon Warrington‟s model (McCarthy 
& Warrington, 1990), which distinguishes 3 subtypes of impaired object recognition: 1) disorders of 
visual sensory discrimination, which reflect selective deficits affecting sensory processing, 
including acuity, shape discrimination, and color discrimination; 2) apperceptive agnosia, which 
refers to disorders of object perception; and 3) associative agnosia, which refers to disorders when 
deriving the meaning of visually presented objects, even in the presence of normal sensory and 
perceptual abilities.    
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 The visuoperceptual deficits were measured with the 15-OT (Pillon et al., 1989) and with the 
Poppelreuter Test (Poppelreuter, 1914; 1917; 1923). They are very similar to The Tangled Figures 
Test (adapted form Rey Tangled Lines Test, 1966).      
MCI subjects, respectively. In our MCI sample, non amnestic MCI single 
domain and amnestic MCI multiple domain report the greatest impairment of 
visual gnosia abilities. The diagnosis of MCI Type III was usually 
formulated because of the prevalence of visual gnosia deficits on the 
other cognitive deficits. According to Alegret et al. (2009), the 
deterioration of visual gnosia performances usually reported in amnestic 
MCI multiple domain, may contribute to an increased risk of developing 
dementia. 
 
Literature presents controversial results on language decline in MCI, 
both for naming and for verbal fluency tasks. In keeping with our 
research, some studies (Bennett et al., 2002; Storandt et al., 2002) 
showed that MCI subjects report a failure of performance on the BNT. 
Moreover, Storandt et al. (2002) demonstrated also that naming deficits 
increase with the progression of cognitive deterioration. In contrast, 
Beinhoff et al. (2005), Balthazar et al. (2007) found no differences 
between MCI subjects and normal controls on the 15-BNT and on the BNT, 
respectively. Controversial results may be due to methodological 
problems, such as the use of different psychodiagnostic tools or the 
heterogeneity of the samples adopted. Anomia, which represents the most 
important language impairment of our sample, is a frequent 
neuropsychological feature of early AD (Laurent et al., 1998). This 
language deficit is associated with left inferior temporal cortex injury 
(Antonucci et al., 2004). Patients with AD vary considerably in the 
extent of language deficits; sometimes, anomia can be nearly as prominent 
as the anterograde amnesia deficit in AD (Knopman et al., 2003). Studies 
on verbal fluency in MCI and incipient dementia yielded mixed results 
(Teng et al., 2010). Saxton and coll. (2004) indicated that category 
fluency decline was one of the predictors of subsequent conversion to AD, 
within a period of 1-1.5 years. A recent work by Murphy et al. (2006) 
found that aMCI subjects produced significantly fewer words on category 
fluency tasks than on phonemic fluency tasks, when compared to healthy 
controls. The researchers concluded that MCI patients experienced 
difficulties in making semantic associations between exemplars of 
subcategories rather than difficulties in searching through lexical 
representations, suggesting degeneration of brain areas beyond that of 
the hippocampus (i.e. inclusion of bitemporal anterior areas supporting 
semantic memory) at this early stage of the disease. In conclusion, the 
verbal fluency task used to detect both lexical-semantic language 
impairment and mental flexibility has been revealed to be a poorly 
accurate psychodiagnostic tool in discriminating healthy elderly people 
from MCI subjects, and MCI subjects from AD patients (Radanovic et al., 
2009). A significant difference was found in the comparison of MCI Type I 
with Type II, probably due to the deterioration of language domain of 
subjects with amnestic MCI multiple domain.   
 
Constructive apraxia performance remains fairly stable in MCI subjects. 
As shown by a recent study of Barth et al. (2005), which evaluated 
neuropsychological deficits of 49 patients with MCI, 80 patients with AD, 
36 with major depression, and 26 elderly controls  by using the CERAD-NP26 
test battery, MCI subjects were significantly impaired compared with AD 
in all CERAD-NP subtests, but not in the constructive apraxia subtest. 
Constructive apraxia performances are more damaged in MCI Type II and IV 
probably because of the frontal domains involvement, according to the 
role of frontal lobe in constructive apraxia performance (Grossi and 
                                                        
26
 The Consortium to Establish a Registry for Alzheimer‟s Disease neuropsychological battery (CERAD-
NP) is a very widely used cognitive test packet for the evaluation of patients with Alzheimer‟s 
disease and other dementia. The CERAD-NP consists of several subtests, such as Verbal fluency (VF), 
modified Boston Naming Test (BNT), Mini-Mental State Examination (MMSE), Word List Memory (WLM), 
Word List Recall (WLR), Word List Recognition (WLRc), Constructional Praxis (CP), and Constructional 
Recall (CR). It is useful for detection and progression monitoring of cognitive impairment. 
Trojano, 2005). The significant difference revealed by comparison of MCI 
Type I with Type II could be related to the involvement of visuo-spatial 
abilities, motor planning and executive control in constructive apraxia 
tasks, which are usually damaged in amnestic MCI multiple domains.  
 
Even if memory represents the cognitive domain most frequently impaired 
in MCI, slight memory loss cannot be considered as the core of MCI. From 
a historical perspective, clinical research on neuropsychological 
features of subjects suffering from Mild Cognitive Impairment 
overestimated the role of declarative memory impairment rather than the 
broader cognitive deterioration that afflicts the majority of subjects 
with MCI. More recently, literature has emphasized the combined role of 
memory disorder and executive dysfunction, even as risk factors for MCI 
conversion into frank dementia (Grober et al., 2008). There are many 
reasons to establish that decline in some aspects of executive 
functioning is a risk factor for the development of dementia. Firstly, 
Baddeley and coll. demonstrated 20 years ago that selective impairment of 
Central Executive is a prominent feature of AD (1986; 1991). Secondly, 
the onset of executive dysfunction typically follows the onset of 
episodic memory impairment in AD, and precedes the impairment of language 
and visual-space abilities (Bondi et al., 2002). Finally, executive 
functioning impairment can be found even among subjects with pure 
amnestic MCI (Royall et al., 2004; Kramer et al., 2006). These 
observations have led to the hypothesis that only when executive 
functioning deteriorates, should an MCI subject be considered to have 
prodromal AD (Albert et al., 2001; Royall et al., 2002).          
According to updated scientific literature (Zhang et al., 2007; Traykof 
et al., 2008; Brand et al., 2009), planning and sensitivity to 
interference deteriorate more frequently within frontal domains than 
selective attention, mental flexibility and inhibitory control. Such an 
observation suggests that these deficits (predominantly present in 
amnestic MCI multiple domain), could represent the main risk factors for 
MCI conversion into dementia.  
The significant difference found between ToL Total Time and Stroop 
Interference/Time is probably due to different cognitive abilities 
measured, such as overall problem-solving speed versus restraint of 
inhibitory control.  
The significant difference found between Stroop Interference/Time and 
Stroop Interference/Error suggest that MCI subjects have an impairment of 
sensitivity to interference as such, regardless of time. Subjects with 
MCI Type II perform significantly more poorly than subjects with MCI Type 
I on Stroop Interference/Error and subjects with MCI Type III on Stroop 
Interference/Time, probably because of the greatest impairment of 
executive functioning.   
The significant difference found between Visual Search Test and Stroop 
Interference/Error as well as between Category Fluency Test and Stroop 
Interference/Error could be attributed to the different cognitive 
abilities examined (selective attention/capacity to produce word by using 
unusual procedure vs restraint of inhibitory control).   
According to literature (Arnáiz et al., 2003; Hunderfound et al., 2006; 
Traykov et al., 2007; Petersen and Negash, 2008), amnestic MCI multiple 
domain with dorsolateral prefrontal cortex and anterior cingulate cortex 
injury
27
, is the highest risk subgroup for incipient dementia. Such an 
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 For a more extensive examination of cognitive deficits due to dorsolateral prefrontal cortex and 
anterior cingulate cortex injury see Grossi and Trojano (2005).     
assumption is confirmed by longitudinal analysis results that showed a 
significant difference for MCI Type II in the comparison of MODA total 
scores between t0 and t2.   
To conclude, we would stress that combined deficits in episodic memory 
(both retrospective and prospective) and executive functioning 
(particularly characterized by planning and sensivity to interference 
impairment) can represent the neuropsychological markers apt to predict 
dementia. Prospective memory deficit makes more evident the involvement 
of executive functioning in cognitive deterioration that affects subjects 
with MCI. According to Rapp and Reischies (2005), cognitive task required 
executive control are significantly affected in the preclinical phase of 
AD and are reliable predictors of the disease before diagnosis.                     
A neuropsychological test battery including measures of delayed recall, 
prospective memory, and attention/executive functions is recommended to 
offer clinicians valuable information for MCI diagnosis and to 
longitudinally observe cognitive decline.     
4.5 LIMITATIONS OF THE STUDY 
Our database claims a high number of MCI subjects tested in a unique 
clinical setting and followed for 9 years. The neuropsychological test 
battery was generally administered  in two parts (a first 
neuropsychological evaluation: cognitive global screening and memory 
system evaluation; a second neuropsychological evaluation: instrumental 
extra-memory functions and executive functioning examination). Because of 
the length of test administration and of the attentive resources required 
of the  subjects, the neuropsychologists had to adequately interact with 
patients to ensure good compliance. 
However, our study presents some critical aspects:  
 our research should be implemented by comparing MCI subjects 
performances with a control group of healthy elderly people and 
with a group of AD patients;  
 the neuropsychological test battery we adopted has been slowly 
implemented through the use of different tests that literature on 
MCI assessment suggested to be specific and sensitive to cognitive 
decline, such as the Tower of London test (Shallice, 1982; 
Culbertson and Zillmer, 2001), introduced at the beginning of 2008. 
It was therefore only possible to evaluate planning abilities for a 
small percentage of the sample (11.11%). The lack of data on ToL 
test is also due to the difficulties presented by many individuals 
to follow the correct procedure for test execution (the 
administration is suspended after three attempts);    
 follow-ups have not been made with regular time intervals, as 
required (6-7 months from the first evaluation). Most of the 
subjects were submitted only to the first examination. A small 
percentage of the sample (17.28%) was reassessed at least twice 
after baseline. This trend lead to “the death of the experimental 
subject”, with the inevitable consequence of missing data; 
 although our study was updated using the latest available software 
(the PROCAPE® software of Bianchi and Pagliuca, 2011) (cf. Bianchi 
and Dai Prà, 2008), statistical analysis was influenced by the 
impossibility to transform all the raw scores into equivalent 
scores (Capitani and Laiacona, 1997). The raw scores of the Boston 
Naming Test, Brixton Test, Go-No-Go FAB subtest, and Tower of 
London, have been transformed using statistical indices such as 
percentiles or cut-off.                     
4.6 FUTURE PERSPECTIVES 
The present study should be implemented with the collection of more 
extensive data in order to allow clinicians to make inferences on MCI 
prognosis. The  characterization of MCI neuropsychological profiles can 
help clinicians clarify specific markers related to MCI subtypes, apt to 
predict dementia and its typologies (cf. 3.4).  
Recent research has indicated that autobiographical (more episodic than 
semantic) memory is also damaged in aMCI subjects (Joubert et al., 2008; 
Murphy et al., 2008). Semantic memory in MCI is under-investigated and 
some studies are controversial concerning impairment (Testa et al., 2004; 
Dudas et al., 2005; Balthazar et al., 2007). Our research should be 
implemented with further investigations about autobiographical and 
semantic memory deficits. Furthermore, preliminary results on the 
greatest impairment of prospective memory rather than retrospective 
memory, should be supported by data analysis conducted on a bigger sample 
size.   
One of the main objectives of this research project was to offer 
clinicians guidelines when assessing MCI and to differentiate its 
subtypes, by indicating the neuropsychological tests with more 
specificity and sensitivity to the cognitive decline shown by MCI 
individuals. Such an investigation should produce a data reduction in 
order to point out the neuropsychological tests necessary to evaluate 
performances of subjects with MCI. 
 
 
 
 
 
 
  
 
 
 
 
 
 
BIBLIOGRAPHY 
Albert, M.S., Moss, M.B., Tanzi, R., Jones, K. (2001) Preclinical 
prediction of AD using neuropsychological tests. Journal of the 
International Neuropsychological Society. 7, 631–639. 
 
Alegret, M., Vendrell, P., Junqué, C., Valldeoriola. F., Nobbe. F.A., et 
al. (2000). Effects of unilateral posteroventral pallidotomy on “on-off” 
cognitive fluctuations in Parkinson‟s disease. Neuropsychologia, 38, 628-
633. 
 
Alescio-Lautier, B., Michel, B.F., Herrera, C., Elahmadi, A., Chambon, 
C., Touzet, C., et. al. (2007).  Visual and visuospatial short-term 
memory in mild cognitive impairment and Alzheimer disease: role of 
attention. Neuropsychologia, 45(8), 1948-60.   
 
Alexopoulos, G.S., Abrams, R.C., Young, B.C. and Shamoian, C.A. (1988). 
Cornell scale for depression in dementia. Biological Psychiatry, 23, 271-
284. 
 
American Psychiatric Association (1952). Diagnostic and statistical 
manual of mental disorders (1st. ed.). Washington, DC: Author.  
 
American Psychiatric Association. (1980). Diagnostic and statistical 
manual of mental disorders (3rd. ed.). Washington, DC: Author.   
 
American Psychiatric Association. (1987). Diagnostic and statistical 
manual of mental disorders (3rd. rev. ed.). Washington, DC: Author.   
 
American Psychiatric Association. (1994). Diagnostic and statistical 
manual of mental disorders (4th. ed.). Washington, DC: Author. 
 
Andersen, K., Nielsen, H., Lolk, A., Andersen, J., Becker, I., and Kragh-
Sørensen, P. (1999). Incidence of very mild to severe dementia and 
Alzheimer‟s disease in Denmark: The Odense Study. Neurology, 52, 85-90.  
 
Antonucci, S., Beeson, P., and Rapcsak, S. (2004). Anomia in patients 
with inferior temporal lobe lesions. Aphasiology, 18(5-7), 543-554.  
 
Arnaiz, E., and Almkvist, O. (2003). Neuropsychological features of mild 
cognitive impairment and pre-clinical Alzheimer's disease. Acta Neurol 
Scand Suppl. 179, 34–41. 
 Arrigoni, G. and De Renzi, E. (1964). Constructional apraxia and 
hemispheric locus of lesion. Cortex, 1, 170-197. 
 
Austad, S. (1997). Why we age? What Science Is Discovering about the 
Body's Journey Through Life. New York: Wiley. 
 
Baddeley, A., Logie, R., Bressi, S., Della Sala, S., Spinnler, H. (1986) 
Dementia and working memory. Quarterly Journal of Experimental 
Psychology, 38A: 603–618. 
 
Baddeley, A., Bressi, S., Della Sala, S., Logie, R., Spinnler, H. (1991) 
The decline of working memory in Alzheimer‟s disease. Brain, 114, 2521–
2542.  
 
Baltes, P.B. and Baltes, M.M. (1990). Successful aging. Cambridge: 
Cambridge University Press.   
 
Balthazar, M.L.F., Martinelli, J.E., Cendes, F., and Damasceno, B.P. 
(2007). Lexical semantic memory in amnestic mild cognitive impairment and 
mild Alzheimer‟s disease. Arq. Neuropsiquiatr., 65, 619-622. 
 
Balthazar, M.L., Cendes, F., and Damasceno, B.P. (2008). Semantic error 
patterns on the Boston Naming Test in normal aging, amnestic mild 
cognitive impairment, and mild Alzheimer's disease: is there semantic 
disruption? Neuropsychology, 22(6),703-709. 
 
Barbeau, E., Didic, M., Tramonti, E., Felician, O., Joubert, S., 
Sontheimer, A., et al. (2004). Evaluation of visual recognition memory in 
MCI patients. Neurology, 62, 1317-1322.  
 
Barth, S., Schönknecht, P., Pantel, J., and Schröder, J. (2005). Mild 
cognitive impairment and Alzheimer's disease: an investigation of the 
CERAD-NP test battery. Fortschr. Neurol. Psychiatr., 73(10), 568-576. 
Baudic, S., Barba, G.D., Thibaudet, M.C., Smagghe, A., Remy, P. and 
Traykov L. (2006). Executive function deficits in early Alzheimer's 
disease and their relations with episodic memory. Archives of  Clinical 
Neuropsychology, 21, 15-21. 
 
Beinhoff, U., Hilbert, V., Bittner, D., Gron, G., Riepe, M.W. (2005). 
Screening for cognitive impairment: a triage for outpatient care. 
Dementia and Geriatric Cognitive Disorders, 20(5): 278-285.   
 
Belleville, S. (2008). Cognitive training for person with mild cognitive 
impairment. International Psychogeriatrics, 20, 57-66. 
 
Bender, A. (1938). Visual Motor Gestalt Test and its Clinical Use. 
Research Monographs N.3. New York, NY: American Orthopsychiatry 
Association. 
 
Bennet, I.J., Golob, E.J., Parker, E.S., and Starr, A. (2006). Memory 
evaluation in Mild Cognitive Impairment using Recall and Recognition 
Tests. Journal of Clinical and Experimental Neuropsychology, 28(8): 1408-
1422.    
 
Benton, L.A. (1974). Revised Visual Retention test: clinical and 
experimental applications (4th ed.). New York, NY: Psychological 
Corporation. 
 
Benton, A.L. and Hamsher, K. (1976). Multilingual Aphasia Examination 
(rev. ed.). Manual of instruction University of Iowa. Iowa City, IA: 
University of Iowa.    
 
Benton, A. L. and Hamsher, K. D. (1989). Multilingual Aphasia 
Examination. Iowa City, IA: AJA Associates. 
 
Benton, A.L., Sivan, A.B., Hamsher Kerry, deS., Varney, N.R., Spreen, O. 
(1994). Contributions to Neuropsychological Assessment. A Clinical Manual 
(2nd ed.). Orlando, FL: Psychological Assessment Resources. 
 
Bergaman, K., Kay, D.W.K. and Foster, E.M. (1971). A follow-up study of 
randomly selected community residents to assess the effects of chronic 
brain syndrome and cerebrovascular disease. Psychiatry, Part II: 
International Congress Series No. 274. Amsterdam: Excerpta Medica. 
 
Bianchetti, A. and Pezzini, A. (2001). Depressione e Demenza. Approccio 
clinico e trattamento. Dementia Update, 9, 25-33.   
 
Bianchi, A., and Dai Prà, M. (2008). Twenty years after Spinnler and 
Tognoni: new instruments in the Italian neuropsychologist‟s toolbox. 
Neurological Science, 29: 209-217.  
 
Birks, J., Grimley, Evans, J., Iakovidou, V., and Tsolaki, M. (2000). 
Rivastigmine for Alzheimer‟s disease. Cochrane Database Systematic 
Review, CD001191.  
 
Bischkopf, J., Busse, A., and Angermeyer, M.C. (2002). Mild cognitive 
impairment: a review of prevalence, incidence, and outcome according to 
current approaches. Acta Psychiatrica Scandinavica, 106, 403–414.  
Birren, J.E., and Schroots, J.F. (1996). History, concepts and theory in 
the psychology of aging. In J.E. Birren and K.W. Schaie (Eds.), Handbook 
of psychology of aging (pp.), New York: Van Nonstrand Reinhold. 
 
Blanco-Campal, A., Coen, R.F., Lawrol, B.A., Walsh, J.B., and Burke, T.E. 
(2008). Detection of prospective memory deficits in mild cognitive 
impairment of suspected Alzheimer‟s disease etiology using a novel event-
based prospective memory task, Journal of the International 
Neuropsychological Society, 15: 154-159.   
 
Blackford, R.C. and La Rue, A. (1989). Criteria for Diagnosing Age 
Associated Memory Impairment: Proposed Improvements From the Field. 
Developmental Neuropsychology, 5(4), 295-306.    
 
Bleuler, E. (1924). The Text Book of Psychiatry. New York, NY: The 
Macmillian Co.  
 
Bondi, M.W., Serody, A.B., Chan, A.S., et al. (2002). Cognitive and 
neuropathologic correlates of Stroop Color-Word Test performance in 
Alzheimer‟s disease. Neuropsychology, 16, 335–343. 
 
Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S. and Larson, 
E.B. (1997). Progression to dementia in patients with isolated memory 
loss. The Lancet, 349, 763-765.  
 
Brandt, J. Aretouli, E.,
 
Neijstrom, E., Samek, J.,
 
Manning, K., Albert, 
M.S., et al. (2009). Selectivity of executive functioning deficit in mild 
cognitive impairment. Neuropsychology, 23(5), 607-618.   
 
Brazzelli, M., Capitani, C., Della Sala, S., Spinnler, H. and Zuffi, M. 
(1994). A neuropsychological instrument adding to the description of 
patients suspected of dementia: The Milan Overall Dementia Assessment. 
Journal of Neurology, Neurosurgery & Psychiatry, 57, 1510-1517.    
 
Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H.M. 
(2007). Forecasting the global burden of Alzheimer‟s disease. Alzheimer’s 
and Dementia, 2007;3:186-191. 
 
Bruscoli, M., and Lovestone, S. (2004). Is MCI really just early 
dementia? A systematic review of conversion studies. International 
Psychogeriatrics, 16, 129-140. 
 
Buccione, I., Perri, R., Carlesimo, G.A., Fadda, L., Serra, L., Scalmana, 
S., et al. (2007). Cognitive and behavioural predictors of progression 
rates in Alzheimer‟s disease. European Journal of Neurology, 14, 440-446.  
 
Burgess, P.W. (1997). Theory and methodology in executive function 
research. In P. Rabbitt P (Ed.). Methodology of frontal and executive 
function (pp. 81-116). Hove, UK: Psychology Press. 
 
Burgess, P. and Shallice, T. (1997). The Hayling and Brixton Tests. Test 
manual. Bury St Edmunds, UK: Thames Valley Test Company. 
 
Buschke, H. (1984). Cued recall in amnesia. Journal of Clinical 
Neuropsychology, 6, 433-440. 
 
Busse, A., Bischkopf, J., Riedel-Heller, S.G.,(2003). Subclassifications  
for mild cognitive impairment: prevalence and predictive validity. 
Psychological Medicine, 33, 1029-1038. 
 
Busse, A., Hensel, A., Guhne, U., Angermeyer, M.C., and Riedel-Heller, 
S.G. (2006). Mild cognitive impairment: long-term course of four clinical 
subtypes. Neurology, 67(12), 2176-2185. 
 
Caine, E.D. (1981). Pseudodementia. Current concepts and future 
direction. Archives of General Psychiatry, 38, 1359-1364.  
 
Cammisuli, D., Pinori, F., Verdiani, C., & Timpano Sportiello, M. 
(2009a).  Cognitive Activation Therapy for mild cognitive impairment and 
mild demented subjects: Opposing Dementia Regression. Paper presented at 
23th European Health Psychology Society (Pisa, Italy). Psychology and 
Health, 24(1): 118-119. 
 
Cammisuli, D., Pinori, F., Verdiani, C., & Timpano Sportiello, M. 
(2009b). Cognitive Activation Therapy for mild cognitive impairment 
subjects and mild demented patients: A pilot-study. Paper presented at 
23th European Health Psychology Society (Pisa, Italy). Psychology and 
Health,  24(1): 118-119. 
 Cammisuli, D., Timpano Sportiello, M., Pinori, F. & Verdiani, C. (2009c). 
Ruolo del programma di attivazione cognitiva per soggetti con mild 
cognitive impairment e pazienti con demenza lieve: la riduzione del 
carico assistenziale a favore del caregiver. Paper presented at 54° 
Congresso Società Italiana di Geriatria e Gerontologia (Firenze, Italia). 
Giornale Italiano di Gerontologia, LVII: 417-417.   
 
Cammisuli, D., Pinori, F., Verdiani, C., & Timpano Sportiello, M. 
(2009d). Adeguamento dell‟assessment neuropsicologico negli interventi di 
attivazione cognitiva per soggetti con mild cognitive impairment e 
pazienti affetti da demenza lieve. Paper presented at X Congresso di 
Psicogeriatria (Gardone Riviera, Italia). Psicogeriatria, 1(Suppl.): 133-
133.   
 
Cammisuli, D., Timpano Sportiello, M., Pinori, F., & Verdiani, C. 
(2010a). La valutazione neuropsicologica del Mild Cognitive Impairment. 
Paper presented at 55° Congresso Società Italiana di Geriatria e 
Gerontologia (Firenze, Italia). Progr.: 73-73.  
 
Cammisuli, D., Timpano Sportiello, M., Pinori, F. & Verdiani, C.  
(2010b). La Terapia di Attivazione per soggetti con Mild Cognitive 
Impairment e Mild Dementia: Efficacia ed Appropriatezza. Paper presented 
at IX Congresso Società Italiana Psicologia della Salute (Bergamo, 
Italia). Abstract book: 353-354. 
 
Cammisuli, D., Timpano Sportiello, M., Pinori, F., Verdiani, C. (2011a). 
Role of activation therapy program for patients suffering from mild 
dementia and subjects with mild cognitive impairment: reducing 
caregiver‟s burden. Giornale Italiano di Gerontologia, LIX(1): pp. 38-45.  
 
Cammisuli, D., & Timpano Sportiello, M. (2011b). The neuropsychological 
features of pure amnestic MCI. Paper presented at VII European 
International Congress of International Association of Gerontology and 
Geriatrics (Bologna, Italy). Aging, Clinical and Experimental Research, 
23(1): 175. 
 
Canning, S.J., Leach, L., Stuss, D., Ngo, L., and Black, S.E. (2004). 
Diagnostic utility of abbreviated fluency measures in Alzheimer‟s disease 
and vascular dementia. Neurology, 24, 534-535. 
 
Capitani, E., and Laiacona, M. (1997). Composite Neuropsychological 
Batteries and Demographic Correction: Standardization Based on Equivalent 
Scores with a Review of Published Data. Journal of Clinical and 
Experimental Neuropsychology,19, 795-809.  
 
Carlesimo, G.A., Mauri, M., Graceffa, A.M., Fadda, L., Loasses, A., 
Lorusso, S., et al. (1998). Memory performance in young, elderly, and 
very old healthy individuals versus patients with Alzheimer‟s disease: 
Evidence for discontinuity between normal and pathological aging. Journal 
of Clinical and Experimental Neuropsychology, 20, 14-29. 
 
Catani, M., Cherubini, A., Howard, R., Tarducci, R., Pelliccioli, G.P., 
Piccirilli, M., et al. (2001). H-MR spectroscopy differentiates mild 
cognitive impairment from normal brain aging. NeuroReport, 12, 2315-2317. 
 
Chantal, S., Braun, C.M., Bouchard, R.W., Labelle, M., and Boulanger, Y. 
(2004). Similar 1H magnetic resonance spectroscopic metabolic pattern in 
the medial temporal lobes of patients with mild cognitive impairment and 
Alzheimer‟s Disease. Brain Research, 1003, 26-35.   
 
Chertkow, H., Massoud, F., Nasreddine, Z., Belleville, S., Joanette, Y., 
Bocti, C., Drolet, V., et al. (2008). Diagnosis and treatment of 
dementia: 3. Mild cognitive impairment and cognitive impairment without 
dementia. Canadian Medical Association Journal, 17(8), 1273-1285.   
 
Christensen, A-L. (1975). Luria’s neuropsychological investigation. 
Copenhagen: Munksgaard. 
 
Christensen, H., Henderson, A.S., Jorm, A.F., Mackinnon, A.J., Scott, R. 
and Korten, A.E. (1995). ICD-10 mild cognitive disorder: epidemiological 
evidence on its validity. Psychological Medicine, 25, 105-120.  
 
Clare, L., and Woods, B. (2005). Cognitive rehabilitation and cognitive 
training for early-stage Alzheimer‟s disease and vascular dementia. 
Cochrane Database Systematic Review,(4)CD003260. 
 
Cooper, B., Bickel, H. and Shaufele, M. (1996). Early development and 
progression of dementing illness in the elderly: a general-practice based 
study. Psychological Medicine, 26, 411-491.  
 
Copeland, J., Kelleher, M., Kellet, J., et al. (1976). A semi-structured 
clinical interview for the assessment of diagnosis of mental state in the 
elderly: geriatric mental state schedule. Development and reliability. 
Psychological Medicine, 6, 439-449. 
 
Copeland, J.R.M., Dewey, M.E. and Griffiths-Jones, H.M. (1986). A 
computerized psychiatric diagnostic system and case-nomenclature system 
for elderly subjects: GMS and AGECAT. Psychological Medicine, 16(1), 89-
99. 
 
Cooper, J.R., Bloom, F.E., and Roth, R.H. (1996). The biochemical basis 
of neuropharmacology (7
th
 ed.).  New York: Oxford University Press.    
 
Costa, A., Perri, R., Zabberoni, S., Barban, F., Caltagirone, C., 
Carlesimo, G.A. (2011). Event-based prospective memory failure in 
amnestic mild cognitive impairment. Neuropsychologia, Mar 17, Epub ahead 
of print.  
 
Crook, T., Bartus, R.T., Ferris, S.H., Withehouse, P. and Cohen, G. 
(1986). Age-associated Memory Impairment: Proposed Diagnostic Criteria 
and Measures of Clinical Change – Report of a National Institute of 
Mental Health Work Group. Developmental Neuropsychology, 2(4), 261-276.  
 
Cummings, J.L., Mega, M., Gray., K., Rosenberg-Thompson, S., Carusi, D.A. 
and Gornbei, J. (1944). The Neuropsychiatric Inventory: comprehensive 
assessment of psychopathology in dementia. Neurology, 44, 2308-2314.   
 
Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J. and 
Albert, M. (2000). Predicting Conversion to Alzheimer Disease Using 
Standardized Clinical Information. Archives of Neurology, 57, 675-680. 
 
Darby, D., Maruff, P., Collie, A., and McStefen, M. (2002). Mild 
Cognitive Impairment can be detected by multiple assessment in a single 
day. Neurology, 59, 1042-1046. 
 
Das, S.K., Bose, P., Biswas, A., Dutt, A., Banerjee, T.K., Hazra, A.M. 
(2007). An epidemiologic study of mild cognitive impairment in Kolkata, 
India. Neurology, 68(23), 2019-2026. 
 
Dawe, B., Procter, A. and Philpot, M., (1992). Concepts of mild memory 
impairment in the elderly and their relationship to dementia: a review. 
International Journal of Geriatric Psychiatry, 7, 473-9. 
 
DeCarli, C. (2003). Mild cognitive impairment: prevalence, prognosis, 
aetiology, and treatment. Lancet Neurology, 2(1), 15-21. 
 
de Leon, M.J., Convit, A., Wolf, O.T., Tarshish, C.Y., DeSanti, S., 
Rusinek, H., et al. (2001). Prediction of cognitive decline in normal 
elderly subjects with 2-[18f]fluoro-2-deoxy-D-glucose/positron-emission 
tomography(FDG/PET). Prot. Natl. Acad. Sci. USA 98, 10966-10971.   
 
Della Sala, S. (2000). Test di Memoria Comportamentale di Rivermead. 
Firenze: Organizzazioni Speciali.  
 
Delis, D.C., Kramer, J.H., Kaplan, E. and Ober, B.A. (1987). California 
Verbal Learning Test (CVLT) (Research ed.). San Antonio, TX: The 
Psychological Corporation. 
 
De Renzi, E. and Vignolo, L.A. (1962). The Token Test: A sensitive test 
to detect disturbances in aphasics. Brain, 85, 665-678.  
 
De Renzi, E., Pieczuro, A. and Vignolo, L.A. (1968). Ideational apraxia: 
a quantitative study. Neuropsychologia, 6, 41-52.  
 
Devanand, P.D., Folz, B.A., Gorlyn, M., Moeller, J.R. and Stern, Y. 
(1997). Questionable Dementia: Clinical Course and Predictors of Outcome. 
Journal of the American Geriatrics Society, 45, 321-328.  
 
Devanand, D.P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, 
S., et al. (2007). Hippocampal and entorhinal atrophy in mild cognitive 
impairment: Prediction of Alzheimer disease. Neurology, 68-828-836.    
 
Di Carlo, A., Lamassa, M., Baldereschi, M., Inzitari, M., Scafato, E., 
Farchi, G., et al. (2007). CIND and MCI in the Italian elderly: 
frequency, vascular risk factors, progression to dementia. Neurology, 
68(22), 1909-1916. 
 
Dickerson, B.C., and Sperling, R.A. (2008). Functional abnormalities of 
medial temporal lobe memory system in mild cognitive impairment and 
Alzheimer‟s Disease: Insights from functional MRI studies. 
Neuropsychologia, 46(6), 1624-1635.  
 
Dobbs, A. R. and Rule, B. G. (1989). Adult age differences in working 
memory. Psychology & Aging, 4, 500-503. 
Dörken, H. and Kral, V. A. (1951). Psychological investigation of senile 
dementia. Geriatrics, 6(3), 151-163. 
 
Du, A.T., Schuff, N., Amend, D., Laakso, M.P., Hsu, Y.Y., Jagust, W.J. et 
al. (2001). Magnetic resonance imaging of the entorhinal cortex and 
hippocampus in mild cognitive imapairment and Alzheimer disease. Journal 
of Neurology Neurosurgery and Psychiatry, 71, 441-447.   
 
Dubois, B., Slachevsky. A., Litvan, I. and Pillon, B. (2000). The FAB: A 
Frontal Assessment Battery at bedside. Neurology, 55, 1621-1626. 
 
Dubois, B. and Albert, M.L. (2004). Amnestic MCI or prodromal Alzheimer‟s 
disease? The Lancet Neurology, 3(4), 246-248.  
 
Dudas, R.B., Clague, F., Thompson , S.A., Graham, K.S., and Hodges, J.R 
(2005). Episodic and semantic memory in mild cognitive impairment. 
Neuropsychologia, 43(9), 1266-1276.  
 
Elby, E., Hogan, D.B. and Parhad, M.D. (1995). Cognitive Impairment in 
the Nondemented Elderly. Results From the Canadian Study of Health and 
Aging. Archives of Neurology, 52, 612-619. 
 
Falgherazzi, C., Stefinlongo, P., and Brugiolo, L. (2009). Trattamento 
farmacologico e non farmacologico della malattia di Alzheimer: evidenze. 
Parte I. Trattamento farmacologico. Giornale di Gerontologia, 57, 209-21.  
 
Farias, S.T., Mungas, D., Reed, B.R., Harvey, D., and DeCarli, C.  
(2009). Progression of mild cognitive impairment to dementia in clinic- 
vs community-based cohorts. Archives of Neurology, 66(9), 1151-1157. 
 
Feldman, H.H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., 
et al. (2007). Effect of rivastigmine on delay to diagnosis of 
Alzheimer's disease from mild cognitive impairment: the InDDEx study. 
Lancet Neurology, 6(6), 501-512.   
  
Fernandez-Turrado, T., Pascual-Millan, L.F., Aguilar-Palacio, I.,  
Burriel-Rosello, A., Santolaria-Martinez, L., and Perez-Lazaro, C. 
(2011). Temporal orientation and cognitive impairment. Rev. Neurol., 
52(6), 341-348.  
 
Ferrari, E., Cravello, L., Muzzoni, B., Casarotti, D., Paltro, M., 
Solerte, S.B., et al. (2004). Age-related changes of the hypothalamic-
pituitary-adrenal axis: pathophysiological correlates. European Journal 
of Endocrinology, 144(4), 319-329.   
 
Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., 
Ganguli, M., et al. (2005). Global prevalence of dementia: a Delphi 
consensus study. Lancet, 366, 2112-2117. 
 
Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, 
E., Gelpi, W., et al. (2007). Conversion from subtypes of mild cognitive 
impairment to Alzheimer dementia. Neurology, 68(4), 288-291. 
 
Fisk, J.D., Marry, H.R. and Rockwood, K. (2003). Variations in case 
definition affect prevalence but not outcomes of mild cognitive 
impairment. Neurology, 61, 1179-1184.   
 
Fliker, C., Ferris, S. and Reisberg, B. (1991). Mild Cognitive Impairment 
in the elderly: predictors of dementia. Neurology, 41, 1006-1009. 
 
Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975). Mini Mental 
State. A practical method for grading the cognitive state of patients for 
the clinician. Journal of Psychiatric Research, 12, 189-198.  
 
Folstein M.F., Folstein, S.E. and McHugh, P.R. (1978). Dementia syndrome 
of depression. In: R. Katzman, R.D. Terry, K.L. Bick, (Eds.) Alzheimer’s 
Disease: Senile Dementia and Related Disorders (pp. 87-93). New York, NY: 
Haven Press.    
 
Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, 
J.R., Dartigues, J.F., et al. (2000). Incidence of dementia and major 
subtypes in Europe: a collaborative study of population-based cohorts. 
Neurology, 54, S10-S15. 
 
Frisoni, G.B., Galluzzi, S., Bresciani, L., Zanetti, O. and Geroldi, C. 
(2002). Mild Cognitive Impairment with subcortical vascular features. 
Journal of Neurology, 249(10), 1423-1432.   
 
Fuld, P.A. (1981). Fuld object memory evaluation. Wood Dale, IL: 
Stoelting. 
 
Furey, M.L., Pietrini, P., Alexander, G.E., Freo, U., Schapiro, M.B., and 
Horwitz, B., (2000). Cholinergic enhancement improbe performance on 
working memory by modulating the functional activity in distrinct brain 
regions: a positron emission tomography regional cerebral blood flow 
study in healthy humans. Brain Research Bullettin, 51(3), 213-218. 
 
Gallassi, R. (2008). L‟esame neuropsicologico in neurologia. In A. 
Bianchi (ed.), L’esame neuropsicologico dell’adulto. Applicazioni 
cliniche e forensi (pp. 169-190). Firenze: Giunti O.S. 
 
Galluzzi, S., Sheu, C.F., Zanetti, O. and Frisoni, G.B. (2005). 
Distinctive Clinical Features of Mild Cognitive Impairment with 
Subcortical Cerebrovascular Disease. Dementia and Geriatric Cognitive 
Disorder, 19, 196-203.     
 
Ganguli, M., Dodge. H.H., Shen, C., and DeKosky, S.T. (2004). Mild 
cognitive impairment, amnestic type: an epidemiologic study. Neurology, 
63(1), 115-121. 
 
Garrett, D.K. et al. (2004). The neuropsychological profile of vascular 
cognitive impairment-no dementia: comparisons to patients at risk for 
cerebrovascular disease and vascular dementia. Archives of Clinical 
Neuropsychology, 19(6), 745-757.  
 
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R.C., Ritchie, K., 
Broich, K., et al. (2006). Mild cognitive impairment. The Lancet, 367, 
1262–1270. 
 
Giannakopoulos, P., Gold, G., Duc, M., Michel, J.P., Hof, P.R., and 
Bouras, C. (1999). Neuroanatomic correlates of visual agnosia in 
Alzheimer‟s disease: a clinicopathologic study. Neurology, 52, 71-77. 
 
Gilbert, J.G. and Ferris, S.H. (1980). Operationalizing memory impairment 
in elderly persons: The Guild Memory Test. Psychological Reports, 47, 
1315-1318. 
 
Gold, M., Goldstein, H.R., and Titusville, N.J. (2004). Galantamine In 
The Treatment of Patients With Mild Cognitive Impairment: Baseline 
Demographics and Psychometric Testing Results. Neurobiology of Aging, 
25:472.  
 
Golden, C.J. (1978). Stroop Color and Word Test: A Manual for Clinical 
and Experimental Uses. Chicago, IL: Stoelting. 
 
Goodglass, H., and Kaplan, E. (1976). Assessment of Aphasia and Related 
Disorders. Philadelphia: Lea and Febiger.  
 
Graham, J.E., Rookwood, K., Beattie, L., Eastwood, R., Gauthier, S. and 
Tuokko, H. (1997). Prevalence and severity of cognitive impairment with 
and without dementia in an elderly population. The Lancet, 349, 1793-
1796.  
Grober, E.,  Hall, C.B., Lipton, R.B., Zonderman, A.B., Resnik, S.M., 
Kawas, C. (2008).  Memory impairment, executive dysfunction, and 
intellectual decline in preclinical Alzheimer's disease. Journal of the 
International neuropsychological Society, 14(2), 266-278. 
Grossi, D., and Trojano, L. (2005). Neuropsicologia dei lobi frontali. 
Bologna: Il Mulino.  
 
Guillozet, A.L., Weintraub, S., Mash, D.C., Mesulam, M.M. (2003). 
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive 
impairment. Archives of Neurology, 60(5), 729-736.   
 
Gurland B.J., Kuriansky J., Sharpe L., Simon R., Stiller P. and Berkett, 
P. (1977). The comprehensive assessment and referral evaluation (CARE): 
Rationale, development and reliability. International Journal of Aging 
and Human Development, 8, 9-42. 
 
Gurland, B.J., Dean, L.L., Copeland, J., Gurland, R. and Golden, R. 
(1982). Criteria for the Diagnosis of Dementia in the Community Elderly. 
The Gerontologist, 22(2), 180-186. 
 
Hachinski, V.C. (1994). Vascular Dementia: a radical definition. 
Dementia, 5, 130-132.  
 
Hampel, H., Teipel, S.J., Fuchsberger, T., Andreasen, N., Wiltfang, J., 
Otto, M., et al. (2004). Value of CSF β-amyloid1-42 and tau as predictors 
of Alzheimer's disease in patients with mild cognitive impairment. 
Molecular Psychiatry, 9, 705-710. 
 
Handler, P. (1960). Radiation and aging, In N.W. Shock (Ed.), Aging, 
Washington, D.C.: American Association for the Advancement of Science. 
 
Hänninen, T., Hallikainen, M., Tuomainen, S., Vanhanen, M., Soininen, H. 
(2002). Prevalence of mild cognitive impairment: a population-based study 
in elderly subjects. Acta Neurologica Scandinavica, 106(3), 148-154.  
 
Haxby, J.V., and Schapiro, M.B. (1992). Longitudinal study of 
neuropsychological function in older adults with Down Syndrome. In C. 
Epstein, and L. Nadel (Eds). Down Syndrome and Alzheimer Disease (pp.35-
50). New York: Wiley-Liss.  
 
Heaton, R.K. (1981). Wisconsin Card Sorting Test Manual. Odessa, FL: 
Psychological Association Resources, Inc.  
 
Heinik, J. (2010). V.A. Kral and the origins of benign senescent 
forgetfulness and mild cognitive impairment. International 
Psychogeriatrics, 22, 395-402.  
 
Henderson, A.S. and Hupper, S.A. (1984). The problem of mild dementia. 
Psychological Medicine, 14, 5-11.  
 
Holcomb, H.H., Links, J., Smith, C., and Wong, D. (1989). Positron 
emission tomography measuring the metabolic and neurochemical 
characteristics of the living human nervous system. In N.C. Andreasen, 
(Ed.), Brain Imaging Applications in Psychiatry (pp. 235-370). Washington 
D.C.: American Psychiatric Press. 
 
Holland, A.J., and Oliver, C. (1995). Down‟s syndrome and the links with 
Alzheimer‟s disease. J. Neurol. Neurosurg. Psychiatry, 39, 111-114.  
 
Honigfield, G., Gillis, R.D. and Klett, C.J. (1966). NOSIE 30: a 
treatment selective ward behavioral scale. Psychological Ref., 19, 180-
182. 
 
Horton, S., Baker, J., and Schorer, J. (2008). Expertise and aging: 
maintain skills through lifespan. European review of aging and physical 
activity, 5(2), 89-96.   
 
Hooper, H.E. (1958). The Hooper Visual Organization Test: Manual. Beverly 
Hills, CA: Western Psychological Services.  
 
Hort, J., Laczò, J., Vyhnàlek, M., Bojar, M., Bure, J. and Vlek, K. 
(2007). Spatial navigation deficit in amnestic mild cognitive impairment. 
Proc Natl Acad Sci, USA 104: 4042-4047. 
 
Hunderfund, A.L., Roberts, R.O., Slusser, T.C., (2006). Mortality in 
amnestic mild cognitive impairment: a prospective community study. 
Neurology, 67, 1764-1768.  
 
Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. and Martin, R.L. 
(1982). A new clinical scale for the staging of dementia. The British 
Journal of Psychiatry, 140, 566-572.  
 
Iachini, T., Iavarone, A., Senese, V.P., Ruotolo, F., and Ruggiero, G. 
(2009).  Visuospatial Memory in Healthy Elderly, AD and MCI: A Review. 
Current Aging Science, 2, 43-59.   
 
Ibáñez, V., Pietrini, P., Alexander, G.E., Furey, M.L., Teichberg, D., 
Rajapakse, J.C. et al., (1998). Regional glucose metabolic abnormalities 
are not the result of atrophy in Alzheimer‟s disease. Neurology, 50, 
1585-1593. 
 
Ingles, J.L, Ventzel, C., Fisk, J.D. and Rockwood, K. (2002). 
Neuropsychological Predictor of Incident Dementia in Patients with 
Vascular Cognitive Impairment, Without Dementia. Stroke, 33, 1999-2002.  
 
Jack, C.R., Shiung, M.M., Weigand, S.D., O‟Brien, P.C., Gunter, J.L., 
Boeve, B.F. (2005). Brain atrophy rates predict subsequent clinical 
conversion in normal elderly and amnestic MCI. Neurology, 65: 1227-1231.  
 
Jack, C.R., Lowe, V.J., Senjem, M.L., et al. (2008). 11C PiB and 
structural MRI provide complementary information in imaging of 
Alzheimer‟s disease and amnestic mild cognitive impairment. Brain, 131, 
665-680.  
 
Jastak, J. and Jastak, S. (1978). Wide Range Achievement Test. 
Wilmington, DE: Jastak Associates. 
 
Jeuptner, M., and Weiller, C. (1995). Review: does measurement of 
regional cerebral blood flow reflect synaptic activity? Implications for 
PET and fMRI. Neuroimage, 2, 148-156. 
 
Jicha, G.A., Parisi, J.E., Dickson, D.W., Johnson, K., Cha, R., Ivnik, 
R.J., et al. (200).Neuropathological outcome of mild cognitive impairment 
following progression to clinical dementia. Archives of Neurology, 63(5), 
674-681. 
 
Joanette, Y., Ska, B., Belleville, S., Lecours, A.R., Peretz, I. and 
Poissant, A. (1999). Evaluation neuropsychologique dans la démence de 
type Alzheimer: un compromis optimal. L'Année gérontologique, 9: 69-83. 
 
Joubert, S., Felicianc, O., Barbeaud, E., Didicc, M., Poncetc, M., and 
Ceccaldic, M. (2008). Patterns of semantic memory impairment in Mild 
Cognitive Impairment, Behavioural Neurology, 19, 35-40.  
 
Jorm, A.F. and Korten, A.E. (1988). Assessment of cognitive decline in 
the elderly by informant interview. British Journal of Psychiatry, 152, 
209-213.  
 
Kaplan E. F., Goodglass H. and Weintraub S. (1983). The Boston Naming 
Test (2nd ed.). Philadelphia, PA: Lea & Febiger.  
 
Karantzoulis, S., Troyer, A.K., and Rich, J.B. (2009). Prospective memory 
in amnestic Mild Cognitive Impairment, Journal of the International 
Neuropsychological Society, 15: 407-415. 
 
Katz, H., S., Down, T.D., Cash, H.R. and Grotz, R.C. (1970). Progress in 
the development of the index of ADL. The Gerontologist, 10(1), 20-30. 
 
Kaufer, D.I., Cummings, J.L., Ketchel, P., Smith, V., MacMillan, A., 
Shelley, T., et al. (2000). Validation of the NPI-Q: a brief clinical 
form of the Neuropsychiatric Inventory. Journal of Neuropsychiatry and 
Clinical Neurosciences, 12, 233-239. 
 
Kazui, Matsuda, A., Hirono, N., Mori, E., Miyoshi, N., Ogino
a
, A., 
Tokunaga
a
 , H. et al. (2005). Everyday memory impairment of patients with 
mild cognitive impairment, Dementia and Geriatric Cognitive Disorders 
19(5–6), 331–337.  
 
Kay, D.W.K., Beamish, P. and Roth, M. (1964). Old mental disorder in 
Newcastle upon Tyne. Part I: A study of prevalence. British Journal of 
Psychiatry, 110, 146-158.    
 
Kiloh, L.G. (1961). Pseudodementia. Acta Psychiatrica Scandinavia, 37, 
336-351.   
Kirby, E., Bandelow, S., and Hogervorst, E. (2010). Visual impairment in 
Alzheimer‟s Disease: a critical review. Journal of Alzheimer’s Disease, 
21(2), 15-34.   
 
Knight, J.A. (2000). The biochemistry of aging. Advances in Chemical 
Chemistry, 35, 1-62.  
 
Knopman, D.S., Boeve, B.F., and Petersen, R.C. (2003). Essentials of the 
Proper Diagnoses of Mild Cognitive Impairment, Dementia and Major 
Subtypes of Dementia. Mayo Clinic Proc., 78, 1290-1308.    
 
Kramer, J.H., Nelson, A., Johnson, J.K., et al. (2006). Multiple 
cognitive deficits in amnestic mild cognitive impairment. Dementia and 
Geriatric Cognitive Disorders. 22, 306–311. 
 
Kral, V.D. (1958). Neuro-psychiatric observations in an old people‟s 
home. Studies of Memory Dysfunction in Senescence. Gerontologist, 13(2), 
169-176. 
 
Kral, V.A. and Wigdor, B.T. (1961). Some relationship among various 
aspects of functioning in a group of relatively well preserved aged 
people. In Proceedings, Third World Congress of Psychiatry, Montreal, 
Canada, June 4-10, Vol. 3 (Toronto: University of Toronto Press and 
McGill University Press), 135-140.     
 
Kral, V.A. (1962). Senescent Forgetfulness: Benign and Malignant. 
Canadian Medical Association Journal, 86(6): 357-260.    
 
Larrieu, S., Letenneur, L., Orgogozo, J.M., Fabrigoule, C., Amieva, H., 
Le Carret, N. et al. (2002). Incidence and outcome of mild cognitive 
impairment in a population-based prospective cohort. Neurology, 59(10), 
1594-1599. 
 
Laatu, S., Revonsuo, A., Jäykkä, H., Portin, R., and Rinne, J.O (2003). 
Visual object recognition in early Alzheimer‟s disease: Deficits in 
semantic processing. Acta Neurologica Scandinavica, 108, 82–89. 
 
 
Laurent, B., Anterion, C., and Allegri, R.F. (1998). Memory and dementia. 
Rev. Neurol., 154(Suppl. 2), S33-S49. 
 
Lawton, M.P. and Brody, E.M. (1969). Assessment of older people: self-
maintaining and instrumental activities of daily living. Gerontologist, 
9(3), 179-186. 
 
Levy, R.C. (1994). Age-Associated Cognitive Decline. International 
Psychogeriatrics, 6(1), 63-68. 
 
Lipowski, Z.J. (1967). Delirium, clouding of consciousness and confusion. 
Journal of Nervous and Mental Disorders, 145, 227-255. 
 
Lobo, A., Launer, L.J., Fratiglioni, L., Andersen, K., Di Carlo, A., 
Breteler, M.M, et al. (2005). Prevalence of dementia and major subtypes 
in Europe: A collaborative study of population-based cohorts. Neurology, 
54, S4-S9. 
 Lonie, J.A., Herrmann, L.L., Donaghey, C.L., and Ebmeier, K.P. (2008). 
Clinical referral patterns and clinical profile in mild cognitive 
impairment. The British Journal of Psychiatry, 192, 59-64.   
 
Lopez, O.L., Jagust, W.J., DeKosky, S.T., Becker, J.T., Fitzpatrick, A., 
Dulberg, C., et al. (2003). Prevalence and classification of mild 
cognitive impairment in the Cardiovascular Health Study Cognition Study: 
part 1. Archives of Neurology, 60(10), 1385-1389. 
 
Luck, T., Luppa, M., Briel, S., and Riedel-Heller, S.G. (2010). Incidence 
of Mild Cognitive Impairment: A systematic review. Dementia and Geriatric 
Cognitive Disorders, 29, 164-175.   
 
McAllister, T.W. (1983). Overview: Pseudodementia. The American Journal 
of Psychiatry, 140, 528-533.  
 
McAllister, T.W. (1985). Recognition of pseudodementia. American Family 
Physician, 32(4), 175-181. 
 
Mack, W. J., Freed, D.M., Williams, B.W. and Henderson, V.W. (1992). 
Boston Naming Test: shortened versions for use in Alzheimer's disease. 
Journal of Gerontology Series B, Psychological Sciences & Social 
Sciences, 47, 154-158. 
 
Machulda, M.M., Ward, H.A., Borowsky, B., Gunter, J.L., Cha, R.H., 
O‟Brien, P.C., et al. (2003). Comparison of memory fMRI response among 
normal, MCI and Alzheimer‟s patients. Neurology, 61, 500-506.   
 
Madden, J., Lubran, J. and Kaplan, L. (1952). Nondementing psychosis in 
elderly persons. Journal of the American Medical Association, 150, 1567-
1572.    
 
Manly, J.J., Tang, M.X., Schupf, N., Stern, Y., Vonsattel, J.P., Mayeux, 
R. (2008). Frequency and course of mild cognitive impairment in a 
multiethnic community. Annals of Neurology, 63(4), 494-506.  
 
Markersbery, W.R., Schmitt, F.A., Kryscio, R.J., Davis, D.G., Smith, 
C.D., Wekstein, D.R. (). Neuropathological substrate of mild cognitive 
impairment. Archives of Neurology, 63(1), 38-46.    
 
Maruyama, M., Matsui, T., Tanji, H., Nemoto, M., Tomita, N., and Ootsuki, 
M. (2004).  Cerebrospinal fluid tau protein and periventricular white 
matter lesions in patients with mild cognitive impairment: implications 
for 2 major pathways. Archives of Neurology, 61(5), 716-720.  
 
Murphy, K.J., Rich, J.B., and Troyer, A.K. (2006). Verbal fluency 
patterns in amnestic mild cognitive impairment are characteristic of 
Alzheimer‟s type dementia. Journal of the International 
Neuropsychological Society, 12, 570-574. 
 
Murphy, K., Troyer, A., Levine, B., and Moscovitch, M. (2008). Episodic 
but not semantic autobiographical memory is reduced in amnestic mild 
cognitive impairment. Neuropsychologia, 46(13), 3116-3123.  
 
Mattis, S. (1988). Dementia Rating Scale. Odessa, FL:  Psychological 
Assessment Resources. 
 McDonald, A., Man, A., Jenkins, R., Richard, L., Gordlove, C. and 
Rodwell, G. (1982). An attempt to determine the impact of four types of 
care upon the elderly in London by the study of matched groups. 
Psychological Medicine, 12, 193-200. 
 
Meeks, T.W., and Jeste, D.V. (2009). Neurobiology of wisdom. Archives of 
General Psychiatry, 66(4), 355-365.   
 
Mendez, M.F., Mendez, M.A., Martin, R., Smyth, K.A., and Whitehouse, P.J. 
(1990). Complex visual disturbances in Alzheimer‟s disease. Neurology,  
1990; 40(3, pt 1):439-443. 
 
Menses, A. (1999). 5-HT system and cognition. Neuroscience & Behavioural 
Review, 23(8), 1111-1125.  
 
Mgekn, I.,  Quinn, R., and Tabet N. (2008). Vitamin E for Alzheimer's 
disease and mild cognitive impairment. Cochrane Database of Systematic 
Reviews, Issue 3, Art. No.: CD002854. 
 
Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, 
D.E. (1997). Metabolic reduction in the posterior cingulate cortex in 
very early Alzheimer‟s Disease. Annals of Neurology, 42, 85-94.  
 
Mondini, S., e Bergamaschi, S. (2005). Training di attivazione cognitiva 
(AT) in pazienti con demenza iniziale. In P. Bisiacchi, P. Tressoldi 
(Eds). Metodologia della riabilitazione delle funzioni cognitive 
nell’adulto e nel bambino (pp. 133-169). Roma: Carocci. 
 
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., & Howerter, 
A. (2000). The unity and diversity of executive functions and their 
contributions to complex “frontal lobe” tasks: A latent variable 
analysis. Cognitive Psychology, 41, 49–100. 
 
Monsch, A.U. et al. (1984). A comparison of category and letter fluency 
in Alzheimer‟s disease and Huntington disease. Neuropsychology, 8, 25-30.    
 
Morris, J., Heyman, A. and Mohs, R. (1989). The consortium to establish a 
registry for Alzheimer‟s Disease (CERAD) part I: clinical and 
neuropsychological assessment of Alzheimer‟s disease. Neurology, 39: 
1159-1165.   
 
Morris, J.C.,  Storandt, M.,  Miller, J.P., McKeel,  D.W., Price, J.L., 
Rubin, E.H., et al. (2001). Mild Cognitive Impairment Represents Early-
Stage Alzheimer Disease. Archives of Neurology, 58, 397-405. 
 
Muangpaisan, W., Intalapaporn, S., and Assantachai, P.(2010).Digit Span 
and Verbal Fluency Tests in Patients with Mild Cognitive Impairment and 
Normal Subjects in Thai-Community. J Med Assoc Thai, 93 (2), 224-30. 
 
Murphy, K.J., Rich, J.B., and Troyer, A.K. (2006). Verbal fluency 
patterns in amnestic mild cognitive impairment are characteristic of 
Alzheimer's type dementia. Journal of the International Neuropsychology 
Society, 12, 570-574.  
 
Namba, H., Iyo, M., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., 
et al. (1999). Human cerebral acetylcholinesterase activity measured with 
positron emission tomography: procedure, normal values and effects of 
age. European Journal of Nuclear Medicine, 26(2), 135-143.   
 
Nelson, H.E. (1982). National Adult Reading Test (NART). Windsor, UK: 
NFER-Nelson. 
 
Nelson, A.P, and O‟Connor, M.G. (2008). Mild Cognitive Impairment: A 
Neuropsychological Perspective. CNS Spectrums, 13(1), 56-64.   
 
Nieoullon, A. (2002). Dopamine and the regulation of cognition and 
attention. Progress in Neurobiology, 67(1): 53-83.  
 
Nielsen, J., Homma, A. and Bjorn-Henriksen, T. (1977). Follow-up 15 years 
after a gerontopsychiatric prevalence study. Comprehensive Psychiatry 
Journal, 18, 533-544.   
 
Nobler, M.S., Mann, J.J., and Sackeim, H.A. (1999). Serotonin, cerebral 
blood flow, and cerebral metabolic rate in geriatric major depression and 
normal aging. Brain Research Reviews, 30(3), 250-256.   
 
Nordlund, A., Rolstad, S., Hellström, P., Sjögren, M., Hansen, S., and 
Wallin, A. (2005). The Goteborg MCI study: Mild cognitive impairment is a 
heterogeneous condition. Journal of Neurology, Neurosurgery, and 
Psychiatry, 76, 1485–1490. 
 
Novelli, G., Papagno, C., Capitani, E., Laiacona, M., Vallar, G. and 
Cappa, S.F. (1986). Tre test clinici di ricerca e produzione lessicale. 
Taratura su soggetti normali. Archivio di Psicologia, Neurologia e 
Psichiatria, 47, 477-505.   
 
Novak, M., and Guest, C. (1989). Cognitive Burden Inventory. 
Gerontologist, 29, 798-803.   
 
O'Connor, D.W., Politt, P.A., Hyde, J.B., Fellowes, J.L., Liller, N.D. 
and Roth, M. (1990). A follow up study of dementia diagnosed in the 
community using the Cambridge Mental Disorders of the Elderly 
Examination. Acta Psychiatrica Scandinavia, 81, 78-82.  
 
O'Connor, D.W., Politt, P.A., Jones, B.J., Hyde, J.B., Fellowes, J.L. and 
Miller, N.D. (1991). Continued clinical validation of dementia diagnosis 
in the community using the Cambridge Mental Disorders of the Elderly 
Examination. Acta Psychiatrica Scandinavia, 83, 41-45.  
 
Orsini, A., Grossi, D., Capitani, E., Laiacona, M., Papagno, C. and 
Vallar, G.  (1987). Verbal and spatial immediate memory span: normative 
data from 1355 adults and 1112 children. Italian Journal of Neurological 
Sciences, 8, 539-548.  
 
Pennanen, C., Kivipelto, M., Tuomainen, S., Hartikainen, P., Hanninen, 
T., Laakso, M.P., et al. ( 2004 ). Hippocampus and entorhinal cortex in 
mild cognitive impairment and early AD. Neurobiology of Aging, 25, 303-
310.  
 
Perri, R., Carlesimo, G.A., Serra, L., Caltagirone, C.  (2005). 
Characterization of memory profile in subjects with amnestic mild 
cognitive impairment. Journal of Clinical and Experimental 
Neuropsychology, 27(8), 1033-1055.  
 Perri, R., Serra, L., Carlesimo, G.A., Caltagirone, C. (2007). Amnestic 
mild cognitive impairment: difference of memory profile in subjects who 
converted or did not convert to Alzheimer's disease. Neuropsychology, 
21(5), 549-558.   
 
Petersen, R.C., Smith, G., Kokmen, E., Innik, R. and Tangalos, E. (1992). 
Memory function in normal aging. Neurology, 42, 396-401.  
 
Petersen R.C., Smith G.E. and Ivnik R.J. (1995). Apolipoprotein E status 
as a predictor of the development of Alzheimer‟s disease in memory-
impaired individuals. JAMA, 273, 1274-1278. 
 
Petersen, R.C., Smith, G.E., Waring, S.T., Ivnik, R.J., Kokmen, E. and 
Tangelos, E.G. (1997). Aging, Memory, and Mild Cognitive Impairment. 
International Psychogeriatrics,  9(Suppl. 1), 65-69. 
 
Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G. and 
Kokmen E. (1999). Mild cognitive impairment: clinical characterization 
and outcome. Archives of  Neurology, 56, 303-308.  
 
Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L. and 
DeKosky S.T. (2001a) Practice parameter: early detection of dementia: 
mild cognitive impairment (an evidence-based review). Report of the 
Quality Standards Subcommittee of the American Academy of Neurology. 
Neurology, 56, 1133-1142. 
 
Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C., Rabins, 
P.V., et al. (2001b). Current Concepts in Mild Cognitive Impairment. 
Archives of Neurology, 58, 1985-1992.  
 
Petersen R.C. (2004). Mild cognitive impairment as a diagnostic entity. 
Journal of Internal Medicine, 256, 183-194. 
 
Petersen, R.C. and Morris, J.C. (2005). Mild Cognitive Impairment as a 
Clinical Entity and Treatment Target. Archives of Neurology, 62, 1060-
1063.  
 
Petersen, R.C. and O‟Brien, J. (2006). Mild Cognitive Impairment Should 
Be Considered for DSM-V. Journal of Geriatric Psychiatry and Neurology, 
19(3), 147-154.   
 
Petersen, R.C. and Negash, S. (2008). Current Concept of Mild Cognitive 
Impairment. CNS Spectrums, 13(1), 45-53.  
 
Petersen, R.C., Rosebud, O.R., Knopman, D.S., Boeve, B.F., Geda, Y.E., 
Ivnik, R.J., et al. (2009). Mild Cognitive Impairment. Ten Years Later. 
Archives of Neurology, 66(12), 1447-1455.  
 
Petersen, R.C., Roberts, R.O., Knopman, D.S., Boeve, B.F., Geda, Y.E., 
Ivnik, R.I., et al. (2009). Mild Cognitive Impairment. Ten Years Later. 
Archives of Neurology, 66(12), 1447-1455.  
 
Petrides, M. and Minler, B. (1982). Deficit on subject-ordered tasks 
after frontal- and temporal- lobe lesions in man. Neuropsychologia, 20, 
249-262.   
 
Pfeiffer, E. (1975). A short portable mental status questionnaire for the 
assessment of organic brain deficit in elderly patients. Journal of the 
American Geriatrics Society, 23, 433-441.   
 
Philips, L.H. (1997). Do “frontal tests” measure executive function? 
Issues of assessment and evidence from fluency tests. In R. Rabbit (Ed.) 
Methodology of Frontal and Executive Function (pp. 191-213). Hove: 
Psychology Press.   
 
Pietrini, P., Azari, N.P., Grady, C.L.  (1993). Pattern of cerebral 
metabolic interactions in a subject at risk for Alzheimer‟s disease 
disease: a longitudinal evaluation. Dementia, 4, 94]101. 
 
Pietrini, P., Furey, M.L., Graff-Radford, N. Freo, U., Alexander, G.E., 
Grady, C.L., et al., (1996). Preferential metabolic involvement of visual 
cortical areas in a subtype of Alzheimer‟s disease: clinical 
implications. American Journal of Psychiatry, 153, 1261-1268. 
 
Pietrini, P., Dani, A., Furey, M.L. et al., (1997a.). Low glucose 
metabolism during brain stimulation in older Down‟s syndrome subjects at 
risk for Alzheimer‟s disease prior to dementia. American  Journal of 
Psychiatry, 154 (8), 1063-1069. 
 
Pietrini, P., Alexander, G.E., Furey, M.L., Darn, A., Mentis, M.J., Barry 
Horwitz, B., Guazzelli, M., et a. (1997b). Cerebral Metabolic Response to 
Passive Audiovisual Stimulation in Patients with Alzheimer‟s Disease and 
Healthy Volunteers Assessed by PET. The Journal of Nuclear Medicine, 
41(4), 575-583. 
 
Pietrini, P., Furey, M.L., and Guazzelli, M., (1999). In vivo 
biochemistry of the brain in understanding human cognition and emotions: 
towards a molecular psychology. Brain Research Bullettin, 50, 417-418. 
 
Pietrini, P., Alexander,  G.E., Furey, M.L., Hampel, H. and  Guazzelli, 
M. (2000). The neurometabolic landscape of cognitive decline: in vivo 
studies with positron emission tomography in Alzheimer‟s disease. 
International Journal of Psychophysiology, 37, 87-98. 
 
Pietrini, P., and Rapoport, S.I. (2000). Functional brain imaging: 
cerebral blood flow and glucose metabolism in healthy human aging. In 
C.E. Coffey, and J.L. Cumming, (Eds.), Textbook of Geriatric 
Neuropsychiatry (2nd ed) (pp. 239-265). Washington, D.C.: American 
Psychiatric Press. 
 
Pihlajamäki, M., O‟keefe, K., Bertram, L., Tanzi, R.E., Dickerson, B.C., 
Blacker, D., et al. (2009). Evidence of altered posteromedial cortical 
fMRI activity in subjects at risk of Alzheimer‟s Disease. Alzheimer’s 
Disease and Associated Disorders, 24(1), 28-36.  
 
Pinori, F., Timpano Sportiello, M., Cammisuli, D., & Verdiani, C. (2010). 
Tecniche di riabilitazione cognitiva per pazienti affetti da demenza 
lieve e soggetti con mild cognitive impairment: una rassegna critica. 
Paper presented at 55° Congresso Società Italiana di Geriatria e 
Gerontologia (Firenze, Italia). Progr.: 73-73.  
 
Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir D.R., 
Ofstedal, M.B., et al. (2008). Prevalence of cognitive impairment without 
dementia in the United States. Annals of Internal Medicine, 148(6), 427-
434. 
 
Post, F. (1965). The psychiatry of later life. Oxford, UK: Pergamon 
Press. 
 
Prichard, J.C. (1837). A Treatise on Insanity and Other Disorders 
Affecting the Mind. London, UK: Sherwood, Gilbert and Piper.   
 
Prichep, L.S. et al. (2006). Prediction of longitudinal cognitive decline 
in normal elderly with subjective complaints using electrophysiological 
imaging. Neurobiology of Aging, 27, 471-478.    
 
Qui, C., Kivipelto, M., and von Strauss, E. (2009). Epidemiology of 
Alzheimer‟s disease: occurrence, determinants, and strategies toward 
intervention. Dialogues in Clinical Neuroscience, 11(2), 111-128.  
 
Rabbitt, P. (1997). Introduction: Methodologies and models in the study 
ofexecutive function. In P. Rabbitt (Ed.), Methodology of frontal and 
executive function (pp. 1–38). Hove, UK: Psychology Press.  
 
Racchi, M., Balduzzi, C., Corsini, E. (2003). Dehydroepiandrosterone 
(DHEA) and the Aging Brain: Flipping a Coin in the “Fountain of Youth”. 
CNS Drugs Reviews, 9(1): 21-40.   
 
Radanovic, M., Diniz, B.S., Mirandez, R.M., et al. (2009). Verbal fluency 
in the detection of mild cognitive impairment and Alzheimer's disease 
among Brazilian Portuguese speakers: the influence of education. 
International Psychogeriatrics, 21(6), 1081-1087. 
 
Rapp MA, and Reischies, F.M. (2005) Attention and executive control 
predict Alzheimer disease in late life: results from the Berlin Aging 
Study (BASE) American Journal of Geriatric Psychiatry, 13, 134–141. 
 
Raskind, M.A., Peskind, E.R., Holmes, C., and Goldenstein, D.S. (1999). 
Patterns of  cerebrospinal fluid cetechols support increased central 
noradrenergic responsiveness in aging and Alzheimer‟s disease. Biological 
Psychiatry, 46(6), 756-765.   
 
Ravaglia, G., Forti, P., Montesi, F., et al. (2007). Mild cognitive 
impairment: epidemiology and dementia risk in an elderly Italian 
population. Journal of  American Geriatric Society. 56(1), 51-58. 
 
Read, D. E. (1980). Neuropsychological Assessment of Memory in Early 
Dementia: Normative data for a new battery of memory tests "Animal 
Naming". Victoria, Canada. Unpublished manuscript. 
 
Reichenfeld, H.F., Bazile, E., Kan, B.B. and Raman, S. (1992). Clinical 
assessment of psychopathology among elderly residents (CAPER): 
development and pilot testing of the screening instrument to detect the 
presence of psychiatric disorders among residents of long-term 
institutions. International Journal of Geriatric Psychiatry, 7, 399-406. 
 
Reifler, B.V. (1982). Arguments for abandoning the term pseudodementia. 
Journal of American Geriatric Society, 30(10), 665-668. 
 
Reisberg, B., Ferris, S., De Leon, M.J. and Croock, T. (1982). The Global 
Deterioration Scale for Assessment of Primary Degenerative Dementia. 
American Journal of Psychiatry, 139(9), 1136-1139.   
 
Reisberg, B., Ferris, S.H., McCarthy, M., Ferris, S.H. and de Leon, M.J. 
(1985). Insight and denial accompanying progressive cognitive decline in 
normal aging and Alzheimer‟s disease. In B. Stanley, (Ed.) Geriatric 
Psychiatry: Ethical and Legal Issues (pp. 37-39) Washington, D.C.: 
American Psychiatric Press. 
 
Reisberg, B. and Ferris, S.H. (1988). The Brief Cognitive Rating Scale 
(BCRS). Psychopharmacology Bulletin, 24, 629-636.   
 
Reisberg, B., Ferris, S.H., Kluger, A., Franssen, E., Wegiel, J. and de 
Leon, M.J. (2008). Mild Cognitive Impairment (MCI): a historical 
perspective. International Psychogeriatrics, 20(1), 18-3.  
 
Reisberg, B. and Gauthier, S. (2008). Current evidence for subjective 
cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) 
stage of subsequently manifest Alzheimer's disease. International 
Psychogeriatrics, 20(1), 1-16. 
 
Reitan, R.M. (1971). Trail Making Test: Results for normal and Brain-
Damaged Children. Perceptual and Motor Skills, 33, 575-581.  
 
Reitan, R.M. (1992). Trail Making Test: manual for administration and 
scoring. Tucson, AZ: Reitan Neuropsychology Laboratory. 
 
Rey, A. (1941). L‟examen Psychologique dans les cas D‟encephapothie 
Traumatique. Archives de Psychologie, 28, 286-340.  
 
Rey, A. (1964). L’examen clinique en psychologie. Paris: Presses 
Universitaires de France. 
 
Ribot, T.A. (1888). Les maladies de la mémoire. Paris: Félix Alcan.   
 
Richards, M., Touchon, J., Ledésert, B. and Ritchie, K. (1999). Cognitive 
decline in aeging: are AAMI and AACD distinct entities? International 
Journal of Geriatric Psychiatry, 14, 534-540.  
 
Ritchie, K., Ledésert, B. and Touchon, J. (1993). The eugeria study of 
cognitive aging: Who are the normal elderly? International Journal of 
Geriatric Psychiatry, 18, 969-977.  
 
Ritchie, K. and Fuhrer, R. (1994).  La mise au point et la validation en 
France d'un test de dépistage de la démence sénile. Revue de Gériatrie, 
19(4), 233-242. 
 
Ritchie, K., Leibovici, D., Ledésert, B. and Touchon, J. (1996). A 
typology of sub-clinical senescent cognitive disorder. British Journal of 
Psychiatry, 168, 470-476.   
 
Ritchie, K., Ledésert, B and Touchon, J. (2000). Subclinical Cognitive 
Impairment: Epidemiology and Clinical Characteristics. Comprehensive 
Psychiatry, 41 (Suppl. 1), 61-65.     
 
Ritchie, K., Artero, S. and Touchon, J. (2001). Classification criteria 
for mild cognitive impairment. A population-based validation study. 
Neurology, 56, 37-42.    
 
Roberts, R.O., Geda, Y.E., Knopman, D.S., . (2008). Men are more likely 
to have mild cognitive impairment than women: the Mayo Clinic Study of 
Aging. Neurology, 70(11)(suppl. 1), A225.  
 
Rorschach, H. (1942). Psychodiagnostics. A diagnostic test based on 
perception. New York, NY: Grune and Stratton. 
 
Rosen, W.G., Terry, R.D., Fuld, P.A., Katzman, R. and Peck, A. (1980). 
Pathological verification of ischemic score in the differentiation of 
dementias. Annals of Neurology, 7, 486-488.   
 
Roth, M. (1955). The natural history of mental disorder in old age. 
Journal of Mental Science, 101: 281-301.  
 
Roth, M. et al. (1986). A standardized instrument for the diagnosis of 
mental disorder in the elderly with special reference to the early 
detection of dementia. British Journal of Psychiatry, 149, 698-709.  
 
Royall, D.R., Chiodo, L.K., Polk, M.J. (2004). Misclassification is 
likely in the assessment of mild cognitive impairment. Neuroepidemiology, 
23, 185–191. 
 
Rubin, D.H., Storandt, M. and Miller, J.P. (1998). A prospective study of 
cognitive function and onset of dementia in cognitively healthy elders. 
Archives of Neurology, 56, 303-308.  
 
Rusinek, H., De Santi, S., Frid, D., Tsui, W.H., Tarshish, C.Y., Convit, 
A., et al. (2003). Regional brain atrophy rate predicts future cognitive 
decline: 6-year longitudinal MR imaging study of normal aging. Radiology, 
229: 691-696.  
 
Saunders, A.M., Schmader, K., Breitner, J.C., Benson, M.D., Brown, W.T., 
Goldfarb, L., et al. (1993). Apolipoprotein E epsilon 4 allele 
distribution in late-onset Alzheimer‟s disease and in other amyloid-
forming diseases. Lancet, 342, 710-711.   
 
Saxton, J., Lopez, O.L., Ratcliff, G., Dulberg, C., Fried, L.P., Carlson, 
M.C., et al. (2004). Preclinical Alzheimer disease: Neuropsychological 
test performance 1.5 to 8 years prior to onset. Neurology, 63, 2341–2347. 
 
Shallice, T. (1982) Specific impairments of planning. Philosophical 
transactions of the Royal Society of London, 298, 199-209. 
 
Small, G.W., Kepe, V., Ercoli, L.M., Siddarth, P., Bookheimer, S.Y., 
Miller, K.J., et al. (2006). PET of brain amyloid and tau in mild 
cognitive impairment. New England  
Journal of Medicine, 355, 2652-2663. 
 
Smith, A. (1982). Symbol Digit Modalities Test. Los Angeles, CA: Western 
Psychological Service. 
 
Smith, G., Petersen, R., Ivnik, R., Malec, J. and Tangalos, E. (1996). 
Subjective memory complaints, psychological distress, and longitudinal 
change in objective memory performance. Psychology and Aging, 11(2), 272-
279.  
 
Solfrizzi, V., Panza, F., Colacicco, A.M., et al. (2004). Italian 
Longitudinal Study on Aging Working Group. Vascular risk factors, 
incidence of MCI, and rates of progression to dementia. Neurology, 
63(10), 1882-1891. 
 
Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., 
Butterworth, M. and Orrell. M. (2003). Efficacy of an evidence-based 
cognitive stimulation therapy program for people with dementia: 
Randomized Controlled Trial. British Journal of Psychiatry, 183, 248-254. 
 
Spector, A., Thorgrimsen, L., Woods, B. and Orrell, M. (2006). Making a 
difference: An evidence-based group program to offer Cognitive 
Stimulation therapy (CST) to people with dementia. UK: Hawker 
Publications. 
 
Spinnler, H. and Tognoni, G. (1987). Standardizzazione e taratura 
italiana di test neuropsicologici. Italian Journal of Neurological 
Sciences, 6(Suppl. 8), 1-120.  
 
Spreen, O. and Benton, A. L. (1977). Neurosensory center comprehensive 
examination for aphasia. Victoria, British Columbia: University of 
Victoria. 
 
Stern, Y., Sano, M.P., Paulson, J. and Mayeux, R. (1987). Modified Mini-
Mental State Examination: Validity and Reliability. Neurology, 37 (Suppl. 
1), 179.  
 
Storandt, M., Grant, E. A., Miller, P., and Morris, J. C. (2002). Rates  
of progression in mild cognitive impairment and early Alzheimer‟s 
disease. Neurology, 59, 1034-1041. 
 
Stott, J., and Spector, A. (2011). A review on the effectiveness of 
memory interventions in mild cognitive impairment. International 
Psychogeriatrics, 1, 1-13.  
 
Sulkava, R. and Amberla, K. (1982). Alzheimer‟s disease and senile 
dementia of Alzheimer‟s type. A neuropsychological study. Acta 
Neurologica Scandinavia, 65, 651-660.   
 
Sulkava, R., Matti, A., Paetau, A., Wikström, J. and Palo, J. (1983). 
Accuracy of clinical diagnosis in primary degenerative dementia: 
correlation with neuropathological findings. Journal of Neurology, 
Neurosurgery, Psychiatry, 46, 9-13.   
 
Sunderland, T. and Minichiello, M. (1997). Dementia Mood Assessment 
Scale. International Psychogeriatrics, 8, 329-331.   
 
Taylor, J. (1931). Selecting Writings of John Hughlings Jackson (Vols. 1 
and 2). London, UK: Hodder and Stoughton.   
 
Teng E.L. and Chui, H.C. (1978). A Modified Mini-Mental State (3MS) 
Examination. Journal of Clinical Psychiatry, 48, 314-318. 
 
Teng, E., Leone-Friedman, J., Woo, S., Kang, C., Harrell, S., Cummings, 
J.-L., et al. (2010). Similar verbal fluency patterns in amnestic mild 
cognitive impairment and Alzheimer's disease. Alzheimer’s and Dementia, 
6(4), 494-495.  
 
Tervo, S., Kivipelto, M., Hanninen, T., Vanhanen, M., Hallikainen, M., 
Mannermaa, A. (2004). Incidence and risk factors for mild cognitive 
impairment: a population-based 3-year follow-up study of cognitively 
healthy elderly subjects. Dementia and Geriatric Cognitive  Disorders, 
17, 196-203. 
 
Testa, J.A., Ivnik, R.J., Boeve, B., Petersen, R.C., Pankratz, V.S., 
Knopman, D., et al. (2004). Confrontation naming does not add incremental 
diagnostic utility in MCI and Alzheimer‟s disease. Journal of 
International Neuropsychology Society, 10, 504-512. 
 
Tierney, M.C., Szalai, J.P., Snow, W.G., et al. (1996). Prediction of 
probable Alzheimer‟s disease in memory impaired patients: a prospective 
longitudinal study. Neurology, 46, 661-665.  
 
Timpano Sportiello, M. (2006a). Questionnaire for caregivers of patients 
with Alzheimer’s disease. Unpublished manuscript.  
 
Timpano Sportiello, M. (2006b, July). Mild Cognitive Impairment: from the 
diagnosis to the prognosis: A neuropsychological contribution. Paper 
presented at 25
th
 International Congress of Applied Psychology (Athens, 
Greece). Abstract book: 132P.     
 
Timpano Sportiello, M. and Cammisuli, D. (2009, July). Mild Cognitive 
Impairment: neuropsychological features. Paper presented at 11
th
 European 
Congress of Psychology (Oslo, Norway). Abstract book: 50-50.  
 
Timpano Sportiello, M. and Cammisuli, D. (2010a, July). Conversion of 
Mild Cognitive Impairment into dementia. Predictive role of cognitive 
deficit in executive functioning. Paper presented at 27
th
 International 
Congress of Applied Psychology, Melbourne, Australia. Abstract book: 
1099-1099 
 
Timpano Sportiello, M., Cammisuli, D., Pinori, F., & Verdiani, C. 
(2010b). Danno dorsolaterale e fattori di rischio nel mild cognitive 
impairment. Paper presented at 55° Congresso Società Italiana di 
Geriatria e Gerontologia (Firenze, Italia). Progr.: 73-73.  
 
Thompson, C., Henri, J.D., Rendell, P.G., Withall, A., and Brodaty, H. 
(2009). Prospective memory functions in mild cognitive impairment and 
early dementia. International Journal of Neuropsychology Society, 16: 
318-325.  
 
Tognoni, G., Ceravolo, R., Nucciarone, B., Bianchi, F., Dell‟Agnello, G., 
Ghicopulos, I., et al. (2005). From mild cognitive impairment to 
dementia: a prevalence study in a district of Tuscany, Italy. Acta 
Neurologica Scandinavica, 112(2): 65-71.    
 
Touchon, J. and Ritchie, K. (1999). Prodromal cognitive disorder in 
Alzheimer‟s disease. International Journal of Geriatric Psychiatry, 14, 
556-563.    
 
Trabucchi, M. (2002). Le Demenze. Milano: UTET. 
 
Traykov, L, Raoux,  N., Latour, F., Gallo, L., Hanon,  O., Baudic, S., et 
al. (2007). Executive functions deficit in Mild Cognitive Impairment. 
Cognitive and Behavioral Neurology, 20(4), 219-24. 
 
Troyer, A.K., and Murphy, K.J. (2007). Memory for intention in amnestic 
mild cognitive impairment: Time and event-based prospective memory. 
Journal of the International Neuropsychological Society, 13, 365-369.  
 
Tschanz, J.T., Welsh-Bohmer, K.A., Lyketsos, C.G., et al. (2006). Cache 
County Investigators. Conversion to dementia from mild cognitive 
disorder: the Cache County Study. Neurology, 67(2), 229-234. 
 
Tuokko, H., Hadjistavropoulos, T., Miller, J.A. and Beattie B.L. (1992). 
The Clock Test: a sensitive measure to differentiate normal elderly from 
those with Alzheimer disease. Journal of the American Geriatric Society, 
40: 579-584. 
 
Tuokko, H.A. and Hultsch, D. (2006). Mild Cognitive Impairment. 
International Perspectives. New York, NY: Taylor and Francis.   
 
Unverzagt, F.W., Gao, S., Baiyewu, O., Ogunniyi, A.O., Gureje, O., 
Perkins, A., et al. (2001). Prevalence of cognitive impairment: data from 
the Indianapolis Study of Health and Aging. Neurology, 57(9), 1655-1662. 
 
Wechsler, D. (1939). The measurement of adult intelligence. Baltimore, 
MD: Williams & Wilkins. 
 
Wechsler, D. (1945). A standardized memory scale for the clinical use. 
Journal of Psychology, 19, 87-95.   
 
Wechsler, D. (1977). Wechsler Adult Intelligence Scale (3rd ed.). San 
Antonio: The Psychological Corporation. 
 
Wechsler, D. (1981). Manual for the Wechsler Adult Intelligence Scale 
Revised. New York, NY: Psychological Corporation. 
 
Wechsler D. (1987). Wechsler Memory Scale-Revised manual. San Antonio, 
TX: Psychological Corporation.  
 
Weintraub, S., Baratz, R., Mesulam, M.M. (1982). Daily living activities 
in the assessment of dementia. In S. Corkin (ed.), Alzheimer’s Disease: A 
Report of Progress (pp. 189-192). New York, NY: Raven Press. 
 
Weintraub, S. (1986). The record of independent living. American Journal 
of Alzheimer’s Disease and Other Dementias, 1, 35-39. 
 
Wells, C.E. (1979). Pseudodementia. American Journal of Psychiatry, 136, 
161-168.   
 
Wilkinson, G.S. (1993). Wide Range Achievement Test (WRAT-3) 
administration manual. Wilmington, DE: Wide Range, Inc. 
 
Wilson, B., Cockburn, J. and Baddeley, A. (1985). The Rivermead 
Behavioural Memory Test. Reading, England: Thames Valley Test Company.  
 
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., 
Wahlund, L.O., Nordberg, A., et al. (2004). Mild Cognitive Impairment-
beyond controversies, towards a consensus: report of the International 
Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 
256, 240-246.   
 
World Health Organization (1978). Mental Disorders: Glossary and Guide to 
their Classification in Accordance with Ninth Revision of the 
International Classification of Disease. Geneva: Authors.   
 
World Health Organization (1990). The ICD-10 Classification of Mental and  
Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. 
Geneva: Authors. 
 
World Health Organization (1993). The ICD-10 Classification of Mental and 
Behavioural Disorders. Diagnostic Criteria for Research. Geneva: Authors.  
 
World Health Organization (2002). The ICD-9-CM International 
Classification of Diseases, Clinical Modification. Geneva: Authors.  
 
World Health Organization (2007). International Statistical 
Classification of Diseases and Related Health Problems 10th Revision 
Version for 2007. Geneva: Authors. 
 
Yousef, G., Ryan, W., Lambert, T. and Kellett, J. (1999). The 
Pseudodementia Scale. European Psychiatry, 13(4): 230.  
 
Zaudig, M. (1992). A New Systematic Method of Measurement and Diagnosis 
of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-
III-R Criteria. International Psychogeriatrics, 4(Suppl. 2), 203-219. 
 
Zhang, Y., Han, B., Verhaeghen, P. and Nilsson, L-G. (2007). Executive 
Functioning in Older Adults with Mild Cognitive Impairment: MCI Has 
Effects on Planning, But Not on Inhibition. Aging, Neuropsychology and 
Cognition, 14, 557-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
Appendix 1. Diagnostic algorithm for Mild Cognitive Impairment diagnosis 
(From: Petersen, 2004) 
 
 
  
 
 
 
 
Appendices 3. Statistical analysis tables 
 
 
 
 
 
Activities of Daily Living Instrumental Activities of Daily Living 
N.  Valid data 104 104 
Missing data 608 608 
Mean .950 .890 
Standard Error of the mean .0141 .0166 
  Standard Deviation .1433 .1697 
Minimum .2 .3 
Maximum  1.0 1.0 
 
 
Autonomy (from MODA) 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 
 
0 6 3,7 4,1 4,1 
1 11 6,8 7,5 11,6 
2 129 79,6 88,4 100,0 
Total 146 90,1 100,0  
Missing data System missing data 16 9,9   
                   Total 162 100,0   
 
 
 
Total Orientation (from MODA) 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 59 36,4 38,6 38,6 
1 38 23,5 24,8 63,4 
2 56 34,6 36,6 100,0 
Total 153 94,4 100,0 
 
Missing data System missing data 9 5,6 
  
                       Total 162 100,0 
  
 
 
 
Temporal Orientation (from MODA) 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 31 4,4 26,1 26,1 
1 17 2,4 14,3 40,3 
2 71 10,0 59,7 100,0 
Total 119 16,7 100,0 
 
Missing data System missing data 592 83,3 
  
                      Total 711 100,0 
  
 
 
 
Temporal Orientation 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 9.369 .2094 
95% confidence interval for the mean Inside Limit 8.942  
Outside Limit 9.796  
Average 5% Trim 9.541  
Median 10.000  
Variance 1,403  
Standard deviation  1.1844  
Minimum 5.0  
Maximum 10.0  
Range 5.0  
Interquartile distance .8  
Asymmetry -2,303 ,414 
Kurtosis 5,451 ,809 
2 Mean 9.464 .1389 
95% confidence interval for the mean Inside Limit 9.187  
Outside Limit 9.741  
Average 5% Trim 9.692  
Median 10.000  
Variance 1,448  
Standard deviation  1.2033  
Minimum 4.7  
Maximum 10.0  
Range 5.3  
Interquartile distance .5  
Asymmetry -3,198 ,277 
Kurtosis 9,942 ,548 
3 Mean 9.800 .1033 
95% confidence interval for the mean Inside Limit 9.535  
Outside Limit 10.065  
Average 5% Trim 9.811  
Median 9.900  
Variance ,064  
Standard deviation  .2530  
Minimum 9.4  
Maximum 10.0  
Range .6  
Interquartile distance .4  
Asymmetry -,889 ,845 
Kurtosis -,781 1,741 
4 Media 9.967 .0333 
95% confidence interval for the mean Inside Limit 9.823  
Outside Limit 10.110  
Average 5% Trim .  
Median 10.000  
Variance ,003  
Standard deviation  .0577  
Minimum 9.9  
Maximum 10.0  
Range .1  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 9.533 .4667 
95% confidence interval for the mean Inside Limit 7.525  
Outside Limit 11.541  
Average 5% Trim .  
Median 10.000  
Variance ,653  
Standard deviation  .8083  
Minimum 8.6  
Maximum 10.0  
Range 1.4  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
 
 
 
 
 
 
 Spatial Orientation 
 Diagnosis* Statistics Standard error 
 1 Mean 3.697 .3906 
95% confidence interval for the mean Inside Limit 2.900  
Outside Limit 4.494  
Average 5% Trim 3.340  
Median 3.000  
Variance 4,882  
Standard deviation  2.2096  
Minimum 3.0  
Maximum 11.3  
Range 8.3  
Interquartile distance .0  
Asymmetry 2,968 ,414 
Kurtosis 7,372 ,809 
2 Mean 2.973 .0187 
95% confidence interval for the mean Inside Limit 2.936  
Outside Limit 3.011  
Average 5% Trim 3.000  
Median 3.000  
Variance ,026  
Standard deviation  .1622  
Minimum 2.0  
Maximum 3.0  
Range 1.0  
Interquartile distance .0  
Asymmetry -5,997 ,277 
Kurtosis 34,889 ,548 
     *Because of the small number of the subjects examined, it was not possible to make comparison with MCI Type III and IV.    
 
 
                                                                             Personal Orientation 
 Diagnosis* Statistics Standard error 
 1 Mean 9.219 .3441 
95% confidence interval for the mean Inside Limit 8.517  
Outside Limit 9.921  
Average 5% Trim 9.521  
Median 10.000  
Variance 3,789  
Standard deviation  1.9466  
Minimum 3.0  
Maximum 10.0  
Range 7.0  
Interquartile distance .0  
Asymmetry -2,596 ,414 
Kurtosis 5,805 ,809 
2 Mean 9.827 .0549 
95% confidence interval for the mean Inside Limit 9.717  
Outside Limit 9.936  
Average 5% Trim 9.893  
Median 10.000  
Variance ,226  
Standard deviation  .4757  
Minimum 7.0  
Maximum 10.0  
Range 3.0  
Interquartile distance .0  
Asymmetry -3,598 ,277 
Kurtosis 16,495 ,548 
4 Mean 9.667 .3333 
95% confidence interval for the mean Inside Limit 8.232  
Outside Limit 11.101  
Average 5% Trim .  
Median 10.000  
Variance ,333  
Standard deviation  .5774  
Minimum 9.0  
Maximum 10.0  
Range 1.0  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
              *Because of the small number of the subjects examined, it was not possible  
                   to make comparison with MCI Type V.  
 
 
 Family Orientation 
 Diagnosis* 
Statistics 
Standard  
error 
 1 Mean 11.055 .4065 
95% confidence interval for the mean Inside Limit 10.225  
Outside Limit 11.885  
Average 5% Trim 11.450  
Median 12.000  
Variance 5,123  
Standard deviation  2.2635  
Minimum 3.0  
Maximum 12.0  
Range 9.0  
Interquartile distance 1.0  
Asymmetry -3,179 ,421 
Kurtosis 9,780 ,821 
2 Mean 11.512 .0879 
95% confidence interval for the mean Inside Limit 11.337  
Outside Limit 11.687  
Average 5% Trim 11.613  
Median 12.000  
Variance ,579  
Standard deviation  .7609  
Minimum 9.0  
Maximum 12.0  
Range 3.0  
Interquartile distance 1.0  
Asymmetry -1,832 ,277 
Kurtosis 3,093 ,548 
3 Mean 11.800 .1633 
95% confidence interval for the mean Inside Limit 11.380  
Outside Limit 12.220  
Average 5% Trim 11.833  
Median 12.000  
Variance ,160  
Standard deviation  .4000  
Minimum 11.0  
Maximum 12.0  
Range 1.0  
Interquartile distance .4  
Asymmetry -2,250 ,845 
Kurtosis 5,125 1,741 
5 Mean 10.900 .6658 
95% confidence interval for the mean Inside Limit 8.035  
Outside Limit 13.765  
Average 5% Trim .  
Median 11.000  
Variance 1,330  
Standard deviation  1.1533  
Minimum 9.7  
Maximum 12.0  
Range 2.3  
Interquartile distance .  
Asymmetry -,387 1,225 
Kurtosis . . 
           *Because of the small number of the subjects examined, it was not possible  
                    to make comparison with MCI Type IV.  
 
 
MODA Total Score 
 
Frequency Percentage 
Valid 
percentage Cumulative percentage 
Valid data 0 7 1,0 4,8 4,8 
1 91 12,8 62,3 67,1 
2 48 6,7 32,9 100,0 
Total 146 20,5 100,0  
Missing data System missing data 566 79,5 
  
                           Total 712 100,0   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
MODA Total Score 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2.939 .2084 
95% confidence interval for the mean Inside Limit 2.515  
Outside Limit 3.364  
Average 5% Trim 2.988  
Median 3.000  
Variance 1,434  
Standard deviation  1.1974  
Minimum 1.0  
Maximum 4.0  
Range 3.0  
Interquartile distance 2.0  
Asymmetry -,807 ,409 
Kurtosis -,902 ,798 
2 Mean 2.485 .1352 
95% confidence interval for the mean Inside Limit 2.216  
Outside Limit 2.753  
Average 5% Trim 2.538  
Median 3.000  
Variance 1,773  
Standard deviation  1.3316  
Minimum .0  
Maximum 4.0  
Range 4.0  
Interquartile distance 3.0  
Asymmetry -,412 ,245 
Kurtosis -1,300 ,485 
3 Mean 3.125 .4795 
95% confidence interval for the mean Inside Limit 1.991  
Outside Limit 4.259  
Average 5% Trim 3.194  
Median 4.000  
Variance 1,839  
Standard deviation  1.3562  
Minimum 1.0  
Maximum 4.0  
Range 3.0  
Interquartile distance 2.5  
Asymmetry -1,210 ,752 
Kurtosis -,470 1,481 
4 Mean 3.333 .3333 
95% confidence interval for the mean Inside Limit 1.899  
Outside Limit 4.768  
Average 5% Trim .  
Median 3.000  
Variance ,333  
Standard deviation  .5774  
Minimum 3.0  
Maximum 4.0  
Range 1.0  
Interquartile distance .  
Asymmetry 1,732 1,225 
Kurtosis . . 
5 Mean 2.800 .7348 
95% confidence interval for the mean Inside Limit .760  
Outside Limit 4.840  
Average 5% Trim 2.889  
Median 3.000  
Variance 2,700  
Standard deviation  1.6432  
Minimum .0  
Maximum 4.0  
Range 4.0  
Interquartile distance 2.5  
Asymmetry -1,736 ,913 
Kurtosis 3,251 2,000 
  
 
 
 
Digit Span 
 
Frequency Percentage 
Valid 
Percentage 
Cumulative 
percentage 
Valid data 0 1 ,1 ,6 ,6 
1 58 8,1 36,3 36,9 
2 101 14,2 63,1 100,0 
Total 160 22,5 100,0  
Missing data System missing data 552 77,5 
  
                      Total 712 100,0 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                        Digit Span 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 3,35 ,148 
95% confidence interval for the mean Inside Limit 3,05  
Corsi Span 
 
Frequency Percentage 
Valid 
Percentage 
Cumulative 
percentage 
Valid data 0 7 1,0 4,4 4,4 
1 103 14,5 64,4 68,8 
2 50 7,0 31,3 100,0 
Total 160 22,5 100,0 
 
Missing 
data 
System missing data 552 77,5 
  
                 Total 712 100,0 
 
 
 
Outside Limit 3,65  
Average 5% Trim 3,44  
Median 4,00  
Variance ,947  
Standard deviation  ,973  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry -1,096 ,361 
Kurtosis -,293 ,709 
2 Mean 3,29 ,104 
95% confidence interval for the mean Inside Limit 3,08  
Outside Limit 3,50  
Average 5% Trim 3,39  
Median 4,00  
Variance 1,077  
Standard deviation  1,038  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -1,164 ,241 
Kurtosis ,155 ,478 
3 Mean 3,13 ,350 
95% confidence interval for the mean Inside Limit 2,30  
Outside Limit 3,95  
Average 5% Trim 3,14  
Median 3,50  
Variance ,982  
Standard deviation  ,991  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 2  
Asymmetry -,312 ,752 
Kurtosis -2,358 1,481 
4 Media 3,67 ,333 
95% confidence interval for the mean Inside Limit 2,23  
Outside Limit 5,10  
Average 5% Trim .  
Median 4,00  
Variance ,333  
Standard deviation  ,577  
Minimum 3  
Maximum 4  
Range 1  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 3,33 ,422 
95% confidence interval for the mean Inside Limit 2,25  
Outside Limit 4,42  
Average 5% Trim 3,37  
Median 4,00  
Variance 1,067  
Standard deviation  1,033  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 2  
Asymmetry -,968 ,845 
Kurtosis -1,875 1,741 
 
 
 
 
 
 
 
 
                                                                                   Corsi Span 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,84 ,152 
95% confidence interval for the mean Inside Limit 2,53  
Outside Limit 3,14  
Average 5% Trim 2,87  
Median 3,00  
Variance ,997  
Standard deviation  ,998  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry -,411 ,361 
Kurtosis -,858 ,709 
2 Mean 2,51 ,131 
95% confidence interval for the mean Inside Limit 2,25  
Outside Limit 2,77  
Average 5% Trim 2,57  
Median 3,00  
Variance 1,727  
Standard deviation  1,314  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry -,390 ,241 
Kurtosis -1,141 ,478 
3 Mean 2,88 ,350 
95% confidence interval for the mean Inside Limit 2,05  
Outside Limit 3,70  
Average 5% Trim 2,86  
Median 2,50  
Variance ,982  
Standard deviation  ,991  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 2  
Asymmetry ,312 ,752 
Kurtosis -2,358 1,481 
4 Mean 3,67 ,333 
95% confidence interval for the mean Inside Limit 2,23  
Outside Limit 5,10  
Average 5% Trim .  
Median 4,00  
Variance ,333  
Standard deviation  ,577  
Minimum 3  
Maximum 4  
Range 1  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 3,00 ,447 
95% confidence interval for the mean Inside Limit 1,85  
Outside Limit 4,15  
Average 5% Trim 3,06  
Median 3,00  
Variance 1,200  
Standard deviation  1,095  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry -1,369 ,845 
Kurtosis 2,500 1,741 
 
 
 
 
 
 
Pairs Associates Learning 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 15 2,1 9,4 9,4 
1 127 17,8 79,4 88,8 
2 18 2,5 11,3 100,0 
Total 160 22,5 100,0  
Missing data System missing data 552 77,5 
  
                       Total 712 100,0 
  
 
Story Recall 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 22 3,1 13,8 13,8 
1 87 12,2 54,4 68,1 
2 51 7,2 31,9 100,0 
Total 160 22,5 100,0  
Missing data System missing data 552 77,5 
  
                     Total 712 100,0 
  
 
 
 
Corsi Suvra-span Learning 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 28 3,9 17,7 17,7 
1 120 16,9 75,9 93,7 
2 10 1,4 6,3 100,0 
Total 158 22,2 100,0  
Missing data System missing data 554 77,8 
  
                     Total 712 100,0 
  
 
 
 
 
 
 
 
 
Pairs Associated Learning 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 1,56 ,171 
95% confidence interval for the mean Inside Limit 1,21  
Outside Limit 1,90  
Average 5% Trim 1,51  
Median 1,00  
Variance 1,252  
Standard deviation  1,119  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 1  
Asymmetry ,542 ,361 
Kurtosis -,223 ,709 
2 Mean 1,95 ,110 
95% confidence interval for the mean Inside Limit 1,73  
Outside Limit 2,17  
Average 5% Trim 1,94  
Mean 2,00  
Variance 1,220  
Standard deviation  1,104  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry ,284 ,241 
Kurtosis -,448 ,478 
3 Mean 2,88 ,295 
95% confidence interval for the mean Inside Limit 2,18  
Outside Limit 3,57  
Average 5% Trim 2,86  
Median 3,00  
Variance ,696  
Standard deviation  ,835  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 2  
Asymmetry ,277 ,752 
Kurtosis -1,392 1,481 
4 Mean 3,00 ,577 
95% confidence interval for the mean Inside Limit ,52  
Outside Limit 5,48  
Average 5% Trim .  
Median 3,00  
Variance 1,000  
Standard deviation  1,000  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance .  
Asymmetry ,000 1,225 
Kurtosis . . 
5 Mean 2,00 ,365 
95% confidence interval for the mean Inside Limit 1,06  
Outside Limit 2,94  
Average 5% Trim 2,00  
Median 2,00  
Variance ,800  
Standard deviation  ,894  
Minimum 1  
Maximum 3  
Range 2  
Interquartile distance 2  
Asymmetry ,000 ,845 
Kurtosis -1,875 1,741 
 
 
 
 
 
Story Recall 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,02 ,227 
95% confidence interval for the mean Inside Limit 1,57  
Outside Limit 2,48  
Average 5% Trim 2,03  
Median 2,00  
Variance 2,214  
Standard deviation  1,488  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,042 ,361 
Kurtosis -1,359 ,709 
2 Mean 2,39 ,143 
95% confidence interval for the mean Inside Limit 2,11  
Outside Limit 2,67  
Average 5% Trim 2,43  
Median 2,00  
Variance 2,038  
Standard deviation  1,428  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry -,209 ,241 
Kurtosis -1,350 ,478 
3 Mean 3,38 ,263 
95% confidence interval for the mean Inside Limit 2,75  
Outside Limit 4,00  
Average 5% Trim 3,42  
Median 3,50  
Variance ,554  
Standard deviation  ,744  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 1  
Asymmetry -,824 ,752 
Kurtosis -,152 1,481 
4 Mean 3,67 ,333 
95% confidence interval for the mean Inside Limit 2,23  
Outside Limit 5,10  
Average 5% Trim .  
Median 4,00  
Variance ,333  
Standard deviation  ,577  
Minimum 3  
Maximum 4  
Range 1  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 2,00 ,516 
95% confidence interval for the mean Inside Limit ,67  
Outside Limit 3,33  
Average 5% Trim 2,06  
Median 2,50  
Variance 1,600  
Standard deviation  1,265  
Minimum 0  
Maximum 3  
Range 3  
Interquartile distance 2  
Asymmetry -,889 ,845 
Kurtosis -,781 1,741 
 
 
Corsi Suvra-span Learning 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 1,28 ,167 
95% confidence interval for the mean Inside Limit ,94  
Outside Limit 1,62  
Average 5% Trim 1,20  
Median 1,00  
Variance 1,206  
Standard deviation  1,098  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 1  
Asymmetry 1,332 ,361 
Kurtosis 1,517 ,709 
2 Mean 1,20 ,100 
95% confidence interval for the mean Inside Limit 1,00  
Outside Limit 1,40  
Average 5% Trim 1,12  
Median 1,00  
Variance 1,000  
Standard deviation  1,000  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 0  
Asymmetry 1,144 ,243 
Kurtosis 1,087 ,481 
3 Mean 2,63 ,375 
95% confidence interval for the mean Inside Limit 1,74  
Outside Limit 3,51  
Average 5% Trim 2,64  
Median 2,50  
Variance 1,125  
Standard deviation  1,061  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry ,045 ,752 
Kurtosis -,940 1,481 
4 Mean 2,67 ,333 
95% confidence interval for the mean Inside Limit 1,23  
Outside Limit 4,10  
Average 5% Trim .  
Median 3,00  
Variance ,333  
Standard deviation  ,577  
Minimum 2  
Maximum 3  
Range 1  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 1,60 ,245 
95% confidence interval for the mean Inside Limit ,92  
Outside Limit 2,28  
Average 5% Trim 1,61  
Median 2,00  
Variance ,300  
Standard deviation  ,548  
Minimum 1  
Maximum 2  
Range 1  
Interquartile distance 1  
Asymmetry -,609 ,913 
Kurtosis -3,333 2,000 
 
 
 
 
  
 
 
 Face Recognition 
 
Frequency Percentage 
Valida 
percentage 
Cumulative 
percentage 
Valid data 0 5 8,5 8,9 8,9 
1 14 23,7 25,0 33,9 
2 37 62,7 66,1 100,0 
Total 56 94,9 100,0  
Missing data System missing data 3 5,1 
  
Total 59 100,0 
  
 
 
 
 
 
 
 
 
 
Picture Recognition 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid 
data 
0 18 30,5 32,1 32,1 
1 12 20,3 21,4 53,6 
2 26 44,1 46,4 100,0 
Total 56 94,9 100,0 
 
Missing 
data 
System missing data 3 5,1 
  
Total 59 100,0 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture Recognition 1 Mean 1,10 ,277 
95% confidence interval for the mean Inside Limit ,47  
Outside Limit 1,73  
Average 5% Trim 1,11  
Median 1,00  
Variance ,767  
 Diagnosis* 
Statistics 
Standard 
error 
Standard deviation  ,876  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 2  
Asymmetry -,223 ,687 
Kurtosis -1,734 1,334 
2 Mean 1,03 ,144 
95% confidence interval for the mean Inside Limit ,74  
Outside Limit 1,32  
Average 5% Trim 1,03  
Median 1,00  
Variance ,783  
Standard deviation  ,885  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 2  
Asymmetry -,053 ,383 
Kurtosis -1,755 ,750 
3 Mean 1,50 ,500 
95% confidence interval for the mean Inside Limit -,09  
Outside Limit 3,09  
Average 5% Trim 1,56  
Median 2,00  
Variance 1,000  
Standard deviation  1,000  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 2  
Asymmetry -2,000 1,014 
Kurtosis 4,000 2,619 
Face Recognition 1 Mean 1,60 ,267 
95% confidence interval for the mean Inside Limit 1,00  
Outside Limit 2,20  
Average 5% Trim 1,67  
Median 2,00  
Variance ,711  
Standard deviation  ,843  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry -1,779 ,687 
Kurtosis 1,406 1,334 
2 Mean 1,55 ,098 
95% confidence interval for the mean Inside Limit 1,35  
Outside Limit 1,75  
Average 5% Trim 1,61  
Median 2,00  
Variance ,362  
Standard deviation  ,602  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry -,998 ,383 
Kurtosis ,077 ,750 
3 Mean 1,25 ,479 
95% confidence interval for the mean Inside Limit -,27  
Outside Limit 2,77  
Average 5% Trim 1,28  
Median 1,50  
Variance ,917  
Standard deviation  ,957  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 2  
Asymmetry -,855 1,014 
Kurtosis -1,289 2,619 
                          *Because of the small number of the subjects examined, it was not possible  
                           to make comparison with MCI Type IV and V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appointment 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid data 0 33 55,9 58,9 58,9 
1 11 18,6 19,6 78,6 
2 12 20,3 21,4 100,0 
Total 56 94,9 100,0  
Missing 
data 
System missing data 3 5,1 
  
                   Total 59 100,0   
 
 
 
 
 
 
 
 
 
 
 
 
 
    Hidden personal belonging 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 24 40,7 42,9 42,9 
1 23 39,0 41,1 83,9 
2 9 15,3 16,1 100,0 
Total 56 94,9 100,0 
 
Missing 
data 
System missing data 3 5,1 
  
                   Total 59 100,0   
 
 
 
 
 
 
 
 
 
 
 
 Diagnosis* Statistics Standard error 
Appointment 1 Mean ,50 ,224 
95% confidence interval for the mean Inside Limit -,01  
Outside Limit 1,01  
Average 5% Trim ,44  
Median ,00  
Variance ,500  
Standard deviation  ,707  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry 1,179 ,687 
Kurtosis ,571 1,334 
2 Mean ,55 ,129 
95% confidence interval for the mean Inside Limit ,29  
Outside Limit ,81  
Average 5% Trim ,50  
Median ,00  
Variance ,632  
Standard deviation  ,795  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry 1,010 ,383 
Kurtosis -,617 ,750 
3 Mean 1,50 ,500 
95% confidence interval for the mean Inside Limit -,09  
Outside Limit 3,09  
Average 5% Trim 1,56  
Median 2,00  
Variance 1,000  
Standard deviation  1,000  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 2  
Asymmetry -2,000 1,014 
Kurtosis 4,000 2,619 
Hidden  
personal 
belonging 
1 Mean ,50 ,224 
95% confidence interval for the mean Inside Limit -,01  
Outside Limit 1,01  
Average 5% Trim ,44  
Median ,00  
Variance ,500  
Standard deviation  ,707  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry 1,179 ,687 
Kurtosis ,571 1,334 
2 Mean ,74 ,129 
95% confidence interval for the mean Inside Limit ,48  
Outside Limit 1,00  
Average 5% Trim ,71  
Median 1,00  
Variance ,632  
Standard deviation  ,795  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry ,520 ,383 
Kurtosis -1,209 ,750 
                          *Because of the small number of the subjects examined, it was not possible to make  
                          comparison with MCI Type IV and V for Appointment subtest, and with III, IV and V 
                          for Hidden personal belonging subtest. 
 
 
   
 
 
 
Rivermead Standardized Profile Score 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 28 3,9 41,2 41,2 
1 33 4,6 48,5 89,7 
2 7 1,0 10,3 100,0 
Total 68 9,6 100,0  
Missing data System missing data 644 90,4 
  
Total 712 100,0 
  
 
Rivermead Standardized Profile Score 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 1,50 ,403 
95% confidence interval for the mean Inside Limit ,63  
Outside Limit 2,37  
Average 5% Trim 1,44  
Median 1,00  
Variance 2,269  
Standard deviation  1,506  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry ,551 ,597 
Kurtosis -1,135 1,154 
2 Mean 1,06 ,181 
95% confidence interval for the mean Inside Limit ,70  
Outside Limit 1,43  
Average 5% Trim ,96  
Median 1,00  
Variance 1,539  
Standard deviation  1,241  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry ,944 ,347 
Kurtosis -,060 ,681 
3 Mean 2,60 ,748 
95% confidence interval for the mean Inside Limit ,52  
Outside Limit 4,68  
Average 5% Trim 2,67  
Median 3,00  
Variance 2,800  
Standard deviation  1,673  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry -1,089 ,913 
Kurtosis ,536 2,000 
                      *Because of the small number of the subjects examined, it was not possible to make comparison  
                      with MCI Type IV and V. 
Rivermead Standardized Score 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data                    0 28 3,9 34,1 34,1 
                   1 29 4,1 35,4 69,5 
                   2 23 3,2 28,0 97,6 
                   3 2 ,3 2,4 100,0 
                Total 82 11,5 100,0  
Missing 
data 
    System missing data 630 88,5 
  
                                Total 712 100,0 
  
   
 
Street’s Completion Test 
 Frequency Percentage Valid percentage Cumulative percentage 
Valid data 0 6 ,8 3,9 3,9 
1 108 15,2 70,1 74,0 
2 40 5,6 26,0 100,0 
Total 154 21,6 100,0  
Missing data System missing data 558 78,4   
                                  Total 712 100,0   
 
Street’s Completion Test 
 Diagnosis Statistics Standard error 
 1 Mean 2,85 ,150 
95% confidence interval for the mean Inside Limit 2,55  
Outside Limit 3,15  
Average 5% Trim 2,89  
Median 3,00  
Variance ,900  
Standard deviation  ,949  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry -,255 ,374 
Kurtosis -,941 ,733 
2 Mean 2,51 ,122 
95% confidence interval for the mean Inside Limit 2,27  
Outside Limit 2,75  
Average 5% Trim 2,56  
Median 3,00  
Variance 1,392  
Standard deviation  1,180  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,287 ,249 
Kurtosis -,919 ,493 
3 Mean 2,33 ,408 
95% confidence interval for the mean Inside Limit 1,39  
Outside Limit 3,27  
Average 5% Trim 2,37  
Median 3,00  
Variance 1,500  
Standard deviation  1,225  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,816 ,717 
Kurtosis ,349 1,400 
4 Mean 3,33 ,333 
95% confidence interval for the mean Inside Limit 1,90  
Outside Limit 4,77  
Average 5% Trim .  
Median 3,00  
Variance ,333  
Standard deviation  ,577  
Minimum 3  
Maximum 4  
Range 1  
Interquartile distance .  
Asymmetry 1,732 1,225 
Kurtosis . . 
5 Mean 2,17 ,654 
95% confidence interval for the mean Inside Limit ,49  
Outside Limit 3,85  
Average 5% Trim 2,19  
Median 2,00  
Variance 2,567  
Standard deviation  1,602  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry ,041 ,845 
Kurtosis -1,311 1,741 
 
 
Constructive Apraxia Test 
 Frequency Percentage Valid percentage Cumulative percentage 
Valid data 0 3 ,4 1,9 1,9 
1 70 9,8 44,6 46,5 
2 84 11,8 53,5 100,0 
Total 157 22,1 100,0  
Missing data System missing data 555 77,9   
                                  Total 712 100,0   
 
Constructive Apraxia Test 
 
                             Diagnosis Statistica Errore std. 
0
a
p
r
a
x
i
a 
1 Mean 3,48 ,124 
95% confidence interval for the mean Inside limit 3,22  
Outside limit 3,73  
Average 5% trim 3,53  
Median 4,00  
Variance ,615  
Standard deviation ,784  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 1  
Asymmetry -1,089 ,374 
Kurtosis -,439 ,733 
2 Mean 2,93 ,118 
95% confidence interval for the mean Inside limit 2,69  
Outside limit 3,16  
Average 5% trim 3,01  
Median 3,00  
Variance 1,359  
Standard deviation 1,166  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,743 ,245 
Kurtosis -,510 ,485 
3 Mean 3,56 ,242 
95% confidence interval for the mean Inside limit 3,00  
Outside limit 4,11  
Average 5% trim 3,62  
Median 4,00  
Variance ,528  
Standard deviation ,726  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 1  
Asymmetry -1,501 ,717 
Kurtosis 1,467 1,400 
4 Mean 3,00 1,000 
95% confidence interval for the mean Inside limit -1,30  
Outside limit 7,30  
Average 5% trim .  
Median 4,00  
Variance 3,000  
Standard deviation 1,732  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 3,50 ,342 
95% confidence interval for the mean Inside limit 2,62  
Outside limit 4,38  
Average 5% trim 3,56  
Median 4,00  
Variance ,700  
Standard deviation ,837  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 1  
Asymmetry -1,537 ,845 
Kurtosis 1,429 1,741 
 
Boston Naming Test 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 32 4,5 25,8 25,8 
1 45 6,3 36,3 62,1 
2 47 6,6 37,9 100,0 
Total 124 17,4 100,0 
 
Missing data System missing data 588 82,6   
                     Total 712 100,0   
 
Boston Naming Test 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 40.875 1.4147 
95% confidence interval for the mean Inside Limit 37.990  
Outside Limit 43.760  
Average 5% Trim 40.931  
Median 41.000  
Variance 64,048  
Standard deviation  8.0030  
Minimum 27.0  
Maximum 53.0  
Range 26.0  
Interquartile distance 13.8  
Asymmetry -,051 ,414 
Kurtosis -1,120 ,809 
2 Mean 33.697 1.1761 
95% confidence interval for the mean Inside Limit 31.354  
Outside Limit 36.040  
Average 5% Trim 33.751  
Median 33.000  
Variance 105,121  
Standard deviation  10.2528  
Minimum 10.0  
Maximum 54.0  
Range 44.0  
Interquartile distance 13.0  
Asymmetry ,085 ,276 
Kurtosis -,562 ,545 
3 Media 38.063 6.3008 
95% confidence interval for the mean Inside Limit 23.163  
Outside Limit 52.962  
Average 5% Trim 38.986  
Median 38.500  
Variance 317,603  
Standard deviation  17.8214  
Minimum 1.5  
Maximum 58.0  
Range 56.5  
Interquartile distance 22.5  
Asymmetry -1,211 ,752 
Kurtosis 2,023 1,481 
4 Mean 40.000 9.0000 
95% confidence interval for the mean Inside Limit -74.356  
Outside Limit 154.356  
Average 5% Trim .  
Median 40.000  
Variance 162,000  
Standard deviation  12.7279  
Minimum 31.0  
Maximum 49.0  
Range 18.0  
Interquartile distance .  
Asymmetry . . 
Kurtosis . . 
5 Mean 29.667 3.4992 
95% confidence interval for the mean Inside Limit 20.672  
Outside Limit 38.662  
Average 5% Trim 29.463  
Median 28.500  
Variance 73,467  
Standard deviation  8.5713  
Minimum 19.0  
Maximum 44.0  
Range 25.0  
Interquartile distance 12.3  
Asymmetry ,772 ,845 
Kurtosis 1,004 1,741 
 
 
 
 
Frontal Assessment Battery 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 85 11,9 59,9 59,9 
1 47 6,6 33,1 93,0 
2 10 1,4 7,0 100,0 
Total 142 19,9 100,0  
Missing data System missing data 570 80,1 
  
                     Total 712          100,0 
  
 
FAB 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 1,58 ,218 
95% confidence interval for the mean Inside Limit 1,13  
Outside Limit 2,02  
Average 5% Trim 1,53  
Median 1,00  
Variance 1,564  
Standard deviation  1,251  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry ,480 ,409 
Kurtosis -,703 ,798 
2 Mean ,61 ,126 
95% confidence interval for the mean Inside Limit ,36  
Outside Limit ,86  
Average 5% Trim ,46  
Median ,00  
Variance 1,431  
Standard deviation  1,196  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 1  
Asymmetry 1,845 ,254 
Kurtosis 2,077 ,503 
3 Mean ,56 ,242 
95% confidence interval for the mean Inside Limit ,00  
Outside Limit 1,11  
Average 5% Trim ,51  
Median ,00  
Variance ,528  
Standard deviation  ,726  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry 1,014 ,717 
Kurtosis ,185 1,400 
4 Mean 1,67 1,202 
95% confidence interval for the mean Inside Limit -3,50  
Outside Limit 6,84  
Average 5% Trim .  
Median 1,00  
Variance 4,333  
Standard deviation  2,082  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance .  
Asymmetry 1,293 1,225 
Kurtosis . . 
5 Mean ,40 ,400 
95% confidence interval for the mean Inside Limit -,71  
Outside Limit 1,51  
Average 5% Trim ,33  
Median ,00  
Variance ,800  
Standard deviation  ,894  
Minimum 0  
Maximum 2  
Range 2  
Interquartile distance 1  
Asymmetry 2,236 ,913 
Kurtosis 5,000 2,000 
  
 
 
 
 
                                                                       Move Score 
 
Frequency Percentage Valid percentage 
 
Cumulative 
percentage 
 
Valid data 0 5 ,7 27,8 27,8 
1 3 ,4 16,7 44,4 
2 10 1,4 55,6 100,0 
Total 18 2,5 100,0  
Missing 
data 
System missing data 694 97,5 
  
                 Total 712 100,0 
  
 
 
 
 
Initiation Time 
 
 
Frequency Percentage 
Valid 
percentage 
Cumulative 
percentage 
Valid 
data 
0 9 1,3 50,0 50,0 
1 5 ,7 27,8 77,8 
2 4 ,6 22,2 100,0 
Total 18 2,5 100,0  
Missin
g data 
Missing data system 694 97,5 
  
                   Total 712 100,0 
  
 
 
Execution Time 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid 
data 
0 13 1,8 72,2 72,2 
1 3 ,4 16,7 88,9 
2 2 ,3 11,1 100,0 
Total 18 2,5 100,0  
Missi
ng 
data 
System missing data 694 97,5 
  
Total 712 100,0 
  
 
Total Time 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 13 1,8 76,5 76,5 
1 3 ,4 17,6 94,1 
2 1 ,1 5,9 100,0 
Total 17 2,4 100,0  
Missing 
data 
System missing data 695 97,6 
  
 
Total 
712 100,0 
  
 
 
Violation  
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 3 ,4 100,0 100,0 
Missing 
data 
System missing data 709 99,6 
  
Total 712 100,0   
 
 
 
 
 
 
 
 
 
 
Move Score 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 18,00 11,106 
95% confidence interval for the mean Inside Limit -17,34  
Outside Limit 53,34  
Average 5% Trim 17,11  
Median 10,00  
Variance 493,333  
Standard deviation  22,211  
Minimum 2  
Maximum 50  
Range 48  
Interquartile distance 39  
Asymmetry 1,577 1,014 
Kurtosis 2,285 2,619 
2 Mean 37,00 9,998 
95% confidence interval for the mean Inside Limit 15,00  
Outside Limit 59,00  
Average 5% Trim 36,00  
Median 21,00  
Variance 1199,455  
Standard deviation  34,633  
Minimum 1  
Maximum 91  
Range 90  
Interquartile distance 68  
Asymmetry ,644 ,637 
Kurtosis -1,291 1,232 
 
Initiation Time 
 Diagnos 
Statistics 
Standard 
error 
 1 Mean 75,50 9,133 
95% confidence interval for the mean Inside Limit 46,43  
Outside Limit 104,57  
Average 5% Trim 75,61  
Median 76,50  
Variance 333,667  
Standard deviation  18,267  
Minimum 56  
Maximum 93  
Range 37  
Interquartile distance 34  
Asymmetry -,122 1,014 
Kurtosis -4,845 2,619 
2 Mean 86,17 18,270 
95% confidence interval for the mean Inside Limit 45,95  
Outside Limit 126,38  
Average 5% Trim 81,69  
Median 62,50  
Variance 4005,606  
Standard deviation  63,290  
Minimum 25  
Maximum 228  
Range 203  
Interquartile distance 73  
Asymmetry 1,284 ,637 
Kurtosis 1,032 1,232 
 
 
Execution Time 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 258,25 95,407 
95% confidence interval for the mean Inside Limit -45,38  
Outside Limit 561,88  
Average 5% Trim 250,94  
Median 192,50  
Variance 36410,250  
Standard deviation  190,815  
Minimum 111  
Maximum 537  
Range 426  
Interquartile distance 332  
Asymmetry 1,695 1,014 
Kurtosis 3,037 2,619 
2 Mean 341,55 63,920 
95% confidence interval for the mean Inside Limit 199,12  
Outside Limit 483,97  
Average 5% Trim 335,72  
Median 302,00  
Variance 44944,073  
Standard deviation  212,000  
Minimum 75  
Maximum 713  
Range 638  
Interquartile distance 377  
Asymmetry ,810 ,661 
Kurtosis -,585 1,279 
 
 
Total Time 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 333,75 100,200 
95% confidence interval for the mean Inside Limit 14,87  
Outside Limit 652,63  
Average 5% Trim 324,72  
Median 252,50  
Variance 40160,250  
Standard deviation  200,400  
Minimum 200  
Maximum 630  
Range 430  
Interquartile distance 337  
Asymmetry 1,834 1,014 
Kurtosis 3,396 2,619 
2 Mean 427,73 71,823 
95% confidence interval for the mean Inside Limit 267,70  
Outside Limit 587,76  
Average 5% Trim 425,81  
Median 373,00  
Variance 56743,818  
Standard deviation  238,210  
Minimum 71  
Maximum 819  
Range 748  
Interquartile distance 353  
Asymmetry ,478 ,661 
Kurtosis -,787 1,279 
 
Violation 
 Diagnosis 
Statistics 
Standard 
error 
 2 Media 8,67 1,667 
95% confidence interval for the mean Inside Limit 1,50  
Outside Limit 15,84  
Average 5% Trim .  
Median 7,00  
Variance 8,333  
Standard deviation  2,887  
Minimum 7  
Maximum 12  
Range 5  
Interquartile distance .  
Asymmetry 1,732 1,225 
Kurtosis . . 
                      *Because of the small number of the subjects examined, it was not possible to make  
                      comparison with MCI Type III and IV at Move Score, Initiation Time, Execution Time, Total  
                      Time and Violation, and with MCI Tipe I at Violation.        
Stroop Interference/Time 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 23 3,2 30,7 30,7 
1 21 2,9 28,0 58,7 
2 31 4,4 41,3 100,0 
Total 75 10,5 100,0  
Missing data System missing data 637 89,5 
  
                       Total 712 100,0 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroop Interference/Error 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 32 4,5 43,2 43,2 
1 27 3,8 36,5 79,7 
2 15 2,1 20,3 100,0 
Total 74 10,4 100,0 
 
Missing data System missing data 638 89,6 
  
                       Total 712 100,0 
  
 
 
Stroop Interference/Time 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,86 ,376 
95% confidence interval for the mean Inside Limit 2,05  
Outside Limit 3,67  
Average 5% Trim 2,95  
Median 3,50  
Variance 1,978  
Standard deviation  1,406  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,869 ,597 
Kurtosis -,605 1,154 
2 Mean 1,80 ,249 
95% confidence interval for the mean Inside Limit 1,30  
Outside Limit 2,30  
Average 5% Trim 1,78  
Median 2,00  
Variance 3,161  
Standard deviation  1,778  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 4  
Asymmetry ,175 ,333 
Kurtosis -1,797 ,656 
3 Mean 3,71 ,286 
95% confidence interval for the mean Inside Limit 3,02  
Outside Limit 4,41  
Average 5% Trim 3,79  
Median 4,00  
Variance ,571  
Standard deviation  ,756  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 0  
Asymmetry -2,646 ,794 
Kurtosis 7,000 1,587 
5 Mean 3,50 ,500 
95% confidence interval for the mean Inside Limit -2,85  
Outside Limit 9,85  
Average 5% Trim .  
Median 3,50  
Variance ,500  
Standard deviation  ,707  
Minimum 3  
Maximum 4  
Range 1  
Interquartile distance .  
Asymmetry . . 
Kurtosis . . 
 
                     *Because of the small number of the subjects examined, it was not possible to make comparison  
                     with MCI Type IV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroop Interference/Error 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,43 ,429 
95% confidence interval for the mean Inside Limit 1,50  
Outside Limit 3,35  
Average 5% Trim 2,48  
Median 2,50  
Variance 2,571  
Standard deviation  1,604  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry -,306 ,597 
Kurtosis -1,642 1,154 
2 Mean 1,26 ,217 
95% confidence interval for the mean Inside Limit ,82  
Outside Limit 1,70  
Average 5% Trim 1,18  
Median ,00  
Variance 2,360  
Standard deviation  1,536  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry ,668 ,337 
Kurtosis -1,198 ,662 
3 Media 2,43 ,649 
95% confidence interval for the mean Inside Limit ,84  
Outside Limit 4,02  
Average 5% Trim 2,48  
Median 3,00  
Variance 2,952  
Standard deviation  1,718  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry -,383 ,794 
Kurtosis -2,107 1,587 
 
                      *Because of the small number of the subjects examined, it was not possible to make comparison  
                      with MCI Type IV and V.   
 
 
 
Visual Search Test 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 
 
 
0 12 1,7 7,6 7,6 
1 104 14,6 66,2 73,9 
2 41 5,8 26,1 100,0 
Total 157 22,1 100,0  
 
Missing data 
 
System missing data 
555 77,9 
  
                     Total 712 100,0   
 
Visual Search Test 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,69 ,165 
95% confidence interval for the mean Inside Limit 2,36  
Outside Limit 3,02  
Average 5% Trim 2,71  
Median 2,00  
Variance 1,146  
Standard deviation  1,070  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 2  
Asymmetry ,039 ,365 
Kurtosis -1,385 ,717 
2 Mean 2,23 ,133 
95% confidence interval for the mean Inside Limit 1,97  
Outside Limit 2,49  
Average 5% Trim 2,25  
Median 2,00  
Variance 1,694  
Standard deviation  1,302  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,058 ,246 
Kurtosis -1,153 ,488 
3 Mean 2,50 ,463 
95% confidence interval for the mean Inside Limit 1,41  
Outside Limit 3,59  
Average 5% Trim 2,56  
Median 2,50  
Variance 1,714  
Standard deviation  1,309  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 2  
Asymmetry -,764 ,752 
Kurtosis ,875 1,481 
4 Mean 1,67 1,202 
95% confidence interval for the mean Inside Limit -3,50  
Outside Limit 6,84  
Average 5% Trim .  
Median 1,00  
Variance 4,333  
Standard deviation  2,082  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance .  
Asymmetry 1,293 1,225 
Kurtosis . . 
5 Mean 2,17 ,654 
95% confidence interval for the mean Inside Limit ,49  
Outside Limit 3,85  
Average 5% Trim 2,19  
Median 2,00  
Variance 2,567  
Standard deviation  1,602  
Minimum 0  
Maximum 4  
Range 4  
Interquartile distance 3  
Asymmetry ,041 ,845 
Kurtosis -1,311 1,741 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brixton 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data                 0 27 3,8 33,8 33,8 
                1 4 ,6 5,0 38,8 
                2 49 6,9 61,3 100,0 
             Total 80 11,2 100,0 
 
Missing data System missing data 632 88,8 
  
                                     Total 712 100,0 
  
 
Brixton 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 19,87 1,312 
95% confidence interval for the mean Inside Limit 17,05  
Outside Limit 22,68  
Average 5% Trim 19,46  
Median 18,00  
Variance 25,838  
Standard deviation  5,083  
Minimum 15  
Maximum 32  
Range 17  
Interquartile distance 7  
Asymmetry 1,080 ,580 
Kurtosis ,696 1,121 
2 Mean 27,58 ,845 
95% confidence interval for the mean Inside Limit 25,88  
Outside Limit 29,27  
Average 5% Trim 27,53  
Median 28,00  
Variance 37,112  
Standard deviation  6,092  
Minimum 16  
Maximum 40  
Range 24  
Interquartile distance 9  
Asymmetry ,056 ,330 
Kurtosis -,660 ,650 
3 Mean 24,57 4,353 
95% confidence interval for the mean Inside Limit 13,92  
Outside Limit 35,22  
Average 5% Trim 24,19  
Median 17,00  
Variance 132,619  
Standard deviation  11,516  
Minimum 14  
Maximum 42  
Range 28  
Interquartile distance 22  
Asymmetry ,776 ,794 
Kurtosis -1,436 1,587 
5 Mean 30,00 1,000 
95% confidence interval for the mean Inside Limit 17,29  
Outside Limit 42,71  
Average 5% Trim .  
Median 30,00  
Variance 2,000  
Standard deviation  1,414  
Minimum 29  
Maximum 31  
Range 2  
Interquartile distance .  
Asymmetry . . 
Kurtosis . . 
                            *Because of the small number of the subjects examined, it was not possible to  
                             make comparison with MCI Type IV. 
 
Verbal  Fluency 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
   Valid data                1 115 16,2 78,8 78,8 
               2 31 4,4 21,2 100,0 
           Total 146 20,5 100,0  
Missing data System missing data 566 79,5 
  
                                  Total 712 100,0 
  
 
Verbal Fluency Test 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,78 ,139 
95% confidence interval for the mean Inside Limit 2,50  
Outside Limit 3,06  
Average 5% Trim 2,81  
Median 3,00  
Variance ,692  
Standard deviation  ,832  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 1  
Asymmetry -,182 ,393 
Kurtosis -,467 ,768 
2 Mean 2,44 ,106 
95% confidence interval for the mean Inside Limit 2,23  
Outside Limit 2,65  
Average 5% Trim 2,43  
Median 2,00  
Variance 1,027  
Standard deviation  1,013  
Minimum 1  
Maximum 4  
Range 3  
Interquartile distance 1  
Asymmetry ,266 ,253 
Kurtosis -1,024 ,500 
3 Mean 3,00 ,327 
95% confidence interval for the mean Inside Limit 2,23  
Outside Limit 3,77  
Average 5% Trim 3,00  
Median 3,00  
Variance ,857  
Standard deviation  ,926  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance 2  
Asymmetry ,000 ,752 
Kurtosis -2,100 1,481 
4 Media 3,33 ,667 
95% confidence interval for the mean Inside Limit ,46  
Outside Limit 6,20  
Average 5% Trim .  
Median 4,00  
Variance 1,333  
Standard deviation  1,155  
Minimum 2  
Maximum 4  
Range 2  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 2,33 ,211 
95% confidence interval for the mean Inside Limit 1,79  
Outside Limit 2,88  
Average 5% Trim 2,31  
Median 2,00  
Variance ,267  
Standard deviation  ,516  
Minimum 2  
Maximum 3  
Range 1  
Interquartile distance 1  
 
 
Go-No-Go FAB subtest 
 Diagnosis 
Statistics 
Standard 
error 
 1 Mean 2,59 ,173 
95% confidence interval for the mean Inside Limit 2,22  
Outside Limit 2,95  
Average 5% Trim 2,65  
Median 3,00  
Variance ,507  
Standard deviation  ,712  
Minimum 1  
Maximum 3  
Range 2  
Interquartile distance 1  
Asymmetry -1,526 ,550 
Kurtosis 1,094 1,063 
2 Mean 1,86 ,156 
95% confidence interval for the mean Inside Limit 1,54  
Outside Limit 2,17  
Average 5% Trim 1,90  
 
 
 
 
Go-No-GO FAB subtest 
 
Frequency Percentage Valid percentage 
Cumulative 
percentage 
Valid data 0 13 1,8 14,8 14,8 
1 33 4,6 37,5 52,3 
2 42 5,9 47,7 100,0 
Total 88 12,4 100,0  
Missing data System missing data 624 87,6 
  
                     Total 71 100,0   
Median 2,00  
Variance 1,361  
Standard deviation  1,167  
Minimum 0  
Maximum 3  
Range 3  
Interquartile distance 2  
Asymmetry -,425 ,319 
Kurtosis -1,350 ,628 
3 Mean 1,88 ,441 
95% confidence interval for the mean Inside Limit ,83  
Outside Limit 2,92  
Average 5% Trim 1,92  
Median 2,00  
Variance 1,554  
Standard deviation  1,246  
Minimum 0  
Maximum 3  
Range 3  
Interquartile distance 3  
Asymmetry -,876 ,752 
Kurtosis -,706 1,481 
4 Mean 2,00 1,000 
95% confidence interval for the mean Inside Limit -2,30  
Outside Limit 6,30  
Average 5% Trim .  
Median 3,00  
Variance 3,000  
Standard deviation  1,732  
Minimum 0  
Maximum 3  
Range 3  
Interquartile distance .  
Asymmetry -1,732 1,225 
Kurtosis . . 
5 Mean 2,00 1,000 
95% confidence interval for the mean Inside Limit -10,71  
Outside Limit 14,71  
Average 5% Trim .  
Median 2,00  
Variance 2,000  
Standard deviation  1,414  
Minimum 1  
Maximum 3  
Range 2  
Interquartile distance .  
Asymmetry . . 
Kurtosis . . 
 
 
 
Group Statistics 
Diagnosis 
Mean Standard Deviation 
1 Story Recall 1,00 ,784 
Pairs Associates Learning ,79 ,579 
Corsi Suvra-span Learning 1,07 ,475 
Stroop Interference/Time 1,43 ,646 
Stroop Interference/Error 1,29 ,726 
Visual Search Test 1,14 ,535 
2  Story Recall  1,19 ,673 
Pairs Associates Learning 1,08 ,498 
Corsi Suvra-span Learning ,90 ,425 
Stroop Interference/Time ,85 ,850 
Stroop Interference/Error ,58 ,710 
Visual Search Test 1,23 ,515 
Total Story Recall 1,15 ,698 
Pairs Associates Learning 1,02 ,528 
Corsi Suvra-span Learning ,94 ,439 
Stroop Interference/Time ,98 ,839 
Stroop Interference/Error ,74 ,767 
Visual Search Test 1,21 ,517 
 
 
 
 
 
 
Test of Equality of Group Means 
Functions Test  Wilks’ Lambda Chi-square df Sig. 
 1 ,741 17,075 6 ,009 
 
  
 
 
Standardized Canonical  
Discriminant Function Coefficients 
 
Function 
1 
Story Recall -,115 
Pairs Associates Learning -,309 
Corsi Learning Suvra-span ,347 
Stroop Interference/Time ,382 
Stroop Interference/Error ,807 
Visual Search Test ,136 
 
 
 
 
Structure Matrix 
 
Function 
1 
Stroop Interference/Error ,708 
Stroop Interference/Time ,510 
Pairs Associates Learning -,414 
Corsi Learning Suvra-span ,290 
Memory of Prose -,193 
Visual Search Test -,119 
 
 
 
 
 
 
 
Classification Results 
  Diagnosis Predicted Group Membership 
Total   1 2 
Original Count 1 11 3 14 
2 7 41 48 
Ungrouped cases 5 4 9 
% 1 78,6 21,4 100,0 
2 14,6 85,4 100,0 
Ungrouped cases 55,6 44,4 100,0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
